<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003877.pub3" GROUP_ID="ORAL" ID="604300112216544446" MERGED_FROM="" MODIFIED="2012-02-11 14:47:50 +0100" MODIFIED_BY="Philip Riley" REVIEW_NO="0048" REVMAN_SUB_VERSION="5.1.6" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2012-02-10 17:27:51 +0000" MODIFIED_BY="Philip Riley">
<TITLE MODIFIED="2010-02-05 12:58:18 +0000" MODIFIED_BY="[Empty name]">Sedation of children undergoing dental treatment</TITLE>
<CONTACT>
<PERSON ID="15472" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Paul</FIRST_NAME>
<MIDDLE_INITIALS>F</MIDDLE_INITIALS>
<LAST_NAME>Ashley</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer</POSITION>
<EMAIL_1>p.ashley@eastman.ucl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Unit of Paediatric Dentistry</DEPARTMENT>
<ORGANISATION>UCL Eastman Dental Institute</ORGANISATION>
<ADDRESS_1>256 Grays Inn Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>WC1X 8LD</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 7915 1022</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2012-02-10 10:21:10 +0000" MODIFIED_BY="Philip Riley">
<PERSON ID="15531" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Liege</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lourenço-Matharu</LAST_NAME>
<SUFFIX/>
<POSITION>Lead Clinician in Dental Paediatric Sedation</POSITION>
<EMAIL_1>liege.matharu@kcl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Unit of Paediatric Dentistry</DEPARTMENT>
<ORGANISATION>King's College London, Dental Institute</ORGANISATION>
<ADDRESS_1>Bessemer Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>SE5 9RS</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="15472" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Paul</FIRST_NAME>
<MIDDLE_INITIALS>F</MIDDLE_INITIALS>
<LAST_NAME>Ashley</LAST_NAME>
<SUFFIX/>
<POSITION>Senior Lecturer</POSITION>
<EMAIL_1>p.ashley@eastman.ucl.ac.uk</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Unit of Paediatric Dentistry</DEPARTMENT>
<ORGANISATION>UCL Eastman Dental Institute</ORGANISATION>
<ADDRESS_1>256 Grays Inn Road</ADDRESS_1>
<ADDRESS_2/>
<CITY>London</CITY>
<ZIP>WC1X 8LD</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 20 7915 1022</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="50BB1C5582E26AA20094E4F45CBA083C" ROLE="AUTHOR">
<PREFIX>Mrs</PREFIX>
<FIRST_NAME>Susan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Furness</LAST_NAME>
<SUFFIX/>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>Susan.Furness@manchester.ac.uk</EMAIL_1>
<EMAIL_2>suefurness@gmail.com</EMAIL_2>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Cochrane Oral Health Group</DEPARTMENT>
<ORGANISATION>School of Dentistry, The University of Manchester</ORGANISATION>
<ADDRESS_1>Coupland III Building, Oxford Rd</ADDRESS_1>
<ADDRESS_2/>
<CITY>Manchester</CITY>
<ZIP>M13 9PL</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 161 275 6877</PHONE_1>
<PHONE_2/>
<FAX_1>+44 161 275 7815</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2012-01-20 10:25:11 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="13" MONTH="1" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="4" MONTH="8" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="10" MONTH="12" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2012-02-09 13:46:17 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-02-08 11:25:16 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>Searches updated to August 2011.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2012-02-09 13:46:17 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="13" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>Major revision to tables and text including addition of meta-analysis of oral midazolam and use of forest plots as another way of displaying data.</P>
<P>Susan Furness now added as author.</P>
<P>All crossover studies removed from the review and 11 new studies added.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-09-22 14:00:45 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-09-22 14:00:45 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="12" YEAR="2010"/>
<DESCRIPTION>
<P>Response to referee comments</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-09-22 14:00:38 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="2" YEAR="2010"/>
<DESCRIPTION>
<P>Updated for 2010</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-09-22 14:00:33 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="7" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2008-07-28 11:25:58 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="11" YEAR="2005"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-02-10 17:27:51 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Eastman Dental Institute</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2012-02-10 17:27:51 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-02-10 17:26:50 +0000" MODIFIED_BY="[Empty name]">
<NAME>British Orthodontic Society (BOS)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The BOS have provided funding for the Cochrane Oral Health Group Global Alliance (see <A HREF="http://www.ohg.cochrane.org">www.ohg.cochrane.org</A>)</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2012-02-10 17:27:18 +0000" MODIFIED_BY="[Empty name]">
<NAME>New York University (NYU)</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION>
<P>NYU have provided funding for the Cochrane Oral Health Group Global Alliance (see <A HREF="http://www.ohg.cochrane.org">www.ohg.cochrane.org</A>)</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2012-02-10 17:27:51 +0000" MODIFIED_BY="[Empty name]">
<NAME>British Society of Paediatric Dentistry (BSPD)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>The BSPD have provided funding for the Cochrane Oral Health Group Global Alliance (see <A HREF="http://www.ohg.cochrane.org">www.ohg.cochrane.org</A>)</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-02-10 17:03:20 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2011-09-26 14:23:01 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2010-02-05 12:58:18 +0000" MODIFIED_BY="[Empty name]">Sedation of children undergoing dental treatment</TITLE>
<SUMMARY_BODY MODIFIED="2011-09-26 14:23:01 +0100" MODIFIED_BY="[Empty name]">
<P>Fear of the dentist may be expressed as unco-operative behaviour in children requiring dental treatment. Behaviour management problems can result in a child's tooth decay going untreated. While behavioural techniques play an important role in managing children, some children still find it difficult to co-operate with dental treatment and may require sedation. This review examined the effectiveness of drugs to sedate a child whilst keeping them conscious. There is some weak evidence that midazolam administered in a drink of juice is effective, and nitrous oxide (laughing gas) may also be effective. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-02-08 15:19:26 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-09-26 14:36:10 +0100" MODIFIED_BY="[Empty name]">
<P>Children's fear about dental treatment may lead to behaviour management problems for the dentist, which can be a barrier to the successful dental treatment of children. Sedation can be used to relieve anxiety and manage behaviour in children undergoing dental treatment. There is a need to determine from published research which agents, dosages and regimens are effective.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-09-26 13:45:07 +0100" MODIFIED_BY="[Empty name]">
<P>To evaluate the efficacy and relative efficacy of conscious sedation agents and dosages for behaviour management in paediatric dentistry.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-02-08 15:19:26 +0000" MODIFIED_BY="[Empty name]">
<P>Electronic searches of MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Dissertation Abstracts, SIGLE, the World Wide Web (Google) and the Community of Science Database were conducted for relevant trials and references up to 4th August 2011. Reference lists from relevant articles were scanned and the authors contacted to identify trials and obtain additional information. There were no language restrictions. Trials pre-1966 were not searched.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-09-26 13:46:32 +0100" MODIFIED_BY="[Empty name]">
<P>Studies were selected if they met the following criteria: randomised controlled trials of conscious sedation comparing two or more drugs/techniques/placebo undertaken by the dentist or one of the dental team in children up to 16 years of age. Crossover trials were excluded.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-02-08 11:54:47 +0000" MODIFIED_BY="[Empty name]">
<P>Information regarding methods, participants, interventions, outcome measures and results were independently extracted, in duplicate, by two review authors. Where information in trial reports was unclear or incomplete authors of trials were contacted. Trials were assessed for risk of bias. The Cochrane Collaboration statistical guidelines were followed.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-02-08 11:59:26 +0000" MODIFIED_BY="[Empty name]">
<P>Thirty-six studies were included with a total of 2810 participants. Thirty trials (83%) were at high risk of bias and six (17%) were at unclear risk of bias. There were 28 different sedatives used with or without inhalational nitrous oxide. Dosages, mode of administration and time of administration varied widely. Trials were grouped into placebo-controlled, dosage and head-to-head comparisons. Meta-analysis of the available data was possible for studies investigating oral midazolam vs placebo only. There is weak evidence from five small clinically heterogeneous trials at high risk of bias, that the use of oral midazolam in doses between 0.25 mg/kg to 0.75 mg/kg is associated with more co-operative behaviour compared to placebo; standardised mean difference (SMD) favoured midazolam (SMD 2.98, 95% confidence interval (CI) 1.58 to 4.37, P &lt; 0.001, I² = 91%), which translates to an increase of approximately 1.8 points on the six-point Houpt behaviour scale. There is very weak evidence from two trials which could not be pooled that inhalational nitrous oxide is more effective than placebo.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2011-10-31 11:52:32 +0000" MODIFIED_BY="[Empty name]">
<P>There is some weak evidence that oral midazolam is an effective sedative agent for children undergoing dental treatment. There is very weak evidence that nitrous oxide inhalation may also be effective. There is a need for further well designed and well reported clinical trials to evaluate other potential sedation agents. Further recommendations for future research are described and it is suggested that future trials evaluate experimental regimens in comparison with oral midazolam or inhaled nitrous oxide.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-02-10 17:03:20 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-02-08 14:06:57 +0000" MODIFIED_BY="[Empty name]">
<P>It is widely recognised that the level of caries in children of industrialised nations has dropped substantially over the last few decades. Unfortunately a significant proportion of these children still have caries and, to make matters worse, much of it remains untreated. In the USA 47% of 6-year olds had evidence of dental caries in 1996 and 39% of this disease was untreated (<LINK REF="REF-NCHS-1996" TYPE="REFERENCE">NCHS 1996</LINK>). Similarly, of the 40% of 5-year olds in the UK who had dental caries, only 27% of these children had received any treatment (<LINK REF="REF-BASCD-1999" TYPE="REFERENCE">BASCD 1999</LINK>). This represents a significant problem, if dentine caries is left it will usually lead to pain and sepsis which can often only be managed by extraction or extensive restoration of the affected teeth. Historically this has been managed in children by use of general anaesthetic. Whilst a proportion of children will always require this process, it is now recognised that it should be avoided wherever possible due to the associated rare risk of death. General anaesthesia is also very costly, it requires the use of specialist facilities and staff such as anaesthetists and specialist nurses.</P>
<P>The obvious alternative is to provide treatment under local anaesthesia, however some children will not be able to accept to this. Barriers to treatment may be dental fear or behaviour management problems (BMP). Estimates of the prevalence of dental fear and BMP are hard to find, however one Swedish study reported a value of 10.5% of children with BMP out of a population of 4 to 11-year olds (<LINK REF="REF-Klingberg-1994" TYPE="REFERENCE">Klingberg 1994</LINK>). Dental fear and BMP are closely related phenomena. Dental fear or anxiety is associated with increased levels of caries and BMP, however not all children who are dentally anxious will present with BMP, one study reported that only 60% of children with dental fear presented with BMP (<LINK REF="REF-Klingberg-1995" TYPE="REFERENCE">Klingberg 1995</LINK>). In turn, children exhibiting BMP may also be dentally anxious, though in the same study only 25% of those children with BMP were dentally anxious.</P>
<P>Methods of managing anxiety and behaviour are therefore required to meet this need. Whilst behavioural techniques that do not involve the use of drugs can play an important part in a child's management, many children will still find it difficult to tolerate dental treatment. In these cases sedation could be considered as a method for reducing anxiety and facilitating the provision of dental treatment.</P>
<P>Views of what constitutes sedation differ between clinicians, however any definition should seek to differentiate sedation from general anaesthetic. Unfortunately many sedative agents can also act as general anaesthetics and the difference in dose required to move from a sedated patient to an anaesthetised patient can be very small and extremely variable between patients. The ideal sedative agent would reduce anxiety and improve behaviour thus facilitating the completion of dental treatment and providing a positive experience for the patient. It could be carried out safely in the primary care sector and have a wide margin of safety. For the purposes of this review, therefore, a widely used definition of sedation will be followed which clearly states the level of consciousness beyond which a patient could be considered to be anaesthetised (<LINK REF="REF-AAP-1992" TYPE="REFERENCE">AAP 1992</LINK>):<BR/>"a state of depression of the central nervous system which reduces anxiety thus enabling treatment to be carried out satisfactorily. During sedation the patient will be able to independently maintain an open mouth, and respond sensibly to verbal commands. In addition, the patient will retain adequate function of protective reflexes such as the laryngeal reflex. The drugs used should carry a margin of safety sufficient to render unintended loss of consciousness extremely unlikely".</P>
<P>This type of sedation will be referred to as conscious sedation or moderate sedation.</P>
<P>This review will not consider agents used to induce so-called 'deep sedation' for the above mentioned reasons. Deep sedation can be defined as (<LINK REF="REF-AAP-1992" TYPE="REFERENCE">AAP 1992</LINK>):<BR/>"a medically controlled state of depression consciousness or unconsciousness from which the patient is not easily aroused. Deep sedation may be accompanied by a partial or complete loss of protective reflexes, including the inability to maintain an airway independently and to respond purposefully to physical stimulation or to verbal command. The state and risks of deep sedation may be indistinguishable from those of general anaesthesia".</P>
<P>Commonly used agents for sedation include the benzodiazepines, nitrous oxide or other agents. Unfortunately these agents are delivered by a large variety of methods (such as oral, rectal and nasal), in a bewildering variety of combinations and in varying doses. They may also be used in conjunction with forms of physical restraint (such as a papoose board). A preliminary search of the literature suggests that very few of these drugs have been assessed against a negative or placebo control to test their efficacy. In addition many of the agents or combinations of agents may induce deep sedation rather than conscious sedation. Finally outcome variables in the majority of studies assessing the different sedative agents appear to focus predominantly on its effect on behaviour rather than anxiety.</P>
<P>The aim of this review is to determine which sedative agents are effective for behaviour management in children who are receiving dental care in order to allow completion of dental treatment.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-02-08 14:32:30 +0000" MODIFIED_BY="[Empty name]">
<P>To evaluate the efficacy and relative efficacy of conscious sedation agents and dosages for behaviour management in paediatric dentistry.</P>
<P>The following subgroup analyses were proposed if data were available.</P>
<OL>
<LI>Age</LI>
<LI>Dental procedure</LI>
</OL>
</OBJECTIVES>
<METHODS MODIFIED="2012-02-08 16:20:25 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-02-08 15:14:33 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-02-08 14:34:15 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised controlled clinical trials (including cluster randomised). Quasi-randomised trials were excluded. Allocation concealment, patient, operator or assessor blinding were not used as entry criteria for this systematic review.</P>
<P>Crossover trials were excluded from this update of the review, as they are not an appropriate study design when the intervention can have a long lasting effect (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). The relationship between pain and anxiety is well established, it is clear that the child's experience of any procedure will have an impact on any subsequent one (<LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-02-08 14:36:27 +0000" MODIFIED_BY="[Empty name]">
<P>Both the following criteria had to be met for a study to be included in this review:<BR/>
</P>
<UL>
<LI>Children and adolescents aged 0 to 16 years of age (including children with specific medical or behavioural problems).</LI>
<LI>Children having simple restorative treatment with local anaesthesia (e.g. fillings, stainless steel crowns), simple extractions or management of dental trauma (e.g. repositioning of tooth, splinting, removal of nerve from tooth).</LI>
</UL>
<P>Studies where children were having complex surgical procedures were not included in this study. Studies were included regardless of whether a measure of anxiety was reported at baseline.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-07-28 11:28:46 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Test group</HEADING>
<P>Any sedative agent via any route of admission that can be administered by a dentist, anaesthetist, sedationist or dental auxiliary in an outpatient setting or dental office. Studies that reported induction of deep sedation were excluded.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Control group</HEADING>
<P>Placebo (including no intervention) or alternative sedation agent or different dosage of the same agent.</P>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-02-08 15:14:33 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Primary</HEADING>
<P>Behaviour</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary</HEADING>
<OL>
<LI>Completion of treatment (yes/no)</LI>
<LI>Postoperative anxiety</LI>
<LI>Adverse events</LI>
</OL>
<P>Behaviour was measured by a range of different indices; where possible these were combined to allow meta-analysis to be carried out. Behaviour for the procedure overall will be recorded; if this information is not available then behaviour at the time of injection will be used.</P>
</SUBSECTION>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-02-08 15:21:26 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2012-02-08 15:19:42 +0000" MODIFIED_BY="[Empty name]">
<P>For the identification of studies included or considered for this review, detailed search strategies were developed for each database searched. These were based on the search strategy developed for MEDLINE but revised appropriately for each database. The subject search used a combination of controlled vocabulary and free text terms based on the search strategy for searching MEDLINE via OVID (prepared and tested by Anne Littlewood, Cochrane Oral Health Group). <I>See</I> <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for Medline search, <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> for Embase search, <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> for OHG trials register search, <LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK> for CENTRAL search strategy, and <LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK> for other searches.</P>
<SUBSECTION>
<HEADING LEVEL="4">Databases searched</HEADING>
<UL>
<LI>Cochrane Oral Health Group's Register to 4th August 2011</LI>
<LI>The Cochrane Central Register of Controlled Trials (CENTRAL from January 2005 to 4th August 2011)</LI>
<LI>MEDLINE (OVID) (1960 to 4th August 2011)</LI>
<LI>EMBASE (OVID) (1945 to 4th August 2011)</LI>
<LI>System for Information on Grey Literature in Europe (SIGLE) (1985 to 2005)</LI>
</UL>
<P>World Wide Web (Google) and the Community of Science Database and Web of Knowledge (up to 4th August 2011), which include ongoing trials funded by the National Institute for Dental Research, were also searched for additional relevant trials and references were cross-checked with those already in the core database.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Language</HEADING>
<P>The search attempted to identify all relevant studies irrespective of language. Non-English papers were translated.</P>
</SUBSECTION>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-02-08 15:21:26 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Handsearching</HEADING>
<P>The following journals were identified as being important to be handsearched for this review. The journals were handsearched by the review authors for the period January 2000 to August 2011.<BR/>
</P>
<UL>
<LI>
<I>International Journal of Paediatric Dentistry</I>
</LI>
<LI>
<I>Dental Update</I>
</LI>
<LI>
<I>Pediatric Dentistry</I>
</LI>
<LI>
<I>Journal of Dentistry for Children</I>
</LI>
<LI>
<I>American Academy of Pediatric Dentistry</I>
</LI>
<LI>
<I>Journal of American Dental Association</I>
</LI>
<LI>
<I>British Dental Journal</I>
</LI>
</UL>
<P>The reference lists of all eligible trials were checked for additional studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Unpublished studies</HEADING>
<P>Specialists in the field known to review authors were contacted for any unpublished data.</P>
<P>Titles and abstracts were assessed by review authors for inclusion in the review.</P>
</SUBSECTION>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-02-08 16:20:25 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-02-08 15:23:11 +0000" MODIFIED_BY="[Empty name]">
<P>Selection of papers suitable for inclusion in this study was carried out, using a specially designed form, independently by two review authors. Any disagreements were resolved by discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-02-08 15:56:04 +0000" MODIFIED_BY="[Empty name]">
<P>Data extraction was carried out on a specially designed form independently by two review authors who were blinded to each other's data. Results were compared to check for inconsistencies and disagreements resolved by discussion. Review authors were not blinded to the journal of publication or the author's names on the papers.</P>
<P>Descriptive data collected (where available) in addition to that already outlined included:</P>
<OL>
<LI>Year study started, if not available, year it was published</LI>
<LI>Country where study was carried out</LI>
<LI>Use of supplemental nitrous oxide gas (N2O)</LI>
<LI>Use of restraints during the procedure</LI>
<LI>Previous dental treatments of patients</LI>
<LI>Anxiety prior to treatment</LI>
<LI>Baseline behaviour</LI>
<LI>Sample size calculation</LI>
<LI>Dental treatment procedure</LI>
<LI>Fasting before the procedure</LI>
<LI>Level of consciousness throughout the procedure</LI>
<LI>Adverse effects</LI>
<LI>Monitoring used</LI>
<LI>Procedure and recovery time</LI>
<LI>Assessment of examiner variability</LI>
<LI>Patient satisfaction/acceptance</LI>
</OL>
<P>The characteristics of the trial participants, interventions and outcomes for the included trials are presented in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. Where information in the published report was incomplete or unclear, trial authors were contacted for clarification or for further information.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-02-08 15:59:18 +0000" MODIFIED_BY="[Empty name]">
<P>All studies meeting the selection criteria were included in this review regardless of quality.</P>
<P>Risk of bias was assessed using the methodology set out in the Cochrane handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Included trials were assessed on the following criteria:</P>
<UL>
<LI>Sequence generation</LI>
<LI>Allocation concealment</LI>
<LI>Blinding - assessed in three groups: patient, operator/sedationist, outcome assessor. If the authors state that a study is double blind then it is assumed that <I>at least</I> the patient and outcome assessor are blinded.</LI>
<LI>Incomplete outcome assessment addressed</LI>
<LI>Free of selective reporting</LI>
<LI>Free of other bias</LI>
</UL>
<P>A description of what was reported to have happened in the study, in sufficient detail to support a judgement about the risk of bias was recorded for each included trial, along with a judgement of low, high or unclear risk of bias. Criteria for risk of bias judgements regarding allocation concealment are given below as described in the Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<UL>
<LI>Low risk of bias - adequate concealment of the allocation (e.g. sequentially numbered, sealed, opaque envelopes or centralised or pharmacy-controlled randomisation).</LI>
<LI>Unclear risk of bias - uncertainty about whether the allocation was adequately concealed (e.g. where the method of concealment is not described or not described in sufficient detail to allow a definite judgement).</LI>
<LI>High risk of bias - inadequate allocation concealment (e.g. investigators knew in advance what the allocated assignment of the next participant would be).</LI>
</UL>
<P>A summary assessment of the risk of bias for the primary outcome (across domains) was undertaken (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Within a study, a summary assessment of low risk of bias was given when there is a low risk of bias for all key domains, unclear risk of bias when there is an unclear risk of bias for one or more key domains, and high risk of bias when there is a high risk of bias for one or more key domains. Across studies, a summary assessment was rated as low risk of bias when most information is from studies at low risk of bias, unclear risk of bias when most information is from studies at low or unclear risk of bias, and high risk of bias when the proportion of information is from studies at high risk of bias sufficient to affect the interpretation of the results.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-02-08 16:05:59 +0000" MODIFIED_BY="[Empty name]">
<P>For dichotomous outcomes such as treatment completion it was planned to calculate risk ratios along with 95% confidence intervals, and for continuous outcomes such as scores on the Frankl behaviour scale outcomes would be reported as mean and standard deviation in each group.</P>
<P>Outcome measures may be reported using validated scales which measure either sedation (e.g. Ramsay sedation scale), emotional status (e.g. Briekopf and Buttner scale), or behaviour (e.g. Frankl behavior scale or Houpt behavior rating scale) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). In each of these scales a higher score is associated with desired behaviour. The Venham scale is used to measure anxiety and in this five-point scale a higher score indicates greater anxiety (i.e. undesirable outcome). In order for outcomes to be comparable between studies, anxiety scores as measured on the Venham scale have been transformed by subtracting the mean score per group from the maximum possible score of five (<I>see</I> <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK> section 9.2.3.2).</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-07-04 16:41:17 +0100" MODIFIED_BY="[Empty name]">
<P>Heterogeneity in the results of the trials was assessed where appropriate by inspection of a graphical display of the results and by formal tests of heterogeneity. </P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-02-08 16:19:12 +0000" MODIFIED_BY="[Empty name]">
<P>Where either dichotomous outcome variables or continuous outcome variables with means and standard deviations are available, these data were recorded.</P>
<OL>
<LI>Completion of treatment (yes/no).</LI>
<LI>Difference in behaviour between test and control groups.</LI>
<LI>Difference in postoperative anxiety between test and control groups.</LI>
<LI>Adverse events.</LI>
</OL>
<P>If data subsequently becomes available then analyses will be carried out in the following order.</P>
<OL>
<LI>Comparison of sedative agents with placebo.</LI>
<LI>Comparison of different dosages of the same agent.</LI>
<LI>Comparison of sedative agents with each other.</LI>
</OL>
<P>If differing ordinal outcome variables were used to measure behaviour then, where possible, these were combined. A random-effects model was planned where there were more than four trials in an analysis. The outcome of standardised mean difference was planned to be used in situations where different scales were used to measure the same outcome.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-02-08 16:20:25 +0000" MODIFIED_BY="[Empty name]">
<P>We propose conducting subgroup analyses for the following groups provided sufficient data exists.</P>
<UL>
<LI>Age</LI>
</UL>
<P>This was subdivided into three groups, 0 to 5, 6 to 11, 12 to 17 (as recommended by the British National Formulary (BNF) when prescribing drugs to children).</P>
<UL>
<LI>Dental procedure</LI>
</UL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2011-10-12 12:44:08 +0100" MODIFIED_BY="[Empty name]">
<P>Sensitivity analysis was planned a priori to compare the study results for risk of bias. Both fixed and random-effects model meta-analyses were undertaken to assess the robustness of the results.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-02-10 17:03:20 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-02-10 17:03:20 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-02-08 16:38:12 +0000" MODIFIED_BY="[Empty name]">
<P>One-hundred-and-fifty-nine studies were identified as possibly meeting the inclusion criteria after reviewing titles and abstracts of studies returned from the initial search. Of these, 36 were found to fulfil the inclusion criteria of the review. Summary details are given in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> tables. Randomised crossover trials are a pragmatic and appropriate design for investigating stable conditions, where the outcome of the first treatment period is unlikely to influence the baseline measures prior to the second treatment (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). However behaviour of children undergoing dental procedures and associated fear is highly influenced by the child's prior experience of dental treatment (<LINK REF="STD-Shapira-1996" TYPE="STUDY">Shapira 1996</LINK>), and so it was decided that crossover trials should not be included in this review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the trials</HEADING>
<P>Dates of publication ranged from 1966 to 2010.</P>
<P>Studies were undertaken in 13 different countries with the greatest proportion of studies (n = 12, 33%) from the USA (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>; <LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>; <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>; <LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>; <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>; <LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>). We included five trials conducted in Turkey (<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK>; <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>), four from India (<LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>; <LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>), three from South Africa (<LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>; <LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>), three from United Kingdom (<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>), two from Mexico (<LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>; <LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>) and one in each of Chile (<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>), China (<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>), Iran (<LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>), Nepal (<LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK>), The Netherlands (<LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>), Saudi Arabia (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>) and Sweden (<LINK REF="STD-Jensen-1999" TYPE="STUDY">Jensen 1999</LINK>).</P>
<P>Only two studies reported a sample size calculation (<LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>). Averley et al conducted a pilot study (<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>) which refers to the collection of information to enable a sample size calculation to be done, and this pilot was then followed by a full trial (<LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>). However a sample size calculation was not reported in the published papers for either of these trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of the participants</HEADING>
<P>Age of patients included in the trials ranged from 1 year to 16 years. Mean age (approximation) for all studies was 4.7 years. The mean number of participants was 78 (standard deviation (SD) = 124) with a total of 2810 subjects randomised in the 36 included trials.</P>
<P>In the majority of studies (n = 26, 72%) subjects were reported as being unco-operative or anxious at the beginning of the study with the Frankl behavioural rating scale most often used to measure baseline behaviour. Eleven of the included studies reported the use of Papoose boards or Pediwrap to support or restrain children during the dental procedure. Papoose boards were used in seven of the studies conducted in the USA (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>; <LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>) and also in China (<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>), Mexico (<LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>) and Saudi Arabia (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>) and the trial by <LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK> used a pediwrap.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of Interventions</HEADING>
<P>A wide variety of drugs either singly or in combination were used (<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>) and delivered orally, intranasally, intravenously, rectally, intramuscularly, submucosally, transmucosally or by inhalation depending on the type of drug and experimental aims. Inhalation sedation required a bulky machine and scavenging system. Intranasal sedation was administered by a metered-dose atomizer. Rectal sedation was usually given with a rectal applicator applied to a syringe inserted 3 to 4 centimetres into the rectum and the buttocks opposed tightly for 1 minute. In some studies, enemas were given to parents to apply 1 hour before each appointment to avoid variations in rectal absorption.</P>
<P>In 12 of the studies (33%) all participants were administered supplemental nitrous oxide/oxygen (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>; <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>; <LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>). Nine of the studies (25%) compared a drug regimen to a placebo, seven of the studies (19%) looked at the effect of varying dosages of the same agent and the remainder compared different drugs or combinations of drugs.</P>
<P>Dental treatment was poorly described on the whole, all subjects appeared to have some sort of restoration under rubber dam or extraction with local anaesthetic, but little information was given on type of restoration, number of teeth involved, type of local anaesthetic or if any attempt was made to ensure similar treatment was provided in control and experimental groups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Characteristics of outcome measures</HEADING>
<P>Of the outcome measures proposed for this review (completion of treatment, difference in behaviour, difference in postoperative anxiety and adverse events), meaningful data could only be extracted on behaviour. Postoperative anxiety was rarely mentioned and in most of the studies almost all the participants completed treatment. Adverse events were recorded but this was not done in a uniform manner between studies.</P>
<P>Outcome variables reported in the trials were predominantly ordinal (e.g. five-point scale for increasing movement) or dichotomous in nature (e.g. success/failure). Methods used for statistical analysis in the trials included both non-parametric (Chi², Wilcoxon matched pairs, Kruskal-Wallis, Mann-Whitney-U, Fishers Exact test, non-parametric two factor ANOVA, McNemar test, sign test) and parametric tests (t-test, ANOVA, Tukey's range test, Friedman two way analysis, method of least squares).</P>
<P>Measures of behaviour or level of sedation scales were commonly used (Houpt or modified versions of Houpt used most frequently (n = 15, 42%). Nineteen different types of measurement scales for behaviour or sedation were used and these are summarised in <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
<P>In the following section summary data are presented first, followed by a more detailed breakdown into three classifications. This is intended to help the reader in meaningful interpretation of the data. The three classifications are as follows:<BR/>
</P>
<OL>
<LI>Studies where test drug(s) were compared to a placebo.</LI>
<LI>Studies where differing dosages of the same drug(s) were compared.</LI>
<LI>Studies comparing different drugs, or combinations of drugs.</LI>
</OL>
<P>Within each of the three classifications, studies have been grouped where possible by the chief agent used e.g. chloral hydrate, nitrous oxide, etc. This was difficult when collating data for studies comparing different drugs or combinations of drugs, therefore some of the grouping decisions made for this table may appear arbitrary. Nevertheless we feel that this grouping helps the reader to understand this data. Drug groupings are in alphabetical order. Where a study compares different drugs with each other and also with a placebo, it has been filed in the placebo section as it was felt this evidence was of greater significance. Where different routes of administration of the same drug have been compared, this has been filed in the dosage section.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">1. Placebo controlled trials</HEADING>
<P>There were nine placebo studies included: one used oral chloral hydrate (<LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>), one used intramuscular meperidine (<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>), five used oral midazolam (<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>) and two used nitrous oxide (<LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>), (<LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>). Three of these were from the USA (<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>; <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>; <LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>), the remainder were from Chile, Turkey, India, Iran, China or the Netherlands respectively.</P>
<P>Where the general medical status of the children was reported it was ASA I and ASA II, in the rest this was assumed. Six papers did not report on the gender balance, seven did not report the weight of the children. The average number of children per study in this group was 44.8, with ages ranging from 4 to 11 years and 403 children in total were included in these nine trials.</P>
<P>Times for witholding food prior to the sedation (NPO - nil per os: nothing by mouth) were given in four papers (<LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>). Monitoring of the children during the sedation included blood pressure, heart rate, oxygen saturation, body temperature and respiratory rate. There was no specified involvement with an anaesthetist during sedation though in some studies patients were assessed by an anaesthetist before treatment.</P>
<P>Papoose board or pedi-wrap was used in one study (<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>). Nitrous oxide was used in conjunction with the main sedative agents under test in two studies (<LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>). A range of outcome variables were used and these are summarised in <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>. One study reported recovery times (<LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>) and three gave the total treatment time (<LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>). Three studies used video cameras to record sedation during dental treatment (<LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">2. Dose comparison trials</HEADING>
<P>There were seven studies which compared different dosages of sedative agents: one used hydroxyzine (<LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>), four used intranasal midazolam (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>) and two used oral midazolam (<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>), (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). Three of these trials were conducted in Turkey, two in the USA and the remaining two in Saudi Arabia and India.</P>
<P>All children were assessed as ASA I and II. All studies described the gender balance but only five recorded mean weight. The average number of children per study in this group was 37.7 with ages ranging from 2 to 9 and a total of 264 children were included in these seven trials.</P>
<P>All studies described NPO times which ranged from either a light breakfast (but no milk) up to nothing from midnight. Monitoring was reported in all studies, using a precordial stethoscope, blood pressure unit and electrocardiograph as well as clinical observations. Two studies mentioned the involvement of anaesthetists (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>).</P>
<P>Use of papoose-board (or equivalent) was mentioned in three studies (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>) and in four nitrous oxide was used in conjunction with the main sedative agent (<LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>). A range of outcome variables were used and these are summarised in <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>. Three studies recorded recovery times (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>) and one gave the total dental treatment time (<LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>). Two studies used video cameras to record dental treatment during sedation (<LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>).</P>
<P>In addition to looking at behaviour ratings and sedation, <LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK> also assessed the effects of fasting on behaviour.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">3. 'Head to head' comparison trials</HEADING>
<P>There were 20 studies comparing different drugs and delivery methods which are summarised in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>. Seven studies were from the USA, with the remainder from Mexico, the UK, Nepal, South Africa, Sweden and Turkey.</P>
<P>All studies reported children's medical status at baseline. In 11 studies gender was not specified and in 17 papers the mean weight of participants was not described. The age of children in these studies ranged from 1 years to 10 years of age and the mean number of children included was 107 with a total of 2143 children included in the 20 trials.</P>
<P>NPO was not mentioned in nine of the studies (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>; <LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>; <LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>; <LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>; <LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>; <LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>). Of those studies reporting NPO, times ranged from midnight to 2 hours before sedation or appointment. Monitoring was well reported in most of the studies and included verbal contact, pulse oximeter, precordial stethoscope, automatic blood pressure, capnograph, nasal respiration monitor, end-tidal carbon dioxide tension. Five studies mentioned the involvement of anaesthetists (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>).<BR/>
<BR/>The use of a papoose board was mentioned in six of the studies (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>; <LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>), and in six nitrous oxide/oxygen inhalation was used in conjunction with sedation (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>; <LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>). A range of outcome variables were used and these are summarised in <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>. Two papers reported dentist and parents preferences after sedation (<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>). Recovery times were given in nine papers (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>; <LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>) and nine gave the total dental treatment time (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>; <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>; <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>; <LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>; <LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>). One study used video cameras to record sedation during dental treatment (<LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-02-10 17:03:20 +0000" MODIFIED_BY="[Empty name]">
<P>Thirty-five crossover trials included in the previous version of this review have now been excluded (<LINK REF="STD-Badalaty-1990" TYPE="STUDY">Badalaty 1990</LINK>; <LINK REF="STD-Dallman--2001" TYPE="STUDY">Dallman 2001</LINK>; <LINK REF="STD-Downs-1997" TYPE="STUDY">Downs 1997</LINK>; <LINK REF="STD-el-Magboul-1995" TYPE="STUDY">el Magboul 1995</LINK>; <LINK REF="STD-Evans-1966" TYPE="STUDY">Evans 1966</LINK>; <LINK REF="STD-Flaitz-1985" TYPE="STUDY">Flaitz 1985</LINK>; <LINK REF="STD-Fuks-1994" TYPE="STUDY">Fuks 1994</LINK>; <LINK REF="STD-Gallardo-1984" TYPE="STUDY">Gallardo 1984</LINK>; <LINK REF="STD-Haas-1996" TYPE="STUDY">Haas 1996</LINK>; <LINK REF="STD-Hartgraves-1994" TYPE="STUDY">Hartgraves 1994</LINK>; <LINK REF="STD-Hasty-1991" TYPE="STUDY">Hasty 1991</LINK>; <LINK REF="STD-Houpt-1985a" TYPE="STUDY">Houpt 1985a</LINK>; <LINK REF="STD-Houpt-1985b" TYPE="STUDY">Houpt 1985b</LINK>; <LINK REF="STD-Houpt-1989" TYPE="STUDY">Houpt 1989</LINK>; <LINK REF="STD-Houpt-1996" TYPE="STUDY">Houpt 1996</LINK>; <LINK REF="STD-Leelataweewud-2000" TYPE="STUDY">Leelataweewud 2000</LINK>; <LINK REF="STD-Lima-2003" TYPE="STUDY">Lima 2003</LINK>; <LINK REF="STD-Lindsay-1980" TYPE="STUDY">Lindsay 1980</LINK>; <LINK REF="STD-Lindsay-1985" TYPE="STUDY">Lindsay 1985</LINK>; <LINK REF="STD-L_x00f6_kken-1994" TYPE="STUDY">Lökken 1994</LINK>; <LINK REF="STD-McCann-1996" TYPE="STUDY">McCann 1996</LINK>; <LINK REF="STD-Musial-2003" TYPE="STUDY">Musial 2003</LINK>; <LINK REF="STD-Myers-2004" TYPE="STUDY">Myers 2004</LINK>; <LINK REF="STD-Primosch-1999" TYPE="STUDY">Primosch 1999</LINK>; <LINK REF="STD-Ram-1999" TYPE="STUDY">Ram 1999</LINK>; <LINK REF="STD-Shapira-1992" TYPE="STUDY">Shapira 1992</LINK>; <LINK REF="STD-Shapira-1996" TYPE="STUDY">Shapira 1996</LINK>; <LINK REF="STD-Shapira-2004" TYPE="STUDY">Shapira 2004</LINK>; <LINK REF="STD-Songvasin-1990" TYPE="STUDY">Songvasin 1990</LINK>; <LINK REF="STD-Sullivan-2001" TYPE="STUDY">Sullivan 2001</LINK>; <LINK REF="STD-Tsinidou-1992" TYPE="STUDY">Tsinidou 1992</LINK>; <LINK REF="STD-Wilson-1993" TYPE="STUDY">Wilson 1993</LINK>; <LINK REF="STD-Wilson-2002" TYPE="STUDY">Wilson 2002</LINK>; <LINK REF="STD-Wilson-2003" TYPE="STUDY">Wilson 2003</LINK>; <LINK REF="STD-Yanase-1996" TYPE="STUDY">Yanase 1996</LINK>). Two previously included trials were deleted because they were assessed as non-randomised (<LINK REF="STD-Evans-1966" TYPE="STUDY">Evans 1966</LINK>; <LINK REF="STD-Poorman-1990" TYPE="STUDY">Poorman 1990</LINK>) and a further ten crossover trials were identified in the updated search and were also excluded (<LINK REF="STD-Al_x002d_Zahrani-2009" TYPE="STUDY">Al-Zahrani 2009</LINK>; <LINK REF="STD-Cathers-2005" TYPE="STUDY">Cathers 2005</LINK>; <LINK REF="STD-Da-Costa-2007" TYPE="STUDY">Da Costa 2007</LINK>; <LINK REF="STD-Gamonal-Aravena-1989" TYPE="STUDY">Gamonal Aravena 1989</LINK>; <LINK REF="STD-Kantovitz-2007" TYPE="STUDY">Kantovitz 2007</LINK>; <LINK REF="STD-Pandey-2010" TYPE="STUDY">Pandey 2010</LINK>; <LINK REF="STD-Pisalchaiyong-2005" TYPE="STUDY">Pisalchaiyong 2005</LINK>; <LINK REF="STD-Sheroan-2006" TYPE="STUDY">Sheroan 2006</LINK>; <LINK REF="STD-Wilson-2006" TYPE="STUDY">Wilson 2006</LINK>; <LINK REF="STD-Wilson-2007" TYPE="STUDY">Wilson 2007</LINK>).</P>
<P>Overall 25 potentially eligible trials were excluded after evaluation of the full article revealed that they were not randomised trials (<LINK REF="STD-Arya-2002" TYPE="STUDY">Arya 2002</LINK>; <LINK REF="STD-Campbell-1998" TYPE="STUDY">Campbell 1998</LINK>; <LINK REF="STD-Davila-1990" TYPE="STUDY">Davila 1990</LINK>; <LINK REF="STD-Duncan-1984" TYPE="STUDY">Duncan 1984</LINK>; <LINK REF="STD-Garton-1970" TYPE="STUDY">Garton 1970</LINK>; <LINK REF="STD-Heard-2010" TYPE="STUDY">Heard 2010</LINK>; <LINK REF="STD-Hulland-2002" TYPE="STUDY">Hulland 2002</LINK>; <LINK REF="STD-Jensen-1998" TYPE="STUDY">Jensen 1998</LINK>; <LINK REF="STD-Kayalibay-1987" TYPE="STUDY">Kayalibay 1987</LINK>; <LINK REF="STD-Kerins-2007" TYPE="STUDY">Kerins 2007</LINK>; <LINK REF="STD-Kopel-1971" TYPE="STUDY">Kopel 1971</LINK>; <LINK REF="STD-Koroluk-2000" TYPE="STUDY">Koroluk 2000</LINK>; <LINK REF="STD-Kramer-1991a" TYPE="STUDY">Kramer 1991a</LINK>; <LINK REF="STD-Kramer-1991b" TYPE="STUDY">Kramer 1991b</LINK>; <LINK REF="STD-Leelataweedwud-2001" TYPE="STUDY">Leelataweedwud 2001</LINK>; <LINK REF="STD-Litman-1998" TYPE="STUDY">Litman 1998</LINK>; <LINK REF="STD-Martinez-2006" TYPE="STUDY">Martinez 2006</LINK>; <LINK REF="STD-Nathan-1987" TYPE="STUDY">Nathan 1987</LINK>; <LINK REF="STD-Primosch-2001" TYPE="STUDY">Primosch 2001</LINK>; <LINK REF="STD-Quarnstrom-1992" TYPE="STUDY">Quarnstrom 1992</LINK>; <LINK REF="STD-Robertson-1998" TYPE="STUDY">Robertson 1998</LINK>; <LINK REF="STD-Sams-1993b" TYPE="STUDY">Sams 1993b</LINK>; <LINK REF="STD-Tobias-1975" TYPE="STUDY">Tobias 1975</LINK>; <LINK REF="STD-Whitehead-1988" TYPE="STUDY">Whitehead 1988</LINK>; <LINK REF="STD-Wilson-1990" TYPE="STUDY">Wilson 1990</LINK>), a further 17 were found not to have comparative groups (<LINK REF="STD-Baldinelli-1989" TYPE="STUDY">Baldinelli 1989</LINK>; <LINK REF="STD-Berge-1999" TYPE="STUDY">Berge 1999</LINK>; <LINK REF="STD-Chaushu-2002" TYPE="STUDY">Chaushu 2002</LINK>; <LINK REF="STD-Doring-1985" TYPE="STUDY">Doring 1985</LINK>; <LINK REF="STD-Duncan-1994" TYPE="STUDY">Duncan 1994</LINK>; <LINK REF="STD-Dunn_x002d_Russell-1993" TYPE="STUDY">Dunn-Russell 1993</LINK>; <LINK REF="STD-Erlandsson-2001" TYPE="STUDY">Erlandsson 2001</LINK>; <LINK REF="STD-Lahoud-2001" TYPE="STUDY">Lahoud 2001</LINK>; <LINK REF="STD-Lindh_x002d_Stromberg-2001" TYPE="STUDY">Lindh-Stromberg 2001</LINK>; <LINK REF="STD-Malamed-1989" TYPE="STUDY">Malamed 1989</LINK>; <LINK REF="STD-Milnes-2000" TYPE="STUDY">Milnes 2000</LINK>; <LINK REF="STD-Moore-1997" TYPE="STUDY">Moore 1997</LINK>; <LINK REF="STD-Myers-1977" TYPE="STUDY">Myers 1977</LINK>; <LINK REF="STD-Oei_x002d_Lim-1991" TYPE="STUDY">Oei-Lim 1991</LINK>; <LINK REF="STD-Roberts-1982" TYPE="STUDY">Roberts 1982</LINK>; <LINK REF="STD-Rohlfing-1998" TYPE="STUDY">Rohlfing 1998</LINK>; <LINK REF="STD-Sanders-1997" TYPE="STUDY">Sanders 1997</LINK>), and seven trials included participants older than 16 years (<LINK REF="STD-Blake-1999" TYPE="STUDY">Blake 1999</LINK>; <LINK REF="STD-Fukuta-1993" TYPE="STUDY">Fukuta 1993</LINK>; <LINK REF="STD-Fukuta-1994" TYPE="STUDY">Fukuta 1994</LINK>; <LINK REF="STD-Hall-2006" TYPE="STUDY">Hall 2006</LINK>; <LINK REF="STD-Roberts-1979" TYPE="STUDY">Roberts 1979</LINK>; <LINK REF="STD-Silver-1994" TYPE="STUDY">Silver 1994</LINK>; <LINK REF="STD-van-der-Bijl-1991" TYPE="STUDY">van der Bijl 1991</LINK>). Three trials were excluded because they evaluated general anaesthetics (<LINK REF="STD-Litman-1997" TYPE="STUDY">Litman 1997</LINK>; <LINK REF="STD-Tanaka-2000" TYPE="STUDY">Tanaka 2000</LINK>; <LINK REF="STD-Veerkamp-1997" TYPE="STUDY">Veerkamp 1997</LINK>), two evaluated premedications prior to the use of a general anaesthetic (<LINK REF="STD-Roelofse-1990" TYPE="STUDY">Roelofse 1990</LINK>; <LINK REF="STD-Roelofse-1993" TYPE="STUDY">Roelofse 1993</LINK>), five used an inappropriate design (<LINK REF="STD-Marshall-1999" TYPE="STUDY">Marshall 1999</LINK>; <LINK REF="STD-Reinemer-1996" TYPE="STUDY">Reinemer 1996</LINK>; <LINK REF="STD-Robbins-1967" TYPE="STUDY">Robbins 1967</LINK>; <LINK REF="STD-Roberts-1992" TYPE="STUDY">Roberts 1992</LINK>; <LINK REF="STD-Sharma-1992" TYPE="STUDY">Sharma 1992</LINK>), six reported outcomes not relevant to this review (<LINK REF="STD-Coldwell-1999" TYPE="STUDY">Coldwell 1999</LINK>; <LINK REF="STD-Kupietzky-1996" TYPE="STUDY">Kupietzky 1996</LINK>; <LINK REF="STD-Machen-1977" TYPE="STUDY">Machen 1977</LINK>; <LINK REF="STD-Sams-1992" TYPE="STUDY">Sams 1992</LINK>; <LINK REF="STD-Wilson-1992" TYPE="STUDY">Wilson 1992</LINK>; <LINK REF="STD-Wilson-2000" TYPE="STUDY">Wilson 2000</LINK>), one evaluated oral flavouring agents (<LINK REF="STD-Isik-2008" TYPE="STUDY">Isik 2008</LINK>), and one scavenging techniques (<LINK REF="STD-Henry-1990" TYPE="STUDY">Henry 1990</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-02-09 14:20:05 +0000" MODIFIED_BY="[Empty name]">
<ALLOCATION MODIFIED="2011-08-16 11:16:40 +0100" MODIFIED_BY="[Empty name]">
<P>Only two studies were assessed as low risk of bias with regard to method of sequence generation (<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>) and both of these also reported adequate allocation concealment. Two other studies were reported as having adequate allocation concealment, but the method of sequence generation in these studies was not described (<LINK REF="STD-Jensen-1999" TYPE="STUDY">Jensen 1999</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>). <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK> used an independent person to select patients, make the random allocation and administer the intervention and in <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>, the principal investigator conducted the subject selection and random allocation. These studies were assessed as unclear and high risk of selection bias respectively. In the remaining 31 trials neither the method of sequence generation, nor any concealment of allocation was described, and these studies were assessed as being at unclear risk of selection bias.</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-02-09 14:15:31 +0000" MODIFIED_BY="[Empty name]">
<P>For avoiding performance and detection bias the ideal situation is when the operator, outcome assessor and patient are all blinded to the intervention. However we acknowledge that in trials of sedative agents in children, blinding of dental operators is difficult in part due to the nature of the equipment and drugs involved, and the need to ensure patient safety during the procedure. Blinding of children participating in these studies is usually possible, especially with young children. Some of the trials incorporated video recordings and one of more outcome assessors, blinded to the allocated treatment, evaluated the outcomes from these recordings.</P>
<P>In many trials the outcome was assessed by the operative dentist carrying out the procedure. In some trials the sedatives were administered by a nurse or researcher and the operator, who was blinded to the intervention, undertook the assessment. In other trials the procedures were videotaped and outcomes were assessed from the recordings, but bias is possible if an unblinded operator interacts with the patients in different ways depending on expectations about the effect of specific sedative.</P>
<P>Where trial reports described double blind trials, this was interpreted to mean patient and outcome assessor were blinded to the allocated treatment. Where the patient and outcome assessor <I>at least</I> were blind to the treatment, the risk of performance and detection biases were deemed to be low. The outcome assessor and operator could be separate individuals or the same person. Twenty (56%) trials were assessed as being at low risk of performance and detection biases (<A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Al_x002d_Rakaf-2001">Al-Rakaf 2001</A>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Avalos_x002d_Arenas-1998">Avalos-Arenas 1998</A>; <LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Averley-2004b">Averley 2004b</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Bui-2002">Bui 2002</A>; <LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Isik-2008a">Isik 2008a</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Jensen-1999">Jensen 1999</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Kapur-2004">Kapur 2004</A>; <LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-McKee-1990">McKee 1990</A>; <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Mortazavi-2009">Mortazavi 2009</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Reeves-1996">Reeves 1996</A>; <LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Roelofse-1996b">Roelofse 1996b</A>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Sams-1993">Sams 1993</A>; <LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Wan-2006">Wan 2006</A>). In six trials only the assessor was blind to the intervention (<A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Lam-2005">Lam 2005</A>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>; <LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>; <A HREF="http://archie.cochrane.org/sections/documents/view?version=74944259900446422542110608190228&amp;format=REVMAN#STD-Veerkamp-1993">Veerkamp 1993</A>), in three trials the operator and the outcome assessor was blinded (<LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>) and in four trials there was no blinding (<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>; <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>; <LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK>). There was no placebo for the oral sedative drug in Group 4 in <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK> which may have compromised blinding.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2011-08-16 11:17:56 +0100" MODIFIED_BY="[Empty name]">
<P>The number of trial participants included in the outcome evaluations was poorly reported in many trials, and it was difficult to determine whether or not drop outs had occurred. In twelve trials assessed as low risk of attrition bias, complete outcome reporting was clear (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>; <LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>), in one trial the risk of attrition bias was assessed as unclear (<LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>) and in the remainder, where incomplete treatment/sedation failure was not recorded, trials were assessed as being at high risk of attrition bias</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-02-09 14:17:16 +0000" MODIFIED_BY="[Empty name]">
<P>All but two of the included trials reported the outcomes described in the methods sections of the reports, and were deemed to be at low risk of reporting bias. <LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK> and <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK> reported the primary outcome, treatment completion, on all the trial participants who received the allocated intervention, but reported secondary outcomes only on those who were deemed to have undergone successful sedation (69% and 78% respectively) of those who received sedation, and 69% and 65% of those randomised.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-02-09 14:20:05 +0000" MODIFIED_BY="[Empty name]">
<P>There was no baseline demographic data reported on the participants in three trials (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>), and little or unclear baseline demographic data in a further three trials (<LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK>; <LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>). In the trial by <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK> baseline demographic data was only provided for 65% of those randomised. The randomisation code in <LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK> was broken early due to significant desaturations in the study and there was a subsequent change to the protocol reducing the high dose Sufentanil 1.5 µg/kg to 1.0 µg/kg.</P>
<SUBSECTION>
<HEADING LEVEL="3">Overall risk of bias</HEADING>
<P>
<I>See</I> <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>. Of the 36 trials included in this review none were assessed as being at low risk of bias overall. Six trials (17%) were assessed as being at unclear risk of bias (<LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>; <LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>) and in the remaining 30 trials (83%) at least one domain was assessed as being at high risk of bias.</P>
<P>In common with many other Cochrane reviews the overall quality of studies was found to be disappointing. Poor reporting was an obvious problem with these studies and this may have masked other defects in design or conduct of these trials.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]">
<P>The trials included in this review presented complex data with a range of different interventions being compared and different outcome measures.</P>
<P>Trials have been placed in three groups (as above):</P>
<UL>
<LI>those comparing active treatment with a placebo;</LI>
<LI>those comparing different doses of the same agent (or different routes of administration of the same agent);</LI>
<LI>those which compare different agents head to head.</LI>
</UL>
<P>Results of individual studies are presented in a narrative format below and differences between interventions are reported as statistically significant if the trial reports P &lt; 0.05. Data from these three groups is summarised in Additional <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>; <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>; <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK> respectively. There were few opportunities to combine data from similar trials for meta-analysis, but where this was possible the data are presented in forest plots in Analyses 1 to 5 in the <LINK TAG="ANALYSES_AND_DATA" TYPE="SECTION">Data and analyses</LINK> section. Data from trials evaluating active interventions compared to placebo, or the following four commonly used agents: chloral hydrate, ketamine, midazolam or nitrous oxide were presented. It was not possible nor did we attempt to combine these data by meta-analysis. However we decided that presenting data within forest plots would help the reader to understand the data. The following rules were used when compiling this information.</P>
<UL>
<LI>Where data was only presented in its raw format this was used to calculate the appropriate mean and standard deviations.</LI>
<LI>Data was treated as continuous even though Houpt (and other scales) were commonly used as outcome measure (ranked scores).</LI>
<LI>Houpt was taken as the standard when ranking behaviour i.e. higher values equal better behaviour. Where scales ran in the reverse order, values were transformed so that higher values equalled better behaviour e.g. anxiety scores as measured on the Venham scale have been transformed by subtracting the mean score per group from the maximum possible score of five (<I>see</I> <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK> section 9.2.3.2).</LI>
<LI>Where dosage studies were analysed, the lowest dosage was compared to the highest dosage. Results from the lowest dosage were listed first.</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="3">1. Placebo studies</HEADING>
<P>
<I>See</I> <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK> and <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Oral midazolam</HEADING>
<P>Five trials compared oral midazolam with placebo (<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>). Three of the trials were assessed at high risk of bias (<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>; <LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>) and in the others risk of bias was unclear.</P>
<P>
<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK> randomised children aged 4 to 10 years to either 75 mg of midazolam or placebo (the range of weight of the children included in the trial is not reported but the stated average weight of 21.65 kg would result in a dose equivalent to 0.35 mg/kg). The actual dose in mg/kg would be expected to vary considerably. The authors used means and standard errors to summarise ranked data in each group with only three categories which was thought to be inappropriate. However subsequent analysis using Wilcoxon's rank test was appropriate. Midazolam was reported to be significantly better than placebo.</P>
<P>
<LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK> used the highest dose in this group of trials, of 0.75 mg/kg and noted vomiting and hiccuping in the midazolam group.</P>
<P>
<LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK> described midazolam delivery in their study as being a mixture of oral and transmucosal with a dose of 0.5 mg/kg.</P>
<P>
<LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK> used the lowest dose of the five trials in this group (0.25 mg/kg).</P>
<P>
<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK> used a dose of 0.5 mg/kg and noted amnesia associated with midazolam use.</P>
<P>The studies were included in the meta-analysis using overall behaviour as measured by Houpt (or a scale in the same direction) as an outcome measure. <LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK> and <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK> did not record Houpt but did use a similar scale (three-point as opposed to six-point). Raw data was supplied by <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>, so this was used to calculate mean and standard deviation (satisfactory scored as 3, unsatisfactory as 1). <LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK> reported standard error so this was converted to standard deviation. <LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK> used a reversed scale so these data were transformed. <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK> appeared to have a reporting error whereby test and control results were transposed. Close examination of the paper shows that values for all measures of behaviour reported in Table 2 are the opposite as described in the text i.e. they suggest the intervention worsens behaviour whereas in the text it states that patient behaviour improved. The same is not true for the physiological measures (Table 2 again), subjects in the intervention group had a significantly lower heart rate. We were unable to contact the authors therefore we have decided this most likely represents an error in reporting and have therefore transposed values for the control and intervention groups.</P>
<P>The results can be seen in <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.2. A random-effects model and standardised mean difference (SMD) was used as the scales were not completely alike. Use of oral midazolam produced a significant improvement in behaviour in all of these trials (SMD 2.98, 95% confidence interval (CI) 1.58 to 4.37, P &lt; 0.0001). The considerable heterogeneity (I² = 91%, P &lt; 0.00001) in this estimate is likely due to the different tools used to measure the outcome in each trial and the range of doses of oral midazolam used from 0.25 mg/kg to 0.75 mg/kg (<I>see</I> <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Nitrous oxide/oxygen</HEADING>
<P>Two studies (<LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>) evaluated nitrous oxide/oxygen sedation compared to placebo and both were assessed as being at high risk of bias. In <LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK> children received 20 to 50% nitrous oxide in oxygen and in <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK> participants received up to 40% nitrous oxide in oxygen. Both trials reported changes in favour of nitrous oxide in either behaviour or anxiety, but no data were available from the Nathan trial (<LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK> reported anxiety on the Venham scale which is in opposite direction to Houpt, so scores transformed for forest plots) (<I>see</I> <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.2). No adverse effects were mentioned.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Chloral hydrate (CH)</HEADING>
<P>In <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK> children were randomly allocated to either 20, 40 or 60 mg/kg of CH or a placebo and then all children received up to 40% nitrous oxide in oxygen as well. This trial was assessed as being at high risk of bias. There was no statistically significant increase in positive behaviour between placebo and any of the oral CH groups, and all participants completed treatment regardless of group. There was no statistically significant difference between placebo and the three active CH groups combined for the outcome of positive behaviour during the operatory (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>.1), possibly due to a strong response to the placebo. However after nitrous oxide/oxygen was administered, there were airway issues, with four children (27%) in the 60 mg/kg CH group not responding to obstruction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Meperidine</HEADING>
<P>Intramuscular meperidine (0.55 to 2.2 mg/kg - calculated from mg/lb given in text) was evaluated in a single study (<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>) which was assessed at high risk of bias. Meperidine was statistically significantly more effective (P &lt; 0.05) than placebo for the outcome of good or better behaviour (good, very good or excellent behaviour) (71% in meperidine groups compared to 13% in placebo) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>.2). However two patients in the meperidine groups (13%) had unmanageable behaviour and treatment had to be aborted and rescheduled. Nausea and vomiting were more frequent in meperidine groups (38% versus 7%) and rates showed a dose response (<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">2. Dosage studies</HEADING>
<P>
<I>See</I> <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Hydroxyzine</HEADING>
<P>One study (<LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>) looked at the effect of a dose of hydroxyzine given 24 hours preoperatively (20 mg) at home followed by a second dose at the appointment (3.7 mg/kg) versus hydroxyzine given at the appointment only (3.7 mg/kg). The study was at high risk of bias. All children also received 50% nitrous oxide. No differences were reported between groups at any of the time points measured. No adverse effects were reported. <LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK> reported the dose as 20 mg/kg hydroxyzine in the main text but 20 mg in the abstract.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Midazolam (intranasal)</HEADING>
<P>Four studies looked at intranasal midazolam (<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>). The participants in the <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK> and <LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK> trials all received nitrous oxide inhalation as well at 50% or 45% respectively. All four studies were at high risk of bias.</P>
<P>
<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK> found that behaviour improved in the group receiving 0.5 mg intranasal midazolam compared to either 0.3 or 0.4 mg/kg (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.1), but there was no statistically significant improvement in behaviour between 0.4 mg group and 0.3 mg group. The number of patients completing treatment increased also (79%, 96% and 100% in groups A, B and C respectively - data from fasting children were used). Authors also reported that fasting made no difference to overall behaviour (P = 0.8286).</P>
<P>
<LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK> compared intranasal midazolam (0.3 mg/kg) to oral midazolam (0.7 mg/kg) and found no differences between groups in mean Houpt behaviour score at any of the times measured - data not available (P = 0.749). As expected, mean time to onset of sedation was much shorter in the intranasal group, but mean duration of sedation (working time) was statistically significantly longer in the group who received oral midazolam (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>).</P>
<P>
<LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK> and <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK> compared 0.2 mg/kg intranasal midazolam versus 0.2 mg/kg intramuscular midazolam. <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK> used the midazolam as a premedication for an unspecified IV sedative, and reported that there was improved behaviour at time of delivery of local anaesthetic and venepuncture in the intramuscular group, and good or excellent sedation was achieved in all of the IM group compared to only 6/11 (54%) of the IN group (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.2).</P>
<P>
<LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK> compared reported no difference with regard to behaviour between the IM and IN groups, which both showed improvement from baseline. Induction of sedation, treatment and recovery however was faster in the intranasal group (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.2). Despite receiving a light snack prior to treatment, none of the children vomited.</P>
<P>Adverse effects were reported by <LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK> and <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK> and included sneezing, coughing, diplopia and hiccups.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Midazolam (oral)</HEADING>
<P>Two studies (<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>) evaluated oral midazolam, with participants in <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK> also receiving nitrous oxide inhalation. <LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK> was assessed as being at high risk of bias and in <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK> risk of bias was unclear.</P>
<P>
<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK> compared 0.5 mg/kg oral midazolam versus 0.35 mg/kg rectal midazolam and found both to be effective with no differences in behaviour between the groups (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). However acceptance of rectal administration by the children was much poorer when compared to oral administration.</P>
<P>
<LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK> randomised children to oral doses of either 0.2 mg/kg, 0.5 mg/kg, 0.75 mg/kg or 1 mg/kg after fasting for 3 to 5 hours. All children also received 40% nitrous oxide in oxygen (<LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). Children in groups 3 and 4 had a statistically significantly greater sedation score compared to those in groups 1 and 2 (P &lt; 0.05) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.1). Sedation was considered inadequate in 86%, 38%, 23% and 38% of children in groups 1 to 4 respectively. Three children in group 4 (1 mg/kg) had delayed recovery time and in one patient a desaturation. Hypoxaemia, vomiting and nausea were reported as adverse effects. Authors recommended the 0.75 mg/kg dose as providing adequate sedation with good recovery time and few adverse effects.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">3. Drug comparison studies (Additional table 5)</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Chloral hydrate/hydroxyzine (CH/H)</HEADING>
<P>Five studies investigated CH/H and compared it to other agents (<LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>; <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>; <LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>). In both <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK> and <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK> all participants also received nitrous oxide inhalation. All five studies in this group were assessed at high risk of bias.</P>
<P>
<LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK> compared chloral hydrate (70 mg/kg)/hydroxyzine (2 mg/kg) with chloral hydrate (70 mg/kg) alone and found significantly decreased crying and movement, but higher rates of oxygen desaturations and deep sedation in the CH/H group. Overall there was no statistically significant difference between the groups at the time of giving the local anaesthetic injection (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>.1 and <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). All participants completed treatment in both groups.</P>
<P>
<LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK> compared oral chloral hydrate (40 mg/kg) plus hydroxyzine (25 mg) with oral triazolam (0.02 mg/kg) in children who also received inhalation of 40% nitrous oxide. The authors reported that both regimens resulted in similar sedation (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>) and one child in the CH/H group experienced vomiting.</P>
<P>In the trial by <LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK> rectal chloral hydrate (50 mg/kg) was compared with either oral chloral hydrate (50 mg/kg) or oral chloral hydrate (30 mg/kg) plus hydroxyzine (25 mg) in children who all received 30 to 50% inhalational nitrous oxide as well. Good or excellent sedation was achieved by 70% of children in both the rectal CH and oral CH/H groups suggesting that these two regimens have equivalent sedative effects compared to oral CH alone which resulted in good/excellent sedation in 40% of children, but the difference was not statistically significant (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>.2 and <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>Chloral hydrate (50 mg/kg) plus hydroxyzine (25 mg) was compared to oral midazolam (0.5 mg/kg) plus acetaminophen (10 mg/kg) (M/A) in <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>. There was no difference in the mean overall behaviour score in each group (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>.3), though the authors noted that children in the chloral hydrate/hydroxyzine group were in a significantly deeper sleep (P = 0.0015). Treatment was aborted for one participant in the CH/H group, and 60% of children in the CH/H group compared with 55% of children in the M/A group had an overall evaluation of good or better sedation, a difference which was not statistically significant. This suggests that the regimens were similar in terms of effective sedation, but approximately 40% of procedures were still difficult.</P>
<P>In a trial by <LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK> children were randomised to sedation with chloral hydrate (50 mg/kg)/hydroxyzine (1.5 mg/kg) or (midazolam 0.5 mg/kg)/hydroxyzine (1.5 mg/kg) or hydroxyzine (2 mg/kg + further 1 mg/kg). Chloral hydrate/hydroxyzine resulted in "quieter" sedation as measured by OHSBRS and mean cardiac rate in each group (<LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>). Authors did not provide any estimates of statistical significance but comment that although hydroxyzine alone is "not controllable", the addition of either choral hydrate or midazolam results in similarly enhanced sedative effects (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Chloral hydrate/promethazine (CH/P)</HEADING>
<P>
<LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK> compared chloral hydrate (50 mg/kg)/promethazine(1 mg/kg) with meperidine (1 mg/kg)/promethazine (1 mg/kg), in children planned to receive inhalational nitrous oxide as well. Three patients did not actually receive nitrous oxide because of their behaviour (one in the CH/P group displayed excellent behaviour and N2O was not required, and two children in the M/P group exhibited extreme head body movements such that the hood could not be used). The authors describe that over all ten time points there was a statistically significantly greater likelihood that children were drowsy or asleep rather than awake and alert in the choral hydrate/promethazine group, but at the time the local anaesthetic injection was administered there was no difference between the two groups (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>.4). Differences between the groups in movement, crying and overall scores statistically significantly favoured the choral hydrate/promethazine group at 40% of the time points measured and in the remainder there was no difference (<LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>). Both groups completed all planned treatment and there was no difference in mean duration of treatment (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). No adverse effects were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Ketamine</HEADING>
<P>Seven studies evaluated ketamine (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>; <LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK>; <LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>; <LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>). In two of these trials (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>) nitrous oxide inhalation was also used at a concentration of 30 to 50% or 35 to 50% respectively. One of the seven trials in this group (<LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>) was assessed at unclear risk of bias and the remainder at high risk of bias.</P>
<P>
<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK> compared 3 mg/kg ketamine with either 0.4 mg/kg midazolam or 1.0 or 1.5 µg/kg sufentanil all administered intranasally. Both ketamine and midazolam induced the same mean sedation score of 4 (where 5 is ideal) and both had short recovery times (7 ±7 and 3 ±2 minutes respectively). Use of sufentanil resulted in heavily sedated children and oxygen desaturations (<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>) - desaturations were of such concern that the operators broke the code during the study to determine which drug was the cause (1.5 µg/kg sufentanil in all four cases). Authors concluded that both intranasal ketamine (3 mg/kg) and midazolam (0.4 mg/kg) resulted in acceptable sedation in children.</P>
<P>Anaesthetists in the trial by <LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK> administered a premedication of 0.5 mg/kg midazolam to all the children followed by a bolus dose plus infusion of either midazolam (0.1 mg/kg followed by 0.004 mg/kg/min), propofol (1 mg/kg followed by 0.06 mg/kg/min) or ketamine (0.5 mg/kg followed by 0.01 mg/kg/min). Ketamine showed higher mean overall behaviour scores when compared to either midazolam or propofol (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>, <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.1 and 3.1.2).</P>
<P>When rectal ketamine (5 mg/kg)/midazolam (0.35 mg/kg) was compared to rectal midazolam (1 mg/kg) alone (<LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>), both regimens were well accepted by 78% and 70% of children, and only one child in the combination group experienced nausea. The combined regimen resulted in a statistically significant improvement in behaviour. Excessive salivation was reported in 26% and 14% and hallucinations in 14% and 42% of children in the midazolam only and ketamine/midazolam groups respectively (<LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>). In this study treatment was aborted in one patient (2%) in the ketamine/midazolam group (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>In a second study (<LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>) children were randomised to either an oral dose of 12.5 mg/kg ketamine or 0.5 ml/kg of standard oral premedication (comprising trimeprazine (6 mg/ml)/physeptone (methadone) (0.4 mg/ml) to which was added droperidol (0.1 mg/ml). Very good or excellent sedation was achieved in 80% of the SOP group and 93% of the ketamine group (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>.1) but this difference was not statistically significant. Overall evaluation, which was more subjective, was good/very good in 67% of the SOP group and 90% of the ketamine group, a difference that was statistically significant (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). There were more adverse effects in the ketamine group (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>) but all participants in both groups completed treatment.</P>
<P>The third trial by this group (<LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>) compared oral ketamine (5 mg/kg) plus midazolam (0.35 mg/kg) with a combination of oral trimeprazine (3 mg/kg) and methadone (0.2 mg/kg) administered 30 minutes prior to dental treatment. In the group receiving the ketamine/midazolam combination, 46% of children were "oriented and calm" at the start of dental treatment compared to 84% in the other group (<LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>.2). However, the more subjective outcome of overall sedation was rated as good or very good in 94% of children in the ketamine/midazolam group compared to 78% in the trimeprazine/methadone group, a statistically significant difference favouring ketamine. However, adverse outcomes of vomiting (4%) and hallucinations (20%) were only observed in the ketamine/midazolam group in this trial.</P>
<P>Two trials evaluated ketamine in combination with inhalation of nitrous oxide (<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>).</P>
<P>
<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK> compared oral ketamine (6 mg/kg) with oral meperidine (2 mg/kg) plus promethazine (0.5 mg/kg) in children who had NPO for 6 hours. Nitrous oxide (30 to 50%) was administered to all the children prior to the local anaesthetic. Overall there was no statistically significant difference in the distribution of sedation outcomes between the groups (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.4), however four children (20%) had treatment aborted in the meperidine/promethazine group compared to none in the ketamine group. Eight children (40%) in the ketamine vomited, half of them during treatment and the remainder during recovery.</P>
<P>In the trial by <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>, oral ketamine (10 mg/kg) was compared with oral ketamine (10 mg/kg) plus promethazine (1.1 mg/kg) in a trial where all the participants also received 50% nitrous oxide inhalation. There was a statistically significant difference in mean Houpt behaviour score favouring ketamine (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>.5) compared to ketamine/promethazine. In one child, planned treatment was aborted (ketamine/promethazine group) but vomiting was only observed in the ketamine group (n = 3, 27%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Midazolam (oral)</HEADING>
<P>Three studies evaluated oral midazolam compared to other sedatives (<LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK>; <LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>). In one of these trials (<LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>) participants also received 40% nitrous oxide by inhalation. All three trials were assessed as being at high risk of bias.</P>
<P>
<LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK> randomised participants to either oral administration of hydroxyzine (1 mg/kg), oral midazolam (0.7 mg/kg), oral administration of ketamine (3 mg/kg) plus midazolam (0.25 mg/kg) or no oral premedication (nitrous oxide alone). All patients in the trial received 40% nitrous oxide. Authors reported that all premedication agents produced better behaviour than just nitrous oxide at all time points (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.4, 4.1.5 and 4.1.6). Ramsay sedation scores were statistically significantly greater in midazolam plus N2O group compared to N2O alone (P &lt; 0.05) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.4). There was no statistically significant difference found between midazolam plus N2O and either hydroxyzine (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.5) or midazolam/ketamine (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.6). A wide variety of adverse effects were recorded including nausea/vomiting, cough, hiccough, enuresis, bronchospasm, hypersalivation, otalgia, hallucination and epistaxis (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>
<LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK> randomised participants to six different oral interventions; midazolam (0.5 mg/kg), ketamine (5 mg/kg), zolpidem (0.4 mg/kg), midazolam (0.4mg/kg) plus ketamine (3 mg/kg), midazolam (0.5 mg/kg) plus tramadol (2 mg/kg) and zolpidem (0.4 mg/kg) plus tramadol (2 mg/kg). The most favourable sedation scores were in the group receiving midazolam plus ketamine followed by the group receiving midazolam plus tramadol (data only presented graphically in paper) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). No adverse effects were reported.</P>
<P>
<LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK> compared midazolam (0.5 mg/kg) to either triclofos (70 mg/kg) or promethazine (1.3 mg/kg), all administered in fruit juice prior to treatment. Sedation scores were reported on an eight-point scale in which a high score indicated poor sedation. In order to use these data in meta-analysis (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>.7) scores were transformed and SD were calculated (<I>see</I> <LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>). No adverse effects were reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Midazolam (rectal)</HEADING>
<P>Rectal sedation was evaluated by <LINK REF="STD-Jensen-1999" TYPE="STUDY">Jensen 1999</LINK> who compared diazepam (0.7 mg/kg) with midazolam (0.3 mg/kg). After 10 minutes there was no significant difference in sedation level between the groups, but after 1 hour there was a statistically significant difference favouring diazepam. More children were agitated with diazepam at 1 hour when comparing rectal midazolam to rectal diazepam (data only presented graphically in paper) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Sevoflurane</HEADING>
<P>Three trials evaluated sevoflurane (<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>; <LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>; <LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>), but used different outcome measures. All were assessed at high risk of bias.</P>
<P>
<LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK> compared sevoflurane (0.1 to 0.3%)/nitrous oxide (40%) with nitrous oxide (40%) alone. There was a statistically significant difference in rate of effective sedation favouring sevoflurane/N2O group (P &lt; 0.001) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>
<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK> was a pilot study which randomised children to either IV midazolam (0.5 mg/min) titrated to induce adequate sedation, or 40% nitrous oxide inhalation plus IV midazolam (0.5 mg/min) titrated to induce adequate sedation, or inhalation of 0.3% sevoflurane plus 40% nitrous oxide plus IV midazolam (0.5 mg/min) titrated to induce adequate sedation. Treatment was successfully completed in 50%, 73% and 83% of children in each group respectively and researchers noted that nine of the 16 children in groups 1 or 2 who failed were subsequently successfully treated with the addition of sevoflurane and nitrous oxide (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
<P>In the subsequent trial (<LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>) the same interventions were used as in the pilot study and treatment completion rates were 54%, 80% and 94% for groups 1 to 3 respectively. Vomiting only occurred in group 3, but incidence was low (n = 6, 2%) (<LINK REF="TBL-06" TYPE="TABLE">Table 6</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-02-09 17:10:23 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-02-09 16:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>In common with the findings from many other systematic reviews, the design and reporting of studies included in this review was mostly poor. In general, the risk of bias for most studies was at best unclear (17% of included trials) and likely to be high (83% of included trials). Combining data from included studies to facilitate a meta-analysis was difficult. The enormous range of sedative agents used both in combination and singly, along with the wide range of outcome measures, precluded meta-analysis of homogenous groups of interventions.</P>
<SUBSECTION>
<HEADING LEVEL="3">Placebo studies</HEADING>
<P>It was possible to carry out a meta-analysis for studies comparing oral midazolam with placebo (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). There is weak, but consistent evidence from five heterogeneous trials, that following administration of oral midazolam the behaviour of children was improved relative to placebo, with variations in the size of the benefit according to the dosage used. Where reported, adverse effects were few and minor. However given the small number of studies (n = 5), participants (n = 182) and high risk of bias for all these papers, this conclusion must obviously be treated with some caution.</P>
<P>There is weak evidence from two trials that nitrous oxide inhalation was also more effective than placebo and no adverse effects were noted. This suggests that this may be an effective method for managing behaviour in children.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Dosage studies</HEADING>
<P>Intranasal midazolam was evaluated in four studies, but the comparators and dosages were different and results conflicting. There is insufficient evidence to determine whether any specific dose of intranasal midazolam is effective.</P>
<P>There is weak evidence from two trials that oral midazolam at a dose of 0.5 to 0.75 mg/kg is an effective sedative for children. However one trial administered both nitrous oxide and midazolam so it is difficult to attribute benefit to midazolam alone.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Comparison Studies</HEADING>
<P>In this group no two studies evaluating the same intervention and comparison found the same effect. There is insufficient evidence to draw any conclusions from these trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse Effects</HEADING>
<P>There is insufficient evidence from trials in this review to support the effectiveness of either chloral hydrate or ketamine. However it should be noted that chloral hydrate was associated with significant adverse effects, specifically airway issues especially when high doses (&gt; 50 mg/kg) were combined with the use of inhalational nitrous oxide. Ketamine was also associated with significant adverse effects.</P>
</SUBSECTION>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-02-09 16:35:41 +0000" MODIFIED_BY="[Empty name]">
<P>It was apparent whilst carrying out this review that there were significant differences in techniques and drugs used between countries and regions. Studies can be loosely grouped into two types, those based on a "North American" model of sedation and those based on a more "European" model. The North American model was typified by use of multiple agents (including adjunctive nitrous oxide) at any age, the use of restraint and intent to induce a deeper level of sedation. The European model was typified by use of single agents (typically nitrous oxide or midazolam) with intent to induce lighter levels of sedation. This is most likely due to cultural and legal differences and needs to be considered when making recommendations for the most effective methods of conscious sedation.</P>
<P>Interpretation of outcome data related to behaviour was difficult. Over half of the studies used the Houpt or a modified Houpt scoring system to record behaviour, however the remaining studies used a wide variety of methodologies. Even within studies using modified versions of the Houpt scale, there was a large variation in how Houpt was modified. Behaviour was recorded in some studies for the whole episode and in others at a series of discrete points such as application of local anaesthetic or venepuncture. Furthermore, many of the outcome measures used relied on observations of movement, yet in a large proportion of studies patients were restrained in a papoose board. It is difficult to determine how this might have influenced recorded values of behaviour. Interestingly participants often completed treatment regardless of which group they were assigned to. This might reflect a lack of baseline anxiety in all participants which then begs the question as to why they were included in the study. Alternatively given the use of papoose boards and supplemental nitrous oxide oxygen perhaps it is not surprising.</P>
<P>The efficacy of a particular agent will be influenced by the baseline anxiety of the child involved. Ideally this should always be recorded and then compared to levels of anxiety after sedation. Baseline values of anxiety were not uniformly reported and very few studies recorded anxiety at the end.</P>
<P>The majority of studies involved sedation in children less than 6 years of age, probably because this age range belongs to a 'pre-co-operative' group. Treatment needs and management of children will vary as they grow and develop. Techniques that are appropriate in a 3-year old may not be appropriate in a 12-year old and vice versa.</P>
<P>In most papers the medical status of the children was ASA 1 and 2. Some of the techniques described may be useful in the management of medically compromised patients, but at present there are no studies carried out in these groups.</P>
<P>Little information was provided on restorative treatment carried out in many of the studies, although several articles mentioned the use of local anaesthesia (LA), mouth prop and rubber dam. Obviously the treatment provided may well influence the behaviour and anxiety of the participant.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-02-09 17:09:19 +0000" MODIFIED_BY="[Empty name]">
<P>In this update (2011) the decision was made to exclude crossover trials. Crossover trials were excluded as they are not an appropriate study design when the intervention can have a lasting effect (Cochrane Handbook for Systematic Reviews of Interventions 16.4.2, <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). It is well recognised that previous treatment episodes influence the anxiety associated with dental treatment, especially in children. Evidence to support this can be found in <LINK REF="REF-Veerkamp-1995" TYPE="REFERENCE">Veerkamp 1995</LINK>. In this study, anxiety in children who received a treatment phase under nitrous oxide was compared with children who received treatment without nitrous oxide approximately 72 weeks after the first phase. They found that overall and peak scores for anxiety were significantly reduced (P &lt; 0.05) in the nitrous oxide group at the start of the second treatment phase when compared to the control group. This decision resulted in a significant proportion of included studies from earlier versions becoming excluded. We felt this approach was justified.</P>
<P>In general reporting of the trials was poor with data such as method of sequence generation and allocation concealment frequently not reported. Participants were poorly described with important information such as gender or weight often missing. Sample size calculations were either not carried out or not reported, and it is likely that many of the trials lacked statistical power to detect a difference between intervention and control. Statistical methods used varied widely between studies even though outcome measures were sometimes similar. In some instances these tests were arguably inappropriate for the types of data usually produced by these studies.</P>
</QUALITY_OF_EVIDENCE>
<AGREEMENT MODIFIED="2012-02-09 17:10:23 +0000" MODIFIED_BY="[Empty name]">
<P>A related review was published by the National Institute for Health and Clinical Excellence on Sedation in Children and Young people (<LINK REF="REF-NICE-2010" TYPE="REFERENCE">NICE 2010</LINK>). It was different from this Cochrane review in that it considered sedation for any medical or dental therapeutic procedure, and it also was restricted to procedures that could be used within the regulatory framework of England and Wales. RCTs with less than 20 subjects were excluded, crossover studies were included. <LINK REF="REF-NICE-2010" TYPE="REFERENCE">NICE 2010</LINK> recommended for dentistry that only midazolam or nitrous oxide be used. In common with this review they found "surprisingly few high quality published reports and clinical trials".</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-02-09 17:34:09 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-02-09 17:11:50 +0000" MODIFIED_BY="[Empty name]">
<P>There is weak evidence from five trials that oral midazolam is an effective agent for sedation of children, and very weak evidence from two trials that nitrous oxide is effective for sedation of children. Although other sedatives have been evaluated, the range of sedatives, regimens, doses, modes of administration and comparisons included makes it impossible to produce a clear statement of implications for practice regarding other agents.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-02-09 17:34:09 +0000" MODIFIED_BY="[Empty name]">
<P>This review is an update to a previous review published in 2006. It is unfortunate that there has been little improvement in the design, statistical power and reporting of studies carried out since then.</P>
<P>The shortfalls of studies reported in this review are many. The principles that researchers should adhere to when designing, carrying out and reporting clinical trials in the future are the CONSORT guidelines (<LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>). There also needs to be a great improvement in reporting of such basic variables as gender, weight, time starved, time of onset of sedation, drop outs, reason for patient failing to complete treatment, etc.</P>
<P>More specific recommendations for studies assessing sedative agents are as follows.</P>
<SUBSECTION>
<HEADING LEVEL="3">Blinding</HEADING>
<P>Ideally the operator, patient and assessor should all be blind to the sedation agent used, however blinding of the operator is problematic. When comparing drugs with different modes of delivery e.g. oral midazolam versus nitrous oxide/oxygen, it would not be appropriate to blind the operator in this instance as techniques of administration are totally different. If this is the case then it is important that the assessor is blind to the allocation. In the aforementioned example this could be achieved by using an inhalation mask to deliver air in the midazolam group and the patient videotaped, to enable blinded outcome assessment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sample</HEADING>
<P>Obviously calculating and reporting sample sizes should be carried out before starting any clinical trial, something that has not been done well to date in trials of sedation agents in children requiring dental treatment. More consideration also needs to be given to the children included in trials, in particular their age. Consideration should be given to dividing age into three broad groups (as recommended by the British National Formulary (BNF) when prescribing drugs to children). These groups are: from 1 to 6 years, from 6 to 12 years and over 12 years of age. There is a need to establish which sedation is more effective for a given age group.</P>
<P>Consideration should also be given to the reasons for sedation which may well vary widely between groups. In pre-co-operative children (under 6) the intention is often to get treatment done. In older children (e.g. over 12) the intention might be to provide a pleasant experience for the patient thus reducing anxiety for further visits. It would also be helpful for research to investigate suitable sedative regimens for dental treatment in medically compromised children of various ages, those with learning difficulties or other behavioural problems such Attention Deficit Hyperactivity Disorder.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Design</HEADING>
<P>Only studies of a parallel design should be carried out. Crossover trials are considered inappropriate because the level of baseline anxiety/behaviour in the second treatment phase is highly dependent on the success or otherwise of the first treatment period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Baseline and outcome variables</HEADING>
<P>At present behaviour is the most commonly used outcome with a wide variety of methods used. Anxiety is sometimes measured before the study commences but rarely afterwards. Treatment completion is not always reported and very rarely statistically tested between groups. Outcome variables are very clinician centred - what was the quality of the sedation? How immobile was the child? etc. These approaches need to change.</P>
<P>Outcome variables need to be more patient centred. This might include satisfaction, reduction in anxiety or other measures relating the patient's perception.</P>
<P>A wider debate needs to be had on the purpose of sedation. The majority of studies to date, focus on the use of sedation as a tool to facilitate the delivery of dental treatment in children. This is important; but sedation could (and should) have a larger role. It could be used to facilitate the introduction of treatment to anxious children with a view to reducing or removing sedation in subsequent visits (an approach taken by <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>). Outcome variables should be chosen to reflect this.</P>
<P>Where behaviour-type outcome measures are used, thought must be given to the appropriateness of movement based measures for children who are restrained e.g. by a papoose board.</P>
<P>Considering the above comments the authors would suggest that reviews have the following "key" or "core" variables in common to allow comparison between studies in future.</P>
<P>1. Some measurement of baseline anxiety.</P>
<P>2. Completion of treatment as the primary outcome variable.</P>
<P>3. Patient satisfaction or preference</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Deep versus conscious sedation</HEADING>
<P>It was originally intended to exclude any papers that dealt with deep sedation for reasons outlined in the introduction. This proved to be impossible because many papers did not state explicitly whether they were practicing conscious or deep sedation, sleeping was also poorly reported. We suspect that in some of these papers deep sedation was undertaken, as participants were reported as falling asleep and mouth props were used. This highlights the importance of reaching a consensus definition of conscious sedation, or at the very least using the definitions already available. Without this information it is impossible for researchers or clinicians in countries where the existing regulatory framework does not permit deep sedation to make appropriate use of published data. Alternatively the definition of deep sedation could be abandoned, as it is not used.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Agents/regimens under test</HEADING>
<P>There are 28 sedative drugs or drug combinations tested for conscious sedation in this review, given either orally, by inhalation, intramuscular injections, intranasally and/or rectally and at varying dosages. The majority were not compared against a placebo or even a drug of known efficacy. We suggest that future trials consider the use of either oral midazolam or possibly nitrous oxide sedation as a comparator.</P>
<P>As mentioned, not all agents are available in all countries and the choice of sedation will depend on cultural acceptance and also laws and availability. It would seem appropriate to identify agents of particular interest and co-ordinate research on these internationally. Furthermore it would seem appropriate for different countries to investigate those drugs and modes of delivery that are most appropriate for them.</P>
<P>A further problem is the use of supplemental nitrous oxide/oxygen. This is often used in studies (particularly from North America) and would be expected to increase the overall level of sedation. Whilst there is nothing wrong in using supplemental nitrous oxide/oxygen it needs to be made clear from the outset that this is the case in clinical trials. Unfortunately it is often not mentioned initially when agents under test are described. For example the drug under investigation should be given as chloral hydrate and nitrous oxide/oxygen rather than just chloral hydrate with a subsequent note buried in the text describing the use of supplemental nitrous oxide oxygen.</P>
<P>Finally the use of papoose boards needs to be clarified. What is the impact of physical restraint on sedative effectiveness? Or anxiety reduction? Further work needs to be done on the role of physical restraints in sedation of children. However it is important that use of papoose board in a clinical trial of sedation should also be specified clearly from the outset.</P>
</SUBSECTION>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2011-09-26 12:49:08 +0100" MODIFIED_BY="[Empty name]">
<P>The review authors would like to thank the two translators, Pati Pungchanchaikul and Jens Poppen. We also acknowledge the help and assistance of the Cochrane Oral Health Group.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-02-09 17:36:54 +0000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Liege Matharu contributed to all aspects of this review, in particular data collection and interpretation of data.</LI>
<LI>Paul Ashley contributed to all aspects of this review, in particular data extraction, analysis and interpretation of data and entering data into RevMan.</LI>
<LI>Sue Furness contributed to all aspects of the 2011 update of this review, in particular data extraction, analysis and interpretation of data and entering data into RevMan.</LI>
</UL>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2012-02-09 17:37:59 +0000" MODIFIED_BY="[Empty name]">
<P>For the current update of this review it was decided that crossover studies should be excluded. Crossover trials are recommended in situations where the underlying condition is stable and the effect of the first intervention period is unlikely to alter the outcome of the second or subsequent intervention period (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). While many researchers have used a crossover trial design to investigate sedation techniques in children it is well known that a negative dental experience has an impact on a patient's willingness to undergo subsequent dental treatment, an effect that may last for many years. In fact trials frequently state that one of the reasons that sedation is desirable for children undergoing potentially frightening and painful dental procedures is the potential effect that dental treatment in childhood may have on the individuals willingness to undergo dental treatment as an adult "that the psychological implications of the first appointment could have a bearing on the second" (<LINK REF="STD-Shapira-1996" TYPE="STUDY">Shapira 1996</LINK>).</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-02-10 17:17:07 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-02-10 17:05:20 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abrams-1993" MODIFIED="2012-02-10 16:04:59 +0000" MODIFIED_BY="[Empty name]" NAME="Abrams 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-10 16:04:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abrams R, Morrison JE, Villasenor A, Hencmann D, Da Fonseca M, Mueller W</AU>
<TI>Safety and effectiveness of intranasal administration of sedative medications (ketamine, midazolam, or sufentanil) for urgent brief pediatric dental procedures</TI>
<SO>Anesthesia Progress</SO>
<YR>1993</YR>
<VL>40</VL>
<NO>3</NO>
<PG>63-6</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:23:05 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alfonzo_x002d_Echeverri-1993" MODIFIED="2012-02-10 16:05:05 +0000" MODIFIED_BY="[Empty name]" NAME="Alfonzo-Echeverri 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-10 16:05:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alfonzo-Echeverri EC, Berg JH, Wild TW, Glass NL</AU>
<TI>Oral ketamine for pediatric outpatient dental surgery sedation</TI>
<SO>Pediatric Dentistry</SO>
<YR>1993</YR>
<VL>15</VL>
<NO>3</NO>
<PG>182-5</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:24:12 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Rakaf-2001" MODIFIED="2012-02-10 16:05:13 +0000" MODIFIED_BY="[Empty name]" NAME="Al-Rakaf 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-02-10 16:05:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Rakaf H, Bello LL, Turkustani A, Adenubi JO</AU>
<TI>Intra-nasal midazolam in conscious sedation of young paediatric dental patients</TI>
<SO>International Journal of Paediatric Dentistry</SO>
<YR>2001</YR>
<VL>11</VL>
<NO>1</NO>
<PG>33-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Avalos_x002d_Arenas-1998" MODIFIED="2012-02-10 16:05:38 +0000" MODIFIED_BY="[Empty name]" NAME="Avalos-Arenas 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-02-10 16:05:38 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Avalos-Arenas V, Moyao-Garcia D, Nava-Ocampo AA, Zayas-Carranza RE, Fragoso-Rios R</AU>
<TI>Is chloral hydrate/hydroxyzine a good option for paediatric dental outpatient sedation?</TI>
<SO>Current Medical Research and Opinion</SO>
<YR>1998</YR>
<VL>14</VL>
<NO>4</NO>
<PG>219-26</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:24:18 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Averley-2004a" MODIFIED="2012-02-10 16:05:42 +0000" MODIFIED_BY="[Empty name]" NAME="Averley 2004a" YEAR="2004">
<REFERENCE MODIFIED="2012-02-10 16:05:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Averley PA, Lane I, Sykes J, Girdler NM, Steen N, Bond S</AU>
<TI>An RCT pilot study to test the effects of intravenous midazolam as a conscious sedation technique for anxious children requiring dental treatment - an alternative to general anaesthesia</TI>
<SO>British Dental Journal</SO>
<YR>2004</YR>
<VL>197</VL>
<NO>9</NO>
<PG>553-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Averley-2004b" MODIFIED="2012-02-10 16:06:44 +0000" MODIFIED_BY="[Empty name]" NAME="Averley 2004b" YEAR="2004">
<REFERENCE MODIFIED="2012-02-10 16:06:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Averley PA, Girdler NM, Bond S, Steen N, Steele J</AU>
<TI>A randomised controlled trial of paediatric conscious sedation for dental treatment using intravenous midazolam combined with inhaled nitrous oxide or nitrous oxide/sevoflurane</TI>
<SO>Anaesthesia</SO>
<YR>2004</YR>
<VL>59</VL>
<NO>9</NO>
<PG>844-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aydintug-2004" MODIFIED="2011-08-09 11:07:14 +0100" MODIFIED_BY="[Empty name]" NAME="Aydintug 2004" YEAR="2004">
<REFERENCE MODIFIED="2011-08-09 11:07:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aydintug YS, Okcu KM, Guner Y, Gunaydin Y, Sencimen M</AU>
<TI>Evaluation of oral or rectal midazolam as conscious sedation for pediatric patients in oral surgery</TI>
<SO>Military Medicine</SO>
<YR>2004</YR>
<VL>169</VL>
<NO>4</NO>
<PG>270-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baygin-2010" MODIFIED="2012-02-10 16:06:59 +0000" MODIFIED_BY="[Empty name]" NAME="Baygin 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-02-10 16:06:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baygin O, Bodur H, Isik B</AU>
<TI>Effectiveness of premedication agents administered prior to nitrous oxide/oxygen</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>2010</YR>
<VL>27</VL>
<NO>4</NO>
<PG>341-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bui-2002" MODIFIED="2008-07-28 11:46:33 +0100" MODIFIED_BY="[Empty name]" NAME="Bui 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-28 11:46:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bui T, Redden RJ, Murphy S</AU>
<TI>A comparison study between ketamine and ketamine-promethazine combination for oral sedation in pediatric dental patients</TI>
<SO>Anesthesia Progress</SO>
<YR>2002</YR>
<VL>49</VL>
<NO>1</NO>
<PG>14-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Faytrouny-2007" MODIFIED="2012-02-10 16:07:33 +0000" MODIFIED_BY="[Empty name]" NAME="Faytrouny 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 16:07:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Faytrouny M, Okte Z, Kucukyavuz Z</AU>
<TI>Comparison of two different dosages of hydroxyzine for sedation in the paediatric dental patient</TI>
<SO>International Journal of Paediatric Dentistry</SO>
<YR>2007</YR>
<VL>17</VL>
<NO>5</NO>
<PG>378-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallardo-1994" MODIFIED="2011-10-31 11:24:55 +0000" MODIFIED_BY="[Empty name]" NAME="Gallardo 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-08-11 17:19:53 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Auil B, Cornejo G, Gallardo F</AU>
<TI>Flunitrazepam and diazepam compared as sedatives in children</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1983</YR>
<VL>50</VL>
<NO>6</NO>
<PG>442-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-10-31 11:24:55 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gallardo F, Cornejo G, Borie R</AU>
<TI>Oral midazolam as premedication for the apprehensive child before dental treatment</TI>
<SO>Journal of Clinical Paediatric Dentistry</SO>
<YR>1994</YR>
<VL>18</VL>
<NO>2</NO>
<PG>123-7</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:24:55 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Isik-2008a" MODIFIED="2012-02-10 16:08:18 +0000" MODIFIED_BY="[Empty name]" NAME="Isik 2008a" YEAR="2008">
<REFERENCE MODIFIED="2012-02-10 16:08:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isik B, Baygin O, Bodur H</AU>
<TI>Premedication with melatonin vs midazolam in anxious children</TI>
<SO>Pediatric anesthesia</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>7</NO>
<PG>635-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Isik-2008b" MODIFIED="2011-05-18 16:24:28 +0100" MODIFIED_BY="[Empty name]" NAME="Isik 2008b" YEAR="2008">
<REFERENCE MODIFIED="2011-05-18 16:24:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isik B, Baygin O, Bodur H</AU>
<TI>Oral midazolam premedication in anxious children: effectiveness of different doses</TI>
<SO>Anestezi Dergisi</SO>
<YR>2008</YR>
<VL>16</VL>
<NO>1</NO>
<PG>34-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jensen-1999" MODIFIED="2012-02-10 16:08:47 +0000" MODIFIED_BY="[Empty name]" NAME="Jensen 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-02-10 16:08:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jensen B, Schroder U, Mansson U</AU>
<TI>Rectal sedation with diazepam or midazolam during extractions of traumatized primary incisors: a prospective, randomized, double-blind trial in Swedish children aged 1.5-3.5 years</TI>
<SO>Acta Odontologica Scandinavia</SO>
<YR>1999</YR>
<VL>57</VL>
<NO>4</NO>
<PG>190-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kapur-2004" MODIFIED="2008-07-28 11:46:42 +0100" MODIFIED_BY="[Empty name]" NAME="Kapur 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-07-28 11:46:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kapur A, Chawla HS, Goyal A, Gauba K, Bhardwaj N</AU>
<TI>Efficacy and acceptability of oral-transmucosal midazolam as a conscious sedation agent in pre-school children</TI>
<SO>Journal of the Indian Society of Pedodontics and Preventive Dentistry</SO>
<YR>2004</YR>
<VL>22</VL>
<NO>3</NO>
<PG>109-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koirala-2006" MODIFIED="2012-02-10 16:09:51 +0000" MODIFIED_BY="[Empty name]" NAME="Koirala 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 16:09:51 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koirala B, Pandey RK, Saksen AK, Kumar R, Sharma S</AU>
<TI>A comparative evaluation of newer sedatives in conscious sedation</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>2006</YR>
<VL>30</VL>
<NO>4</NO>
<PG>273-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lahoud-2002" MODIFIED="2009-11-26 09:52:59 +0000" MODIFIED_BY="[Empty name]" NAME="Lahoud 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lahoud GY, Averley PA</AU>
<TI>Comparison of sevoflurane and nitrous oxide mixture with nitrous oxide alone for inhalation conscious sedation in children having dental treatment: a randomised controlled trial</TI>
<SO>Anaesthesia</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>5</NO>
<PG>446-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lam-2005" MODIFIED="2012-02-10 16:11:39 +0000" MODIFIED_BY="[Empty name]" NAME="Lam 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-02-10 16:11:39 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lam C, Udin, RD, Malamed SF, Good DL, Forrest JL</AU>
<TI>Midazolam premedication in children: a pilot study comparing intramuscular and intranasal administration</TI>
<SO>Anesthesia Progress</SO>
<YR>2005</YR>
<VL>52</VL>
<NO>2</NO>
<PG>56-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lee_x002d_Kim-2004" MODIFIED="2012-02-10 16:12:00 +0000" MODIFIED_BY="[Empty name]" NAME="Lee-Kim 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-02-10 16:12:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lee-Kim SJ, Fadavi S, Punwani I, Koerber A</AU>
<TI>Nasal versus oral midazolam sedation for pediatric dental patients</TI>
<SO>Journal of Dentistry for Children</SO>
<YR>2004</YR>
<VL>71</VL>
<NO>2</NO>
<PG>126-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McKee-1990" NAME="McKee 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McKee K, Nazif MM, Jackson DL, Barnhart DC, Close J, Moore PA</AU>
<TI>Dose-responsive characteristics of meperidine sedation in preschool children</TI>
<SO>Pediatric Dentistry</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>4</NO>
<PG>222-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Meyer-1990" MODIFIED="2009-11-26 09:52:45 +0000" MODIFIED_BY="[Empty name]" NAME="Meyer 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Meyer M, Mourino AP, Farrington FH</AU>
<TI>Comparison of triazolam to a chloral hydrate/hydroxyzine combination in the sedation of pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>5</NO>
<PG>283-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moody-1986" MODIFIED="2011-09-26 14:38:56 +0100" MODIFIED_BY="[Empty name]" NAME="Moody 1986" YEAR="1986">
<REFERENCE MODIFIED="2011-09-26 14:38:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moody EH Jr, Mourino AP, Campbell RL</AU>
<TI>The therapeutic effectiveness of nitrous oxide and chloral hydrate administered orally, rectally, and combined with hydroxyzine for pediatric dentistry</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1986</YR>
<VL>53</VL>
<NO>6</NO>
<PG>425-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moore-1984" NAME="Moore 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore PA, Mickey EA, Hargreaves JA, Needleman HL</AU>
<TI>Sedation in pediatric dentistry: a practical assessment procedure</TI>
<SO>Journal American Dental Association</SO>
<YR>1984</YR>
<VL>109</VL>
<NO>4</NO>
<PG>564-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mortazavi-2009" MODIFIED="2011-10-31 11:26:44 +0000" MODIFIED_BY="[Empty name]" NAME="Mortazavi 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-10-31 11:26:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mortazavi M, Pourhashemi SJ, Khosravi MB, Ashtari S, Ghaderi F</AU>
<TI>Assessment of a low dose of IV midazolam used orally for conscious sedation in pediatric dentistry</TI>
<SO>Daru</SO>
<YR>2009</YR>
<VL>17</VL>
<NO>2</NO>
<PG>79-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nathan-1988" MODIFIED="2009-11-26 09:52:35 +0000" MODIFIED_BY="[Empty name]" NAME="Nathan 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nathan JE, Venham LL, West MS, Werboff J</AU>
<TI>The effects of nitrous oxide on anxious young pediatric patients across sequential visits: a double-blind study</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1988</YR>
<VL>55</VL>
<NO>3</NO>
<PG>220-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rai-2007" MODIFIED="2012-02-10 16:12:27 +0000" MODIFIED_BY="[Empty name]" NAME="Rai 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 16:12:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rai K, Hegde M, Goel K</AU>
<TI>Sedation in uncooperative children undergoing dental procedures: a comparative evaluation of midazolam, propofol and ketamine</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>2007</YR>
<VL>32</VL>
<NO>1</NO>
<PG>1-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reeves-1996" MODIFIED="2011-10-31 11:27:04 +0000" MODIFIED_BY="[Empty name]" NAME="Reeves 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-10-31 11:27:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reeves ST, Wiedenfeld KR, Wrobleski J, Hardin CL, Pinosky ML</AU>
<TI>A randomized double-blind trial of chloral hydrate/hydroxyzine versus midazolam/acetaminophen in the sedation of pediatric dental outpatients</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1996</YR>
<VL>63</VL>
<NO>2</NO>
<PG>95-100</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:27:04 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roelofse-1996a" NAME="Roelofse 1996a" YEAR="1996">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roelofse JA, Joubert JJ, Roelofse PG</AU>
<TI>A double-blind randomized comparison of midazolam alone and midazolam combined with ketamine for sedation of pediatric dental patients</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1996</YR>
<VL>54</VL>
<NO>7</NO>
<PG>838-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roelofse-1996b" MODIFIED="2012-02-10 16:12:43 +0000" MODIFIED_BY="[Empty name]" NAME="Roelofse 1996b" YEAR="1996">
<REFERENCE MODIFIED="2012-02-10 16:12:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roelofse JA, Joubert JJ, Swart LC, Stander I, Roelofse PG</AU>
<TI>An evaluation of the effect of oral ketamine and standard oral premedication in the sedation of paediatric dental patients</TI>
<SO>Journal of the Dental Association of South Africa</SO>
<YR>1996</YR>
<VL>51</VL>
<NO>4</NO>
<PG>197-201</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:27:18 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roelofse-1998" MODIFIED="2012-02-10 16:15:07 +0000" MODIFIED_BY="[Empty name]" NAME="Roelofse 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-02-10 16:15:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roelofse JA, Louw LR, Roelofse PG</AU>
<TI>A double blind randomized comparison of oral trimeprazine-methadone and ketamine-midazolam for sedation of pediatric dental patients for oral surgical procedures</TI>
<SO>Anaesthesia Progress</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>1</NO>
<PG>3-11</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:27:27 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sams-1993a" MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]" NAME="Sams 1993a" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sams DR, Cook EW, Jackson JG, Roebuck BL</AU>
<TI>Behavioral assessments of two drug combinations for oral sedation</TI>
<SO>Pediatric Dentistry</SO>
<YR>1993</YR>
<VL>15</VL>
<NO>3</NO>
<PG>186-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shashikiran-2006" MODIFIED="2012-02-10 16:17:29 +0000" MODIFIED_BY="[Empty name]" NAME="Shashikiran 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 16:17:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shashikiran ND, Reddy SV, Yavagal CM</AU>
<TI>Conscious sedation--an artist&#8217;s science! An Indian experience with midazolam</TI>
<SO>Journal of the Indian Society of Pedodontics and Preventive Dentistry</SO>
<YR>2006</YR>
<VL>24</VL>
<NO>1</NO>
<PG>7-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singh-2002" MODIFIED="2012-02-10 16:17:56 +0000" MODIFIED_BY="[Empty name]" NAME="Singh 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-02-10 16:17:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singh N, Pandey RK, Saksena AK, Jaiswal JN</AU>
<TI>A comparative evaluation of oral midazolam with other sedatives as premedication in pediatric dentistry</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>2002</YR>
<VL>26</VL>
<NO>2</NO>
<PG>161-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torres_x002d_Perez-2007" MODIFIED="2012-02-10 16:18:21 +0000" MODIFIED_BY="[Empty name]" NAME="Torres-Perez 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 16:18:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torres-Perez J, Tapia-Garcia I, Rosales-Berber MA, Hernandez-Sierra JF, Pozos-Guillen AJ</AU>
<TI>Comparison of three conscious sedation regimens for pediatric dental patients</TI>
<SO>Journal of Paediatric Dentistry</SO>
<YR>2007</YR>
<VL>31</VL>
<NO>2</NO>
<PG>183-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Veerkamp-1993" MODIFIED="2012-02-10 16:24:24 +0000" MODIFIED_BY="[Empty name]" NAME="Veerkamp 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-10 16:23:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veerkamp JS, Gruythuysen RJ, Hoogstraten J, van Amerongen WE</AU>
<TI>Dental treatment of fearful children using nitrous oxide. Part 4: Anxiety after two years</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1993</YR>
<VL>60</VL>
<NO>4</NO>
<PG>372-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-10 16:24:24 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veerkamp JS, Gruythuysen RJ, van Amerongen WE, Hoogstraten J</AU>
<TI>Dental treatment of fearful children using nitrous oxide. Part 2: The parents' point of view</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1992</YR>
<VL>59</VL>
<NO>2</NO>
<PG>115-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-12-04 14:12:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Veerkamp JS, Gruythuysen RJ, van Amerongen WE, Hoogstraten J</AU>
<TI>Dental treatment of fearful children using nitrous oxide. Part 3: Anxiety during sequential visits</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1993</YR>
<VL>60</VL>
<NO>3</NO>
<PG>175-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-10 16:20:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veerkamp JS, van Amerongen WE, Hoogstraten J, Groen HJ</AU>
<TI>Dental treatment of fearful children, using nitrous oxide. Part I: Treatment times</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1991</YR>
<VL>58</VL>
<NO>6</NO>
<PG>453-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wan-2006" MODIFIED="2012-02-10 16:27:06 +0000" MODIFIED_BY="[Empty name]" NAME="Wan 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 16:27:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wan K, Jing Q, Zhao JZ</AU>
<TI>Evaluation of oral midazolam as conscious sedation for pediatric patients in oral restoration</TI>
<SO>Chinese Medical Sciences Journal</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>3</NO>
<PG>163-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-02-10 17:05:20 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Al_x002d_Zahrani-2009" MODIFIED="2011-05-18 16:03:59 +0100" MODIFIED_BY="[Empty name]" NAME="Al-Zahrani 2009" YEAR="2009">
<REFERENCE MODIFIED="2011-05-18 16:03:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Al-Zahrani AM, Wyne AH, Sheta SA</AU>
<TI>Comparison of oral midazolam with a combination of oral midazolam and nitrous oxide-oxygen inhalation in the effectiveness of dental sedation for young children</TI>
<SO>Journal of the Indian Society of Pedodontics and Preventive Dentistry</SO>
<YR>2009</YR>
<VL>27</VL>
<NO>1</NO>
<PG>9-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Arya-2002" NAME="Arya 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arya VS, Damle SG</AU>
<TI>Comparative evaluation of midazolam and propofol as intravenous sedative agents in the management of unco-operative children</TI>
<SO>Journal of the Indian Society of Pedodontics and Preventative Dentistry</SO>
<YR>2002</YR>
<VL>20</VL>
<NO>1</NO>
<PG>6-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Badalaty-1990" MODIFIED="2012-02-10 16:28:18 +0000" MODIFIED_BY="[Empty name]" NAME="Badalaty 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-02-10 16:28:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Badalaty MM, Houpt MI, Koenigsberg SR, Maxwell KC, Desjardins PJ</AU>
<TI>A comparison of chloral hydrate and diazepam sedation in young children</TI>
<SO>Pediatric Dentistry</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>1</NO>
<PG>33-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baldinelli-1989" NAME="Baldinelli 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baldinelli L, Melloti R</AU>
<TI>Outpatient intravenous sedation</TI>
<SO>Anesthesia Progress</SO>
<YR>1989</YR>
<VL>36</VL>
<NO>4-5</NO>
<PG>157-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Berge-1999" NAME="Berge 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berge TI</AU>
<TI>Acceptance and side effects of nitrous oxide oxygen sedation for oral surgical procedures</TI>
<SO>Acta Odontologica Scandinavica</SO>
<YR>1999</YR>
<VL>57</VL>
<NO>4</NO>
<PG>201-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Blake-1999" NAME="Blake 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Blake K</AU>
<TI>A comparison of midazolam and propofol for dental sedation</TI>
<SO>National Research Register Document</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Campbell-1998" NAME="Campbell 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Campbell RL, Ross GA, Campbell JR, Mourino AP</AU>
<TI>Comparison of oral chloral hydrate with intramuscular ketamine, meperidine, and promethazine for pediatric sedation-preliminary report</TI>
<SO>Anesthesia Progress</SO>
<YR>1998</YR>
<VL>45</VL>
<NO>2</NO>
<PG>46-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cathers-2005" MODIFIED="2012-02-10 16:30:35 +0000" MODIFIED_BY="[Empty name]" NAME="Cathers 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-02-10 16:30:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cathers JW, Wilson CF, Webb MD, Alvarez ME, Schiffman T, Taylor S</AU>
<TI>A comparison of two meperidine/hydroxyzine sedation regimens for the uncooperative pediatric dental patient</TI>
<SO>Pediatric Dentistry</SO>
<YR>2005</YR>
<VL>27</VL>
<NO>5</NO>
<PG>395-400</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chaushu-2002" NAME="Chaushu 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chaushu S, Gozal D, Becker A</AU>
<TI>Intravenous sedation: an adjunct to enable orthodontic treatment for children with disabilities</TI>
<SO>European Journal of Orthodontics</SO>
<YR>2002</YR>
<VL>24</VL>
<NO>1</NO>
<PG>81-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coldwell-1999" NAME="Coldwell 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coldwell SE, Awamura KA, Milgrom P, Depner KS, Kaufman E, Preston KL et al</AU>
<TI>Side effects of triazolam in children</TI>
<SO>Pediatric Dentistry</SO>
<YR>1999</YR>
<VL>21</VL>
<NO>1</NO>
<PG>18-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Da-Costa-2007" MODIFIED="2012-02-10 16:31:10 +0000" MODIFIED_BY="[Empty name]" NAME="Da Costa 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 16:31:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>da Costa LR, da Costa PS, Lima AR</AU>
<TI>A randomized double-blinded trial of chloral hydrate with or without hydroxyzine versus placebo for pediatric dental sedation</TI>
<SO>Brazilian Dental Journal</SO>
<YR>2007</YR>
<VL>18</VL>
<NO>4</NO>
<PG>334-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dallman--2001" MODIFIED="2010-11-09 13:39:05 +0000" MODIFIED_BY="[Empty name]" NAME="Dallman  2001" YEAR="2001">
<REFERENCE MODIFIED="2010-11-09 13:39:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dallman JA, Ignelzi MA Jr, Briskie DM</AU>
<TI>Comparing the safety, efficacy and recovery of intranasal midazolam vs. oral chloral hydrate and promethazine</TI>
<SO>Pediatric Dentistry</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>5</NO>
<PG>424-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Davila-1990" NAME="Davila 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Davila JM</AU>
<TI>Restraint and sedation of the dental patient with developmental disabilities</TI>
<SO>Special Care Dentist</SO>
<YR>1990</YR>
<VL>10</VL>
<NO>6</NO>
<PG>210-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Doring-1985" NAME="Doring 1985" YEAR="1985">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doring KR</AU>
<TI>Evaluation of an alphaprodine-hydroxyzine combination as a sedative agent in the treatment of the pediatric dental patient</TI>
<SO>Journal of the American Dental Association</SO>
<YR>1985</YR>
<VL>111</VL>
<NO>4</NO>
<PG>567-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Downs-1997" MODIFIED="2010-11-09 13:40:02 +0000" MODIFIED_BY="[Empty name]" NAME="Downs 1997" YEAR="1997">
<REFERENCE MODIFIED="2010-11-09 13:40:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Downs AT, Dembo J, Ferretti G, Lyons TD, Pelphery A</AU>
<TI>A comparative study of midazolam to meperidine/promethazine as an IM sedative technique for the pediatric dental patient</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1997</YR>
<VL>64</VL>
<NO>3</NO>
<PG>197-200</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duncan-1984" MODIFIED="2012-02-10 16:31:43 +0000" MODIFIED_BY="[Empty name]" NAME="Duncan 1984" YEAR="1984">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duncan GH, Moore P</AU>
<TI>Nitrous oxide and the dental patient: a review of adverse reactions</TI>
<SO>Journal of the American Dental Association</SO>
<YR>1984</YR>
<VL>108</VL>
<NO>2</NO>
<PG>213-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Duncan-1994" MODIFIED="2012-02-10 16:31:54 +0000" MODIFIED_BY="[Empty name]" NAME="Duncan 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Duncan WK, De Ball S, Perkins TM</AU>
<TI>Chloral hydrate sedation: A simple technique</TI>
<SO>Compendium</SO>
<YR>1994</YR>
<VL>15</VL>
<NO>7</NO>
<PG>884-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunn_x002d_Russell-1993" MODIFIED="2012-02-10 16:32:18 +0000" MODIFIED_BY="[Empty name]" NAME="Dunn-Russell 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-10 16:32:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunn-Russell T, Adair SM, Sams DR, Russell CM, Barenie JT</AU>
<TI>Oxygen saturation and diffusion hypoxia in children following nitrous oxide sedation</TI>
<SO>Pediatric Dentistry</SO>
<YR>1993</YR>
<VL>15</VL>
<NO>2</NO>
<PG>88-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-el-Magboul-1995" MODIFIED="2012-02-10 16:32:54 +0000" MODIFIED_BY="[Empty name]" NAME="el Magboul 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-02-10 16:32:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>el Magboul KM, O'Sullivan EA, Curzon ME</AU>
<TI>A clinical trial comparing two doses of oral temazepam for sedation of paediatric dental patients</TI>
<SO>International Journal of Paediatric Dentistry</SO>
<YR>1995</YR>
<VL>5</VL>
<NO>2</NO>
<PG>97-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erlandsson-2001" NAME="Erlandsson 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erlandsson AL, Backman B, Stenstrom A, Stecksen-Blicks C</AU>
<TI>Conscious sedation by oral administration of midazolam in paediatric dental treatment</TI>
<SO>Swedish Dental Journal</SO>
<YR>2001</YR>
<VL>25</VL>
<NO>3</NO>
<PG>97-104</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Evans-1966" MODIFIED="2012-02-10 16:33:49 +0000" MODIFIED_BY="[Empty name]" NAME="Evans 1966" YEAR="1966">
<REFERENCE MODIFIED="2012-02-10 16:33:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Evans WO, Tannenbaum K, Turek B, Ailing EF</AU>
<TI>A method for evaluating the use of premedicating agents in difficult pedodontic patients</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1966</YR>
<VL>33</VL>
<PG>317-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Flaitz-1985" MODIFIED="2012-02-10 16:34:17 +0000" MODIFIED_BY="[Empty name]" NAME="Flaitz 1985" YEAR="1985">
<REFERENCE MODIFIED="2012-02-10 16:34:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flaitz CM, Novak AJ</AU>
<TI>Evaluation of the sedative effect of rectally administered diazepam for the young dental patient</TI>
<SO>Pediatric Dentistry</SO>
<YR>1985</YR>
<VL>7</VL>
<NO>4</NO>
<PG>292-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-11-09 13:42:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Flaitz CM, Nowak AJ, Hicks MJ</AU>
<TI>Double-blind comparison of rectally administered diazepam to placebo for pediatric sedation: the cardiovascular response</TI>
<SO>Anesthesia Progress</SO>
<YR>1985</YR>
<VL>32</VL>
<NO>6</NO>
<PG>232-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fuks-1994" MODIFIED="2011-10-31 11:32:29 +0000" MODIFIED_BY="Paul Francis Ashley" NAME="Fuks 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-10-31 11:32:29 +0000" MODIFIED_BY="Paul Francis Ashley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fuks AB, Kaufman E, Ram D, Hovav S, Shapira J</AU>
<TI>Assessment of two doses of intranasal midazolam for sedation of young pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>1994</YR>
<VL>16</VL>
<NO>4</NO>
<PG>301-5</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:32:29 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fukuta-1993" MODIFIED="2012-02-10 16:34:48 +0000" MODIFIED_BY="[Empty name]" NAME="Fukuta 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-10 16:34:48 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fukuta O, Braham RL, Yanase H, Atsumi N, Kurosu K</AU>
<TI>The sedative effect of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 1: the effect of a 0.2 mg/kg dose</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>1993</YR>
<VL>17</VL>
<NO>4</NO>
<PG>231-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fukuta-1994" MODIFIED="2012-02-10 16:35:18 +0000" MODIFIED_BY="[Empty name]" NAME="Fukuta 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-02-10 16:35:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fukuta O, Braham RL, Yanase H, Kurosu K</AU>
<TI>The sedative effects of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 2: optimal concentration of intranasal midazolam</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>1994</YR>
<VL>18</VL>
<NO>4</NO>
<PG>259-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallardo-1984" MODIFIED="2010-11-09 13:43:31 +0000" MODIFIED_BY="[Empty name]" NAME="Gallardo 1984" YEAR="1984">
<REFERENCE MODIFIED="2010-11-09 13:43:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallardo F, Cornejo G, Auil B</AU>
<TI>Premedication with flunitrazepam, diazepam and placebo in the apprehensive child</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1984</YR>
<VL>51</VL>
<NO>3</NO>
<PG>208-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gamonal-Aravena-1989" MODIFIED="2012-02-10 16:37:46 +0000" MODIFIED_BY="[Empty name]" NAME="Gamonal Aravena 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-02-10 16:37:26 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gamonal Aravena J</AU>
<TI>Effectiveness of chlormezanone and flunitrazepam in treatment of difficult children</TI>
<SO>Revista Dental de Chile</SO>
<YR>1989</YR>
<VL>80</VL>
<NO>2</NO>
<PG>64-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garton-1970" NAME="Garton 1970" YEAR="1970">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garton J</AU>
<TI>Intravenous sedation in dental practice</TI>
<SO>Dental Student</SO>
<YR>1970</YR>
<VL>48</VL>
<NO>9</NO>
<PG>66-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Haas-1996" MODIFIED="2010-11-09 13:44:31 +0000" MODIFIED_BY="[Empty name]" NAME="Haas 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-11-09 13:44:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Haas DA, Nenninger SA, Yacobi R, Magathan JG, Grad HA, Copp PE et al</AU>
<TI>A pilot study of the efficacy of oral midazolam for sedation in pediatric dental patients</TI>
<SO>Anesthesia Progress</SO>
<YR>1996</YR>
<VL>43</VL>
<NO>1</NO>
<PG>1-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-2006" MODIFIED="2012-02-10 16:39:41 +0000" MODIFIED_BY="[Empty name]" NAME="Hall 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 16:39:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall DL, Tatakis DN, Walters JD, Rezvan E</AU>
<TI>Oral clonidine pre-treatment and diazepam/meperidine sedation</TI>
<SO>Journal of Dental Research</SO>
<YR>2006</YR>
<VL>85</VL>
<NO>9</NO>
<PG>854-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hartgraves-1994" MODIFIED="2012-02-10 16:39:54 +0000" MODIFIED_BY="Paul Francis Ashley" NAME="Hartgraves 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-02-10 16:39:54 +0000" MODIFIED_BY="Paul Francis Ashley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hartgraves PM, Primosch RE</AU>
<TI>An evaluation of oral and nasal midazolam for pediatric dental sedation</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1994</YR>
<VL>61</VL>
<NO>3</NO>
<PG>175-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hasty-1991" MODIFIED="2011-10-31 11:33:06 +0000" MODIFIED_BY="[Empty name]" NAME="Hasty 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-10-31 11:33:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasty MF, Vann WF Jr, Dilley DC, Anderson JA</AU>
<TI>Conscious sedation of pediatric dental patients: an investigation of chloral hydrate, hydroxyzine pamoate, and meperidine vs. chloral hydrate and hydroxyzine pamoate</TI>
<SO>Pediatric Dentistry</SO>
<YR>1991</YR>
<VL>13</VL>
<NO>1</NO>
<PG>10-9</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:33:06 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heard-2010" MODIFIED="2012-02-10 16:40:10 +0000" MODIFIED_BY="[Empty name]" NAME="Heard 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-02-10 16:40:10 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heard C, Smith J, Creighton P, Joshi P, Feldman D, Lerman J</AU>
<TI>A comparison of four sedation techniques for pediatric dental surgery</TI>
<SO>Pediatric Anesthesia</SO>
<YR>2010</YR>
<VL>20</VL>
<NO>10</NO>
<PG>924-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Henry-1990" MODIFIED="2012-02-10 16:40:21 +0000" MODIFIED_BY="[Empty name]" NAME="Henry 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-02-10 16:40:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Henry RJ, Jerrell RG</AU>
<TI>Ambient nitrous oxide levels during pediatric sedations</TI>
<SO>Pediatric Dentistry</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>20</NO>
<PG>87-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Houpt-1985a" MODIFIED="2010-11-09 13:48:05 +0000" MODIFIED_BY="[Empty name]" NAME="Houpt 1985a" YEAR="1985">
<REFERENCE MODIFIED="2010-11-09 13:48:05 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Houpt MI, Weiss NJ, Koenigsberg SR, Desjardins PJ</AU>
<TI>Comparison of chloral hydrate with and without promethazine in the sedation of young children</TI>
<SO>Pediatric Dentistry</SO>
<YR>1985</YR>
<VL>7</VL>
<NO>1</NO>
<PG>41-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Houpt-1985b" MODIFIED="2010-11-09 13:48:13 +0000" MODIFIED_BY="[Empty name]" NAME="Houpt 1985b" YEAR="1985">
<REFERENCE MODIFIED="2010-11-09 13:48:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Houpt MI, Sheskin RB, Koenigsberg SR, Desjardins PJ, Shey Z</AU>
<TI>Assessing chloral hydrate dosage for young children</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1985</YR>
<VL>52</VL>
<NO>5</NO>
<PG>364-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Houpt-1989" MODIFIED="2010-11-09 13:48:22 +0000" MODIFIED_BY="[Empty name]" NAME="Houpt 1989" YEAR="1989">
<REFERENCE MODIFIED="2010-11-09 13:48:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Houpt M, Manetas C, Joshi A, Desjardins P</AU>
<TI>Effects of chloral hydrate on nitrous oxide sedation of children</TI>
<SO>Pediatric Dentistry</SO>
<YR>1989</YR>
<VL>11</VL>
<NO>1</NO>
<PG>26-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Houpt-1996" MODIFIED="2010-11-09 13:48:30 +0000" MODIFIED_BY="[Empty name]" NAME="Houpt 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-11-09 13:48:30 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Houpt MI, Kupietzky A, Tofsky NS, Koenigsberg SR</AU>
<TI>Effects of nitrous oxide on diazepam sedation of young children</TI>
<SO>Pediatric Dentistry</SO>
<YR>1996</YR>
<VL>18</VL>
<NO>3</NO>
<PG>236-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hulland-2002" NAME="Hulland 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hulland SA, Freilich MM, Sandor GK</AU>
<TI>Nitrous oxide-oxygen or oral midazolam for pediatric outpatient sedation</TI>
<SO>Oral Surgery Oral Medicine Oral Pathology Oral Radiology Endodontics</SO>
<YR>2002</YR>
<VL>93</VL>
<NO>6</NO>
<PG>643-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Isik-2008" MODIFIED="2012-02-10 16:40:49 +0000" MODIFIED_BY="[Empty name]" NAME="Isik 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-02-10 16:40:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Isik B, Baygin O, Bodur H</AU>
<TI>Effect of drinks that are added as flavouring in oral midazolam premedication on sedation success</TI>
<SO>Pediatric Anaesthesia</SO>
<YR>2008</YR>
<VL>18</VL>
<NO>6</NO>
<PG>494-500</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jensen-1998" MODIFIED="2012-02-10 16:42:30 +0000" MODIFIED_BY="[Empty name]" NAME="Jensen 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jensen B, Schroder U</AU>
<TI>Acceptance of dental care following early extractions under rectal sedation with diazepam in preschool children</TI>
<SO>Acta Odontologica Scandinavica</SO>
<YR>1998</YR>
<VL>56</VL>
<NO>4</NO>
<PG>229-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kantovitz-2007" MODIFIED="2012-02-10 16:42:42 +0000" MODIFIED_BY="[Empty name]" NAME="Kantovitz 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 16:42:42 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kantovitz KR, Puppin-Rontani RM, Gaviao MB</AU>
<TI>Sedative effect of oral diazepam and chloral hydrate in the dental treatment of children</TI>
<SO>Journal of the Indian Society of Pedodontics and Preventive Dentistry</SO>
<YR>2007</YR>
<VL>25</VL>
<NO>2</NO>
<PG>69-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kayalibay-1987" NAME="Kayalibay 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kayalibay H</AU>
<TI>The use of chloral hydrate for enteral sedation in adaptation of patients in pedodontics</TI>
<SO>Dent Contemporary Dentistry</SO>
<YR>1987</YR>
<VL>2</VL>
<NO>1</NO>
<PG>20-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerins-2007" MODIFIED="2012-02-10 16:45:03 +0000" MODIFIED_BY="[Empty name]" NAME="Kerins 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 16:45:03 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerins CA, McWhorter AG, Seale NS</AU>
<TI>Pharmacologic behavior management of pediatric dental patients diagnosed with attention deficit disorder/attention deficit hyperactivity disorder</TI>
<SO>Pediatric Dentistry</SO>
<YR>2007</YR>
<VL>29</VL>
<NO>6</NO>
<PG>507-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kopel-1971" MODIFIED="2012-02-10 16:45:12 +0000" MODIFIED_BY="[Empty name]" NAME="Kopel 1971" YEAR="1971">
<REFERENCE MODIFIED="2012-02-10 16:45:12 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kopel HM</AU>
<TI>Hydroxyzine as a pre-operative sedative: a double blind study with apprehensive children</TI>
<SO>Anesthesia Progress</SO>
<YR>1971</YR>
<VL>18</VL>
<NO>6</NO>
<PG>127-33</PG>
<IDENTIFIERS MODIFIED="2009-11-26 09:38:03 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-11-26 09:35:35 +0000" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Koroluk-2000" MODIFIED="2012-02-10 16:49:22 +0000" MODIFIED_BY="[Empty name]" NAME="Koroluk 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-02-10 16:49:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Koroluk LD</AU>
<TI>Dental anxiety in adolescents with a history of childhood dental sedation</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>2000</YR>
<VL>67</VL>
<NO>3</NO>
<PG>200-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kramer-1991a" MODIFIED="2012-02-10 16:45:45 +0000" MODIFIED_BY="[Empty name]" NAME="Kramer 1991a" YEAR="1991">
<REFERENCE MODIFIED="2012-02-10 16:45:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kramer N, Krafft T, Kunzelmann KH, Hickel R</AU>
<TI>Individually controlled sedation using midazolam</TI>
<SO>Deutsche Zahnarzthiche Zeitschrift</SO>
<YR>1991</YR>
<VL>46</VL>
<NO>2</NO>
<PG>142-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kramer-1991b" MODIFIED="2012-02-10 16:46:09 +0000" MODIFIED_BY="[Empty name]" NAME="Kramer 1991b" YEAR="1991">
<REFERENCE MODIFIED="2012-02-10 16:46:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kramer N, Krafft T, Hunzelmann KH, Hickel R</AU>
<TI>Sedation under rectal application of midazolam</TI>
<SO>Deutsche Zahnarzthiche Zeitschrift</SO>
<YR>1991</YR>
<VL>46</VL>
<NO>9</NO>
<PG>609-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kupietzky-1996" MODIFIED="2012-02-10 16:46:47 +0000" MODIFIED_BY="[Empty name]" NAME="Kupietzky 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-02-10 16:46:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kupietzky A, Holan G, Shapira J</AU>
<TI>Intranasal midazolam better at effecting amnesia after sedation than oral hydroxyzine: a pilot study</TI>
<SO>Pediatric Dentistry</SO>
<YR>1996</YR>
<VL>18</VL>
<NO>1</NO>
<PG>32-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lahoud-2001" NAME="Lahoud 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lahoud GY, Averley PA, Hanlon MR</AU>
<TI>Sevoflurane inhalation conscious sedation for children having dental treatment</TI>
<SO>Anaesthesia</SO>
<YR>2001</YR>
<VL>56</VL>
<NO>5</NO>
<PG>476-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leelataweedwud-2001" NAME="Leelataweedwud 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leelataweedwud P, Vann WF Jr</AU>
<TI>Adverse events and outcomes of conscious sedation for pediatric patients: study of an oral sedation regimen</TI>
<SO>Journal of the American Dental Association</SO>
<YR>2001</YR>
<VL>132</VL>
<NO>11</NO>
<PG>1531-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leelataweewud-2000" MODIFIED="2012-02-10 16:50:04 +0000" MODIFIED_BY="[Empty name]" NAME="Leelataweewud 2000" YEAR="2000">
<REFERENCE MODIFIED="2012-02-10 16:50:04 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leelataweewud P, Vann WF Jr, Dilley DC, Lucas WJ</AU>
<TI>The physiological effects of supplemental oxygen versus nitrous oxide/oxygen during conscious sedation of pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>2</NO>
<PG>125-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lima-2003" MODIFIED="2012-02-10 16:50:29 +0000" MODIFIED_BY="[Empty name]" NAME="Lima 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-02-10 16:50:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lima AR, da Costa LR, da Costa PS</AU>
<TI>A randomized, controlled, crossover trial of oral midazolam and hydroxyzine for pediatric dental sedation</TI>
<SO>Pesquisa Odontologica Brasileira</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>3</NO>
<PG>206-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindh_x002d_Stromberg-2001" NAME="Lindh-Stromberg 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindh-Stromberg U</AU>
<TI>Rectal administration of midazolam for conscious sedation of uncooperative children in need of dental treatment</TI>
<SO>Swedish Dental Journal</SO>
<YR>2001</YR>
<VL>25</VL>
<NO>3</NO>
<PG>105-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindsay-1980" MODIFIED="2012-02-10 16:51:33 +0000" MODIFIED_BY="[Empty name]" NAME="Lindsay 1980" YEAR="1980">
<REFERENCE MODIFIED="2012-02-10 16:51:33 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindsay SJ, Roberts GJ</AU>
<TI>Methods for behaviour research on dentally anxious children. The example of relative analgesia</TI>
<SO>British Dental Journal</SO>
<YR>1980</YR>
<VL>149</VL>
<NO>6</NO>
<PG>175-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindsay-1985" MODIFIED="2010-11-09 14:00:48 +0000" MODIFIED_BY="[Empty name]" NAME="Lindsay 1985" YEAR="1985">
<REFERENCE MODIFIED="2010-11-09 14:00:02 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindsay SJ, Yates JA</AU>
<TI>The effectiveness of oral diazepam in anxious child dental patients</TI>
<SO>British Dental Journal</SO>
<YR>1985</YR>
<VL>159</VL>
<NO>5</NO>
<PG>149-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Litman-1997" NAME="Litman 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Litman RS, Kottra JA, Berkowitz RJ, Ward DS</AU>
<TI>Breathing patterns and levels of consciousness in children during administration of nitrous oxide or after midazolam premedication</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1997</YR>
<VL>55</VL>
<NO>12</NO>
<PG>1372-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Litman-1998" NAME="Litman 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Litman RS, Kottra JA, Verga KA, Berkowitz RJ, Ward DS</AU>
<TI>Chloral hydrate sedation: the additive sedative and respiratory depressant effects of nitrous oxide</TI>
<SO>Anesthesia Analgesic</SO>
<YR>1998</YR>
<VL>86</VL>
<NO>4</NO>
<PG>724-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-L_x00f6_kken-1994" MODIFIED="2011-10-31 11:39:35 +0000" MODIFIED_BY="[Empty name]" NAME="Lökken 1994" YEAR="1994">
<REFERENCE MODIFIED="2011-10-31 11:39:35 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lökken P, Bakstad OJ, Fonnelop E, Skogedal N, Hellsten K, Bjerkelund CE et al</AU>
<TI>Conscious sedation by rectal administration of midazolam or midazolam plus ketamine as alternatives to general anesthesia for dental treatment of uncooperative children</TI>
<SO>Scandinavian Journal of Dental Research</SO>
<YR>1994</YR>
<VL>102</VL>
<NO>5</NO>
<PG>274-80</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:39:35 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Machen-1977" NAME="Machen 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Machen JB, Ayer WA, Mueller BH</AU>
<TI>Psychomotor effects of nitrous oxide-oxygen sedation on children</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1977</YR>
<VL>44</VL>
<NO>3</NO>
<PG>219-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malamed-1989" NAME="Malamed 1989" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malamed SF, Quinn CL, Hatch HG</AU>
<TI>Pediatric sedation with intramuscular and intravenous midazolam</TI>
<SO>Anesthesia Progress</SO>
<YR>1989</YR>
<VL>36</VL>
<NO>4-5</NO>
<PG>155-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marshall-1999" MODIFIED="2011-01-18 19:51:00 +0000" MODIFIED_BY="[Empty name]" NAME="Marshall 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-01-18 19:51:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marshall WR, Weaver BD, McCutcheon P</AU>
<TI>A study of the effectiveness of oral midazolam as a dental pre-operative sedative and hypnotic</TI>
<SO>Special Care in Dentistry</SO>
<YR>1999</YR>
<VL>19</VL>
<NO>6</NO>
<PG>259-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinez-2006" MODIFIED="2012-02-10 16:52:06 +0000" MODIFIED_BY="[Empty name]" NAME="Martinez 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 16:52:06 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez D, Wilson S</AU>
<TI>Children sedated for dental care: a pilot study of the 24-hour postsedation period</TI>
<SO>Pediatric Dentistry</SO>
<YR>2006</YR>
<VL>28</VL>
<NO>3</NO>
<PG>260-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McCann-1996" MODIFIED="2010-11-09 14:02:54 +0000" MODIFIED_BY="[Empty name]" NAME="McCann 1996" YEAR="1996">
<REFERENCE MODIFIED="2010-11-09 14:02:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McCann W, Wilson S, Larsen P, Stehle B</AU>
<TI>The effects of nitrous oxide on behavior and physiological parameters during conscious sedation with a moderate dose of chloral hydrate and hydroxyzine</TI>
<SO>Pediatric Dentistry</SO>
<YR>1996</YR>
<VL>18</VL>
<NO>1</NO>
<PG>35-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Milnes-2000" NAME="Milnes 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Milnes AR, Maupome G, Cannon J</AU>
<TI>Intravenous sedation in pediatric dentistry using midazolam, nalbuphine and droperidol</TI>
<SO>Pediatric Dentistry</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>2</NO>
<PG>113-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Moore-1997" NAME="Moore 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore PA, Finder RL, Jackson DL</AU>
<TI>Multidrug intravenous sedation: Determinants of the sedative dose of midazolam</TI>
<SO>Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics</SO>
<YR>1997</YR>
<VL>84</VL>
<NO>1</NO>
<PG>5-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Musial-2003" MODIFIED="2012-02-10 16:52:45 +0000" MODIFIED_BY="[Empty name]" NAME="Musial 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-02-10 16:52:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Musial KM, Wilson S, Preisch J, Weaver J</AU>
<TI>Comparison of the efficacy of oral midazolam alone versus midazolam and meperidine in the pediatric dental patient</TI>
<SO>Pediatric Dentistry</SO>
<YR>2003</YR>
<VL>25</VL>
<NO>5</NO>
<PG>468-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myers-1977" NAME="Myers 1977" YEAR="1977">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myers M, Shoaf HK</AU>
<TI>The intramuscular use of a combination of meperidine, promethazine and chlorpromazine for sedation of the child dental patient</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1977</YR>
<VL>44</VL>
<NO>6</NO>
<PG>453-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Myers-2004" MODIFIED="2010-11-09 14:05:07 +0000" MODIFIED_BY="[Empty name]" NAME="Myers 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-11-09 14:05:07 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Myers GR, Maestrello CL, Mourino AP, Best AM</AU>
<TI>Effect of submucosal midazolam on behaviour and physiologic response when combined with oral chloral hydrate and nitrous oxide sedation</TI>
<SO>Pediatric Dentistry</SO>
<YR>2004</YR>
<VL>26</VL>
<NO>1</NO>
<PG>37-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nathan-1987" NAME="Nathan 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nathan JE, West MS</AU>
<TI>Comparison of chloral hydrate-hydroxyzine with and without meperidine for management of the difficult pediatric patient</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1987</YR>
<VL>54</VL>
<NO>6</NO>
<PG>437-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Oei_x002d_Lim-1991" MODIFIED="2012-02-10 16:53:01 +0000" MODIFIED_BY="[Empty name]" NAME="Oei-Lim 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-02-10 16:53:01 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Oei-Lim LB, Vermeulen-Cranch DM, Bouvy-Berends EC</AU>
<TI>Conscious sedation with propofol in dentistry</TI>
<SO>British Dental Journal</SO>
<YR>1991</YR>
<VL>170</VL>
<NO>9</NO>
<PG>340-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pandey-2010" MODIFIED="2012-02-10 16:53:36 +0000" MODIFIED_BY="[Empty name]" NAME="Pandey 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-02-10 16:53:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pandey RK, Padmanabhan MY, Saksena AK, Chandra G</AU>
<TI>Midazolam-fentanyl analgo-sedation in pediatric dental patients - a pilot study</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>2010</YR>
<VL>35</VL>
<NO>1</NO>
<PG>105-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pisalchaiyong-2005" MODIFIED="2011-05-18 16:12:34 +0100" MODIFIED_BY="[Empty name]" NAME="Pisalchaiyong 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-05-18 16:12:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pisalchaiyong T, Trairatvorakul C, Jirakijja J, Yuktarnonda W</AU>
<TI>Comparison of the effectiveness of oral diazepam and midazolam for the sedation of autistic patients during dental treatment</TI>
<SO>Pediatric Dentistry</SO>
<YR>2005</YR>
<VL>27</VL>
<NO>3</NO>
<PG>198-206</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poorman-1990" MODIFIED="2011-10-31 11:42:05 +0000" MODIFIED_BY="Paul Francis Ashley" NAME="Poorman 1990" YEAR="1990">
<REFERENCE MODIFIED="2011-10-31 11:42:05 +0000" MODIFIED_BY="Paul Francis Ashley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poorman TL, Farrington FH, Mourino AP</AU>
<TI>Comparison of a chloral hydrate/hydroxyzine combination with and without meperidine in the sedation of pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>5</NO>
<PG>288-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Primosch-1999" MODIFIED="2012-02-10 16:54:49 +0000" MODIFIED_BY="[Empty name]" NAME="Primosch 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-02-10 16:54:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Primosch RE, Buzzi IM, Jerrell G</AU>
<TI>Effect of nitrous oxide-oxygen inhalation with scavenging on behavioral and physiological parameters during routine pediatric dental treatment</TI>
<SO>Pediatric Dentistry</SO>
<YR>1999</YR>
<VL>21</VL>
<NO>7</NO>
<PG>417-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-11 17:20:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Primosch RE, Buzzi IM, Jerrell G</AU>
<TI>Monitoring pediatric dental patients with nasal mask capnography</TI>
<SO>Pediatric Dentistry</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>2</NO>
<PG>120-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Primosch-2001" NAME="Primosch 2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Primosch RE, Bender F</AU>
<TI>Factors associated with administration route when using midazolam for pediatric conscious sedation</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>2001</YR>
<VL>68</VL>
<NO>4</NO>
<PG>233-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Quarnstrom-1992" MODIFIED="2012-02-10 16:54:29 +0000" MODIFIED_BY="[Empty name]" NAME="Quarnstrom 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-02-10 16:54:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Quarnstrom FC, Milgrom P, Moore PA</AU>
<TI>Experience with triazolam in preschool children</TI>
<SO>Anesthesia and Pain Control in Dentistry</SO>
<YR>1992</YR>
<VL>1</VL>
<NO>3</NO>
<PG>157-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ram-1999" MODIFIED="2011-10-31 11:42:38 +0000" MODIFIED_BY="[Empty name]" NAME="Ram 1999" YEAR="1999">
<REFERENCE MODIFIED="2011-10-31 11:42:38 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ram D, Mamber E, Chosack A, Fuks AB</AU>
<TI>The effect of metoclopramide and hydroxyzine in sedation of infants undergoing dental treatment</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1999</YR>
<VL>66</VL>
<NO>1</NO>
<PG>49-52</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:42:38 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Reinemer-1996" MODIFIED="2011-10-31 11:42:46 +0000" MODIFIED_BY="[Empty name]" NAME="Reinemer 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-10-31 11:42:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Reinemer HC, Wilson CF, Webb M</AU>
<TI>A comparison of two oral ketamine-diazepam regimens for sedating anxious pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>1996</YR>
<VL>18</VL>
<NO>4</NO>
<PG>294-300</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:42:46 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robbins-1967" NAME="Robbins 1967" YEAR="1967">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Robbins MB</AU>
<TI>Chloral hydrate and promethazine as premedicants for the apprehensive child</TI>
<SO>Journal of Dentistry for Children</SO>
<YR>1967</YR>
<VL>34</VL>
<NO>5</NO>
<PG>327-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roberts-1979" MODIFIED="2012-02-10 16:55:53 +0000" MODIFIED_BY="[Empty name]" NAME="Roberts 1979" YEAR="1979">
<REFERENCE MODIFIED="2012-02-10 16:55:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberts GJ, Gibson A, Porter J, de Zoysa S</AU>
<TI>Relative analgesia. An evaluation of the efficacy and safety</TI>
<SO>British Dental Journal</SO>
<YR>1979</YR>
<VL>146</VL>
<NO>6</NO>
<PG>177-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roberts-1982" NAME="Roberts 1982" YEAR="1982">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberts GJ, Wignall BK</AU>
<TI>Efficacy of the laryngeal reflex during oxygen-nitrous oxide sedation (relative analgesia)</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>1982</YR>
<VL>54</VL>
<NO>12</NO>
<PG>1277-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roberts-1992" MODIFIED="2012-02-10 16:56:53 +0000" MODIFIED_BY="[Empty name]" NAME="Roberts 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-02-10 16:56:53 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roberts SM, Wilson CF, Seale NS, McWhorter AG</AU>
<TI>Evaluation of morphine as compared to meperidine when administered to the moderately anxious pediatric dental patient</TI>
<SO>Pediatric Dentistry</SO>
<YR>1992</YR>
<VL>14</VL>
<NO>5</NO>
<PG>306-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robertson-1998" NAME="Robertson 1998" YEAR="1998">
<REFERENCE PRIMARY="NO" TYPE="UNPUBLISHED">
<AU>Robertson HG</AU>
<TI>A comparison between nitrous oxide and oral midazolam for sedation in paediatric dentistry</TI>
<SO>University of New Castle upon Tyne - Diploma in Conscious Sedation &amp; Pain Control in Dentistry</SO>
<YR>1998</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roelofse-1990" MODIFIED="2012-02-10 16:57:20 +0000" MODIFIED_BY="[Empty name]" NAME="Roelofse 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-02-10 16:57:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roelofse JA, van der Bijl P, Stegmann DH, Hartshorne JE</AU>
<TI>Preanesthetic medication with rectal midazolam in children undergoing dental extractions</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1990</YR>
<VL>48</VL>
<NO>8</NO>
<PG>791-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roelofse-1993" MODIFIED="2012-02-10 16:57:34 +0000" MODIFIED_BY="[Empty name]" NAME="Roelofse 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-10 16:57:34 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Roelofse JA, van der Bijl P</AU>
<TI>Comparison of rectal midazolam and diazepam for premedication in pediatric dental patients</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1993</YR>
<VL>51</VL>
<NO>5</NO>
<PG>525-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rohlfing-1998" MODIFIED="2012-02-10 16:57:52 +0000" MODIFIED_BY="[Empty name]" NAME="Rohlfing 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-02-10 16:57:52 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rohlfing GK, Dilley DC, Lucas WJ, Vann WF Jr</AU>
<TI>The effect of supplemental oxygen on apnea and oxygen saturation during pediatric conscious sedation</TI>
<SO>Pediatric Dentistry</SO>
<YR>1998</YR>
<VL>20</VL>
<NO>8</NO>
<PG>8-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sams-1992" NAME="Sams 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sams DR, Thornton JB, Wright JT</AU>
<TI>The assessment of two oral sedation drug regimens in pediatric dental patients</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1992</YR>
<VL>59</VL>
<NO>4</NO>
<PG>306-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sams-1993b" MODIFIED="2012-02-10 16:59:16 +0000" MODIFIED_BY="[Empty name]" NAME="Sams 1993b" YEAR="1993">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sams DR, Russell CM</AU>
<TI>Physiologic response and adverse reactions in pediatric dental patients sedated with promethazine and chloral hydrate or meperidine</TI>
<SO>Pediatric Dentistry</SO>
<YR>1993</YR>
<VL>15</VL>
<NO>6</NO>
<PG>422-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanders-1997" NAME="Sanders 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanders BJ, Avery DR</AU>
<TI>The effect of sleep on conscious sedation: a follow-up study</TI>
<SO>Journal Clinical Pediatric Dentistry</SO>
<YR>1997</YR>
<VL>21</VL>
<NO>2</NO>
<PG>131-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapira-1992" MODIFIED="2010-11-09 14:08:28 +0000" MODIFIED_BY="[Empty name]" NAME="Shapira 1992" YEAR="1992">
<REFERENCE MODIFIED="2010-11-09 14:08:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapira J, Holan G, Guelmann M, Cahan S</AU>
<TI>Evaluation of the effect of nitrous oxide and hydroxyzine in controlling the behavior of the pediatric dental patient</TI>
<SO>Pediatric Dentistry</SO>
<YR>1992</YR>
<VL>14</VL>
<NO>3</NO>
<PG>167-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapira-1996" MODIFIED="2012-02-10 17:01:29 +0000" MODIFIED_BY="[Empty name]" NAME="Shapira 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-02-10 17:01:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapira J, Holan G, Botzer E, Kupietzky A, Tal E, Fuks AB</AU>
<TI>The effectiveness of midazolam and hydroxyzine as sedative agents for young pediatric dental patients</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1996</YR>
<VL>63</VL>
<NO>6</NO>
<PG>421-5</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:43:39 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapira-2004" MODIFIED="2010-11-09 14:08:40 +0000" MODIFIED_BY="[Empty name]" NAME="Shapira 2004" YEAR="2004">
<REFERENCE MODIFIED="2010-11-09 14:08:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapira J, Kupietzky A, Kadari A, Fuks AB, Holan G</AU>
<TI>Comparison of oral midazolam with and without hydroxyzine in the sedation of pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>2004</YR>
<VL>26</VL>
<NO>6</NO>
<PG>492-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharma-1992" MODIFIED="2012-02-10 17:02:15 +0000" MODIFIED_BY="[Empty name]" NAME="Sharma 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-02-10 17:02:15 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharma RK, Pinto RR, Mirchandani NN</AU>
<TI>Use of sedation analgesia for pediatric dentistry</TI>
<SO>Journal of the Indian Society of Pedodontics Preventive Dentistry</SO>
<YR>1992</YR>
<VL>10</VL>
<NO>1</NO>
<PG>28-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sheroan-2006" MODIFIED="2012-02-10 17:02:36 +0000" MODIFIED_BY="[Empty name]" NAME="Sheroan 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 17:02:36 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sheroan MM, Dilley DC, Lucas WJ, Vann WF</AU>
<TI>A prospective study of 2 sedation regimens in children: chloral hydrate, meperidine, and hydroxyzine versus midazolam, meperidine, and hydroxyzine</TI>
<SO>Anesthesia Progress</SO>
<YR>2006</YR>
<VL>53</VL>
<NO>4</NO>
<PG>83-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Silver-1994" NAME="Silver 1994" YEAR="1994">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silver T, Wilson C, Webb M</AU>
<TI>Evaluation of two dosages of oral midazolam as a conscious sedation for physically and neurologically compromised pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>1994</YR>
<VL>16</VL>
<NO>5</NO>
<PG>350-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Songvasin-1990" MODIFIED="2012-02-10 17:03:09 +0000" MODIFIED_BY="[Empty name]" NAME="Songvasin 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-02-10 17:03:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Songvasin C, Pasavorakul A</AU>
<TI>A comparison of the child's behavior between two groups of oral sedative drugs</TI>
<SO>Journal of the Dental Association of Thailand</SO>
<YR>1990</YR>
<VL>40</VL>
<NO>6</NO>
<PG>237-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sullivan-2001" MODIFIED="2010-11-14 19:19:17 +0000" MODIFIED_BY="Paul Francis Ashley" NAME="Sullivan 2001" YEAR="2001">
<REFERENCE MODIFIED="2010-11-14 19:19:17 +0000" MODIFIED_BY="Paul Francis Ashley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sullivan DC, Wilson CF, Webb MD</AU>
<TI>A comparison of two oral ketamine-diazepam regimens for the sedation of anxious pediatric dental patients</TI>
<SO>Pediatric Dentistry</SO>
<YR>2001</YR>
<VL>23</VL>
<NO>3</NO>
<PG>223-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tanaka-2000" NAME="Tanaka 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tanaka M, Sato M, Saito A, Nishikawa T</AU>
<TI>Reevaluation of rectal ketamine premedication in children: comparison with rectal midazolam</TI>
<SO>Anaesthesiology</SO>
<YR>2000</YR>
<VL>93</VL>
<NO>5</NO>
<PG>1217-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tobias-1975" NAME="Tobias 1975" YEAR="1975">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tobias M, Lipschultz DH, Album MM</AU>
<TI>A study of three preoperative sedative combinations</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1975</YR>
<VL>42</VL>
<NO>6</NO>
<PG>453-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tsinidou-1992" MODIFIED="2011-10-31 11:44:09 +0000" MODIFIED_BY="[Empty name]" NAME="Tsinidou 1992" YEAR="1992">
<REFERENCE MODIFIED="2011-10-31 11:44:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsinidou KG, Curzon ME, Sapsford DJ</AU>
<TI>A study to compare the effectiveness of temazepam and a chloral hydrate/hydroxyzine combination in sedating paediatric dental patients</TI>
<SO>International Journal of Paediatric Dentistry</SO>
<YR>1992</YR>
<VL>2</VL>
<NO>3</NO>
<PG>163-9</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:44:09 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-van-der-Bijl-1991" MODIFIED="2012-02-10 17:03:27 +0000" MODIFIED_BY="[Empty name]" NAME="van der Bijl 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-02-10 17:03:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>van der Bijl P, Roelofse JA, Joubert JJ, van Zyl JF</AU>
<TI>Comparison of various physiologic and psychomotor parameters in patients sedated with intravenous lorazepam, diazepam, or midazolam during oral surgery</TI>
<SO>Journal of Oral and Maxillofacial Surgery</SO>
<YR>1991</YR>
<VL>49</VL>
<NO>7</NO>
<PG>672-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Varpio-1991" NAME="Varpio 1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Varpio M, Wellfelt B</AU>
<TI>Some characteristics of children with dental behaviour problems. Five-year follow-up pedodontic treatment</TI>
<SO>Swedish Dental Journal</SO>
<YR>1991</YR>
<VL>15</VL>
<NO>2</NO>
<PG>83-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Veerkamp-1997" NAME="Veerkamp 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Veerkamp JSJ, Porcelijn T, Gruythuysen RJ</AU>
<TI>Intravenous sedation for outpatient treatment of child dental patients: an exploratory study</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1997</YR>
<VL>64</VL>
<NO>1</NO>
<PG>48-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whitehead-1988" NAME="Whitehead 1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Whitehead BG, Durr DP, Adair SM, Proskin HM</AU>
<TI>Monitoring of sedated pediatric dental patients</TI>
<SO>ASDC Journal of Dentistry for Children</SO>
<YR>1988</YR>
<VL>55</VL>
<NO>5</NO>
<PG>329-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1990" NAME="Wilson 1990" YEAR="1990">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson S</AU>
<TI>Conscious sedation and pulse oximetry: false alarms?</TI>
<SO>Pediatric Dentistry</SO>
<YR>1990</YR>
<VL>12</VL>
<NO>4</NO>
<PG>228-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1992" NAME="Wilson 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson S</AU>
<TI>Chloral hydrate and its effects on multiple physiological parameters in young children: a dose-response study</TI>
<SO>Pediatric Dentistry</SO>
<YR>1992</YR>
<VL>14</VL>
<NO>3</NO>
<PG>171-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-1993" MODIFIED="2011-10-31 11:44:31 +0000" MODIFIED_BY="[Empty name]" NAME="Wilson 1993" YEAR="1993">
<REFERENCE MODIFIED="2011-10-31 11:44:31 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson S</AU>
<TI>Facial electromyography and chloral hydrate in the young dental patient</TI>
<SO>Pediatric Dentistry</SO>
<YR>1993</YR>
<VL>15</VL>
<NO>5</NO>
<PG>343-7</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:44:31 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-2000" NAME="Wilson 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson S, Easton J, Lamb K, Orchardson R, Casamassimo P</AU>
<TI>A retrospective study of chloral hydrate, meperidine, hydroxyzine, and midazolam regimens used to sedate children for dental care</TI>
<SO>Pediatric Dentistry</SO>
<YR>2000</YR>
<VL>22</VL>
<NO>2</NO>
<PG>107-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-2002" MODIFIED="2012-02-10 17:04:23 +0000" MODIFIED_BY="[Empty name]" NAME="Wilson 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-02-10 17:04:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wilson KE, Welbury RR, Girdler NM</AU>
<TI>A randomised, controlled, crossover trial of oral midazolam and nitrous oxide for paediatric dental sedation</TI>
<SO>Anaesthesia</SO>
<YR>2002</YR>
<VL>57</VL>
<NO>9</NO>
<PG>860-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-08-15 16:37:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson KE, Welbury RR, Girdler NM</AU>
<TI>A study of the effectiveness of oral midazolam sedation for orthodontic extraction of permanent teeth in children: a prospective, randomised, controlled, crossover trial</TI>
<SO>British Dental Journal</SO>
<YR>2002</YR>
<VL>192</VL>
<NO>8</NO>
<PG>457-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-2003" MODIFIED="2010-11-09 14:14:29 +0000" MODIFIED_BY="[Empty name]" NAME="Wilson 2003" YEAR="2003">
<REFERENCE MODIFIED="2010-11-09 14:14:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson KE, Girdler NM, Welbury RR</AU>
<TI>Randomized, controlled, cross-over clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions</TI>
<SO>British Journal of Anaesthesia</SO>
<YR>2003</YR>
<VL>91</VL>
<NO>6</NO>
<PG>850-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-2006" MODIFIED="2012-02-10 17:05:00 +0000" MODIFIED_BY="[Empty name]" NAME="Wilson 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-10 17:05:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson KE, Girdler NM, Welbury RR</AU>
<TI>A comparison of oral midazolam and nitrous oxide sedation for dental extractions in children</TI>
<SO>Anaesthesia</SO>
<YR>2006</YR>
<VL>61</VL>
<NO>12</NO>
<PG>1138-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson-2007" MODIFIED="2012-02-10 17:05:20 +0000" MODIFIED_BY="[Empty name]" NAME="Wilson 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-02-10 17:05:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson KE, Welbury RR, Girdler NM</AU>
<TI>Comparison of transmucosal midazolam with inhalation sedation for dental extractions in children. A randomized, cross-over, clinical trial</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>2007</YR>
<VL>51</VL>
<NO>8</NO>
<PG>1062-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yanase-1996" MODIFIED="2011-10-31 11:44:54 +0000" MODIFIED_BY="[Empty name]" NAME="Yanase 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-10-31 11:44:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yanase H, Braham RL, Fukuta O, Kurosu K</AU>
<TI>A study of the sedative effect of home-administered oral diazepam for the dental treatment of children</TI>
<SO>International Journal of Paediatric Dentistry</SO>
<YR>1996</YR>
<VL>6</VL>
<NO>1</NO>
<PG>13-7</PG>
<IDENTIFIERS MODIFIED="2011-10-31 11:44:54 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-02-10 17:17:07 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-02-10 17:13:10 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-1992" MODIFIED="2012-02-10 17:08:38 +0000" MODIFIED_BY="[Empty name]" NAME="AAP 1992" TYPE="JOURNAL_ARTICLE">
<TI>American Academy of Pediatrics Committee on Drugs: Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures</TI>
<SO>Pediatrics</SO>
<YR>1992</YR>
<VL>89</VL>
<NO>6 Pt 1</NO>
<PG>1110-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-BASCD-1999" MODIFIED="2012-02-10 17:10:38 +0000" MODIFIED_BY="[Empty name]" NAME="BASCD 1999" TYPE="JOURNAL_ARTICLE">
<AU>Pitts NB, Evans DJ, Nugent ZJ</AU>
<TI>The dental caries experience of 5-year-old children in the United Kingdom. Surveys coordinated by the British Association for the Study of Community Dentistry in 1999/2000</TI>
<SO>Community Dental Health</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>1</NO>
<PG>49-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-02-10 17:11:55 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]</TI>
<SO>The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klingberg-1994" MODIFIED="2012-02-10 17:12:19 +0000" MODIFIED_BY="[Empty name]" NAME="Klingberg 1994" TYPE="JOURNAL_ARTICLE">
<AU>Klingberg G, Vannas Lofqvist L, Bjarnason S, Noren JG</AU>
<TI>Dental behaviour management problems in Swedish children</TI>
<SO>Community Dentistry and Oral Epidemiology</SO>
<YR>1994</YR>
<VL>22</VL>
<NO>3</NO>
<PG>201-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Klingberg-1995" MODIFIED="2008-11-10 11:21:53 +0000" MODIFIED_BY="[Empty name]" NAME="Klingberg 1995" TYPE="JOURNAL_ARTICLE">
<AU>Klingberg G, Berggren U, Carlsson SG, Noren JG</AU>
<TI>Child dental fear: cause-related factors and clinical effects</TI>
<SO>European Journal of Oral Science</SO>
<YR>1995</YR>
<VL>103</VL>
<NO>6</NO>
<PG>405-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2008-11-10 11:21:53 +0000" MODIFIED_BY="[Empty name]" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<NO>9263</NO>
<PG>1191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NCHS-1996" MODIFIED="2008-11-10 11:21:53 +0000" MODIFIED_BY="[Empty name]" NAME="NCHS 1996" TYPE="BOOK">
<AU>National Centre for Health Statistics (NCHS)</AU>
<SO>Third National Health and Nutrition Examination Survey (NHANES III) reference manuals and reports [CD-ROM]</SO>
<YR>1996</YR>
<PB>NCHS, US Department of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention</PB>
<CY>Hyattsville (MD)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NICE-2010" MODIFIED="2011-10-21 14:01:27 +0100" MODIFIED_BY="[Empty name]" NAME="NICE 2010" TYPE="BOOK">
<AU>National Institute for Health and Clinical Excellence</AU>
<TI>Sedation for diagnostic and therapeutic procedures in children and young people. </TI>
<SO>http://guidance.nice.org.uk/CG112</SO>
<YR>2010</YR>
<VL>Clinical Guideline 112</VL>
<PB>National Institute for Health and Clinical Excellence</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Veerkamp-1995" MODIFIED="2012-02-10 17:13:10 +0000" MODIFIED_BY="[Empty name]" NAME="Veerkamp 1995" TYPE="JOURNAL_ARTICLE">
<AU>Veerkamp JS, Gruythuysen RJM, Hoogstraten J, van Amerongen WE</AU>
<TI>Anxiety reduction with nitrous oxide: a permanent solution</TI>
<SO>Journal of Dentistry for Children</SO>
<YR>1995</YR>
<VL>62</VL>
<NO>1</NO>
<PG>44-8</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-02-10 17:17:07 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Matharu-2006" MODIFIED="2012-02-10 17:17:07 +0000" MODIFIED_BY="[Empty name]" NAME="Matharu 2006" TYPE="COCHRANE_REVIEW">
<AU>Matharu L, Ashley PF</AU>
<TI>Sedation of anxious children undergoing dental treatment</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-02-10 17:17:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-02-10 17:17:07 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="Art. No.: CD003877. DOI: 10.1002/14651858.CD003877.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2010-11-09 13:12:28 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-02-10 14:27:48 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-02-10 12:51:59 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-02-10 10:33:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abrams-1993">
<CHAR_METHODS MODIFIED="2012-02-10 10:33:47 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel design, pilot study<BR/>Funding: grant from Children's Hospital Research Institute</P>
<P>Location: USA<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 10:33:53 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children whose "unruly or hysterical behavior precluded adequate examination or treatment"<BR/>n = 30 (10 per group with sufentanil divided into two subgroups of 5 each)<BR/>Age range = 17 to 62 months<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 10:22:48 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 10) ketamine 3 mg/kg<BR/>Group 2 (n = 10) midazolam 0.4 mg/kg<BR/>Group 3 (n = 5) sufentanil 1 µg/kg<BR/>Group 4 (n = 5) sufentanil 1.5 µg/kg<BR/>All intranasal, administered by paediatric anaesthesiologist or dentist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-09 09:24:31 +0100" MODIFIED_BY="[Empty name]">
<P>Sedation scoring criteria, recovery time</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Sufentanil 1.5 µg/kg and ketamine caused significant desaturations as recorded by pulse oximeter</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 10:32:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<CHAR_METHODS MODIFIED="2012-02-10 10:23:48 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel design RCT</P>
<P>Funded by College of Dentistry Research Centre, King Saud University, Riyadh</P>
<P>Location: Saudi Arabia<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 10:24:19 +0000" MODIFIED_BY="[Empty name]">
<P>Unco-operative ("Frankl behavior score 1 or 2")<BR/>n = 38 children<BR/>Mean age (SD) in years and gender<BR/>Group 1 (n = 12), 3.75 (0.75), 6 male, 6 female<BR/>Group 2 (n = 13), 4.3 (0.65), 6 male, 7 female<BR/>Group 3 (n = 13), 4 (0.71), 6 male, 7 female<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 10:32:50 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam 0.3 mg/kg<BR/>Group 2: midazolam 0.4 mg/kg<BR/>Group 3: midazolam 0.5 mg/kg<BR/>All intranasal</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 10:32:36 +0000" MODIFIED_BY="[Empty name]">
<P>Papoose board. Groups subdivided into fasting and non-fasting</P>
<P>Error in Table 1 on page 36 where 49 was written instead of 4.9<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 10:35:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<CHAR_METHODS MODIFIED="2011-07-19 14:51:06 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel design<BR/>Funding: not stated</P>
<P>Location: USA</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-09-21 15:26:42 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: "Unco-operative behaviour during initial screening evaluation e.g. refusing to separate from parent, sit in dental chair, open mouth"<BR/>n = 40<BR/>Mean age (SD) in months<BR/>Group 1 (n = 20), 40.4 (10.2)<BR/>Group 2 (n = 20), 37.5 (10.6)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 10:34:54 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: ketamine 6 mg/kg<BR/>Group 2: meperidine 2.0 mg/kg + promethazine 0.5 mg/kg<BR/>All oral, administered by paediatric anaesthesiologist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Modified Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 10:35:07 +0000" MODIFIED_BY="[Empty name]">
<P>Papoose board (loose straps)<BR/>30-50:50 nitrous oxide/oxygen given to all participants</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 10:36:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<CHAR_METHODS MODIFIED="2011-07-19 15:00:42 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel design RCT</P>
<P>Funding: not stated</P>
<P>Location: Mexico<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 10:36:13 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: ASA I healthy children undergoing dental procedures</P>
<P>n = 40<BR/>Mean age (SD) in months and gender<BR/>Group 1 (n = 20), 27.7 (2.9), 13 male, 7 female<BR/>Group 2 (n = 20), 29.2 (3.6), 14 male, 6 female</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 10:36:25 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: chloral hydrate 70 mg/kg + placebo<BR/>Group 2: chloral hydrate 70 mg/kg + hydroxyzine 2 mg/kg<BR/>All oral, administered by nurse</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Papoose board</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 10:39:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Averley-2004a">
<CHAR_METHODS MODIFIED="2012-02-10 10:38:09 +0000" MODIFIED_BY="[Empty name]">
<P>Pilot study, parallel group</P>
<P>Funding: NHS R&amp;D Award</P>
<P>Location: UK<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 10:38:45 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children aged 6-14 who are anxious (Wong &amp; Baker scale), unco-operative (Venham scale) requiring 'invasive' dental procedures<BR/>65 randomised<BR/>mean age (SD) in years, gender, weight (SD) kg<BR/>Group 1 (n = 20), 9.3 (2.2) years, (13 males and 7 females), 33.6 (11.2) kg<BR/>Group 2 (n = 22), 9.6 (2.3) years, (15 males and 5 females), 37.6 (14.6) kg<BR/>Group 3 (n = 23), 9.9 (2.2) years, (4 males and 16 females), 36.1 (11.8) kg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 10:39:15 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam (IV) 0.5 mg/min+ air; nasal inhalation<BR/>Group 2: midazolam (IV) 0.5 mg/min titrated+ nitrous oxide 40% (nasal inhalation)<BR/>Group 3: midazolam (IV) 0.5 mg/min titrated + nitrous oxide 40% (nasal inhalation) + sevoflurane 0.3% (nasal inhalation)</P>
<P>Administered by anaesthetist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-08-25 10:06:15 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: completion of treatment<BR/>Secondary: level of co-operation during treatment, recovery time, perception of anxiety and pain and parent's satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 10:39:30 +0000" MODIFIED_BY="[Empty name]">
<P>Secondary outcomes reported only for successful sedations</P>
<P>Dr Averley was contacted to clarify blinding and to enquire about any unpublished literature on conscious sedation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:20:40 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Averley-2004b">
<CHAR_METHODS MODIFIED="2012-02-10 10:43:58 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Funding: NHS R&amp;D Award and sevoflurane provided by Abbott Laboratories</P>
<P>Location: UK<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 10:51:18 +0000" MODIFIED_BY="[Empty name]">
<P>Unco-operative children<BR/>848 children randomised, 697 children received intervention and evaluated<BR/>Gender, mean age (SD), &amp; weight (SD)<BR/>Group 1 ( n = 222, 81 males), 9.1 (2.7) years, 36.3 (13.4) kg<BR/>Group 2 ( n = 306, 127 males), 9.5 (2.7) years, 37.8 (14.1) kg<BR/>Group 3 (n = 320, 103 males), 9.6 (2.5) years, 37.7 (14) kg<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:20:40 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam (IV) 0.5 mg/min + air (nasal inhalation)<BR/>Group 2: midazolam (IV) 0.5 mg/min + nitrous oxide 40% (nasal inhalation)<BR/>Group 3: midazolam (IV) 0.5 mg/min + nitrous oxide 40% (nasal inhalation) + sevoflurane 0.3% (nasal inhalation)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-06 14:03:37 +0100" MODIFIED_BY="[Empty name]">
<P>Primary: completion of treatment<BR/>Secondary: level of co-operation during treatment, recovery time, perception of anxiety and pain and parent's satisfaction</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-10-12 15:50:43 +0100" MODIFIED_BY="[Empty name]">
<P>Secondary outcomes reported only for successful sedations<BR/>Anaesthetist involvement<BR/>Group 1 not included in the analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:22:42 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aydintug-2004">
<CHAR_METHODS MODIFIED="2012-02-10 11:22:26 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Turkey</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:22:42 +0000" MODIFIED_BY="[Empty name]">
<P>Unco-operative (Frankl)</P>
<P>n = 50</P>
<P>Mean age (unclear, possibly SD) in years</P>
<P>Mean weight (unclear, possibly SD) in kg</P>
<P>Group 1 (n = 25), (18 males, 7 females), 5.36 (1.7) years, 19.068 (3.43) kg</P>
<P>Group 2 (n = 25), (12 males, 13 females), 4.96 (1.513) years, 17.804 (3.08)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-19 13:42:26 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: Midazolam 0.5mg/kg Oral</P>
<P>Group 2: Midazolam 0.35mg/kg Rectal</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-06 14:03:37 +0100" MODIFIED_BY="[Empty name]">
<P>Ramsay sedation score, Acceptance of LA, Acceptance of Sedation, Operating conditions</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:25:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baygin-2010">
<CHAR_METHODS MODIFIED="2012-02-10 11:23:08 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Turkey</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:24:28 +0000" MODIFIED_BY="[Empty name]">
<P>Unco-operative (Frankl &gt; 3)</P>
<P>n = 60 (n = 15 per group)</P>
<P>Mean age (unclear, possibly SD) in years, mean weight (unclear, possibly SD) in kg</P>
<P>Group 1 (n = 15), 10 males, 5 females, 5.33 (0.62) years, 18.93 (2.31) kg</P>
<P>Group 2 (n = 15), 11 males, 4 females, 5.27 (0.80) years, 19.07 (3.62) kg</P>
<P>Group 3 (n = 15), 9 males, 6 females, 5.20 (0.41) years, 18.20 (2.34) kg</P>
<P>Group 4 (n = 15), 6 males, 9 females, 5.53 (0.99) years, 20.01 (3.99) kg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-19 13:54:57 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: 1 mg/kg hydroxyzine oral + 40% nitrous oxide oxygen</P>
<P>Group 2: 0.7 mg/kg midazolam + 40% nitrous oxide oxygen</P>
<P>Group 3: 3 mg/kg ketamine + 0.25 mg/kg midazolam + 40% nitrous oxide oxygen</P>
<P>Group 4: 40% nitrous oxide oxygen</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:25:05 +0000" MODIFIED_BY="[Empty name]">
<P>Treatment completion, Ramsay sedation scale, bispectral index, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-08-11 15:26:51 +0100" MODIFIED_BY="[Empty name]">
<P>No placebo used</P>
<P>40% nitrous oxide all patients</P>
<P>Sample size calculation given</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:25:47 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bui-2002">
<CHAR_METHODS MODIFIED="2012-02-10 11:25:26 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: Not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-19 13:57:55 +0100" MODIFIED_BY="[Empty name]">
<P>Unco-operative children<BR/>n = 22<BR/>Mean age (SD) in months<BR/>Group 1 (n = 11), 34 (6.28) months<BR/>Group 2 (n = 11), 33 (6.65) months<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:25:38 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: ketamine (10 mg/kg) + promethazine (1.1 mg/kg)<BR/>Group 2: ketamine (10 mg/kg)<BR/>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-09 11:02:01 +0100" MODIFIED_BY="[Empty name]">
<P>Houpt, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:25:47 +0000" MODIFIED_BY="[Empty name]">
<P>Papoose board<BR/>35:65 nitrous oxide/oxygen given to all participants<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:28:04 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Faytrouny-2007">
<CHAR_METHODS MODIFIED="2012-02-10 11:26:12 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Funding: not stated</P>
<P>Location: Turkey</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:27:37 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: unco-operative fearful healthy children, ASA I, requiring sedation due to Frankl score of definitely negative or negative</P>
<P>n = 30, 14 females, 16 males</P>
<P>Mean age (SD) months</P>
<P>Group 1 (n = 15), 61.9 (11.9) months</P>
<P>Group 2 (n = 15), 53.7 (12.8) months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:27:42 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: hydroxyzine 20 mg 24 hours before + hydroxyzine 3.7 mg/kg at the appointment</P>
<P>Group 2: hydroxyzine 3.7 mg/kg at the appointment</P>
<P>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-05 12:58:19 +0000" MODIFIED_BY="[Empty name]">
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:28:04 +0000" MODIFIED_BY="[Empty name]">
<P>20 mg/kg as stated in the text a mistake as this appears to be high. 20 mg in the abstract, presumably this is the correct value</P>
<P>50:50 nitrous oxide/oxygen given to all participants</P>
<P>Pediwrap used after sedation achieved</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:29:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gallardo-1994">
<CHAR_METHODS MODIFIED="2012-02-10 11:28:32 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Chile</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:28:57 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children referred to pedodontic clinic for treatment after treatment refusal following conventional psychological approach<BR/>n = 32, age range = 4 to 10 years<BR/>17 male, 15 female</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:29:01 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam 7.5 mg<BR/>Group 2: placebo<BR/>All oral, administered by dental assistant<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:29:13 +0000" MODIFIED_BY="[Empty name]">
<P>Overall sedation, mental attitude, hypnotic effects, motor activity, ease of treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:30:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Isik-2008a">
<CHAR_METHODS MODIFIED="2012-02-10 11:29:33 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel</P>
<P>Funding: not stated</P>
<P>Location: Turkey</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:30:02 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children requiring sedation for dental procedures</P>
<P>Mean age (SD) in years, gender, mean weight (SD) in kg</P>
<P>Group 1 (n = 15), 4.87 (0.99), 7 males, 8 females, 18.87 (2.5)</P>
<P>Group 2 (n = 15), 4.93 (1.11), 7 males, 8 females, 17.87 (3.88)</P>
<P>Group 3 (n = 15), 4.93 (1.10), 8 males, 7 females, 18.6 (3.31)</P>
<P>Group 4 (n = 15), 5.01 (1.03), 9 males, 6 females, 19.73 (4.77)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:30:22 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: 3 mg melatonin, 60 minutes prior to treatment</P>
<P>Group 2: 0.5 mg/kg melatonin, 60 minutes prior to treatment</P>
<P>Group 3: 0.75 mg/kg midazolam, 15 minutes prior to treatment</P>
<P>Group 4: placebo (half group 15 minutes prior to treatment and half 60 minutes prior to treatment)</P>
<P>All oral, administered by nurse</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-06 14:03:37 +0100" MODIFIED_BY="[Empty name]">
<P>Ramsay sedation score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:30:48 +0000" MODIFIED_BY="[Empty name]">
<P>40:60 nitrous oxide/oxygen given to all</P>
<P>Sample size calculation given</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:35:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Isik-2008b">
<CHAR_METHODS MODIFIED="2012-02-10 11:32:22 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Turkey</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:33:19 +0000" MODIFIED_BY="[Empty name]">
<P>Unco-operative, Frankl scores 3, 4</P>
<P>Mean age (SD) in years, gender, mean weight (SD) in kg</P>
<P>Group 1 (n = 14), 4.6 (1.2), 7 males, 7 females, 15.6 (2.8)</P>
<P>Group 2 (n = 13), 4.4 (1.0), 8 males, 5 females, 16.2 (2.4)</P>
<P>Group 3 (n = 13), 4.4 (0.9), 6 males, 7 females, 16.1 (2.4)</P>
<P>Group 4 (n = 13), 4.3 (0.9), 5 males, 8 females, 15.8 (2.6)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:35:37 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: 0.2 mg/kg midazolam</P>
<P>Group 2: 0.5 mg/kg midazolam</P>
<P>Group 3: 0.75 mg/kg midazolam</P>
<P>Group 4: 1 mg/kg midazolam</P>
<P>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:35:51 +0000" MODIFIED_BY="[Empty name]">
<P>Ramsay sedation score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:35:56 +0000" MODIFIED_BY="[Empty name]">
<P>40:60 nitrous oxide/oxygen given to all</P>
<P>Translated from Turkish</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:36:58 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jensen-1999">
<CHAR_METHODS MODIFIED="2011-07-19 15:05:14 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Funding: grants from Swedish Dental Association</P>
<P>Location: Sweden<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:36:39 +0000" MODIFIED_BY="[Empty name]">
<P>n = 90<BR/>Median age (age range) in months and gender<BR/>Group 1 (n = 45), 32 (18 to 44), 23 male, 22 female<BR/>Group 2 (n = 45), 29 (15 to 44), 23 male, 22 female<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:36:45 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: diazepam 0.7 mg/kg<BR/>Group 2: midazolam 0.3 mg/kg<BR/>All rectal, administered by dentist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:36:51 +0000" MODIFIED_BY="[Empty name]">
<P>Wilton's sedation scale, acceptance of treatment (Holst)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:36:58 +0000" MODIFIED_BY="[Empty name]">
<P>Dr Jensen was contacted to clarify blinding and to enquire about any unpublished literature on conscious sedation</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:37:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kapur-2004">
<CHAR_METHODS MODIFIED="2012-02-10 11:37:24 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: India</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:37:28 +0000" MODIFIED_BY="[Empty name]">
<P>Potentially unco-operative (not measured), healthy children ASA I with &gt; 1 carious deciduous mandibular molar requiring a class II amalgam restoration<BR/>n = 40<BR/>Age: younger than 4 years old - no differences at baseline with regards to age, sex and body weight<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:37:42 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam 0.5 mg/kg oral/transmucosal<BR/>Group 2: placebo (same volume)</P>
<P>Administered by chief investigator</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:37:51 +0000" MODIFIED_BY="[Empty name]">
<P>Completion of treatment, sedation time, treatment time</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Type of tooth or cavity matched for dental treatment</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:39:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Koirala-2006">
<CHAR_METHODS MODIFIED="2012-02-10 11:38:28 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Nepal</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:38:32 +0000" MODIFIED_BY="[Empty name]">
<P>6 experimental groups, n = 120</P>
<P>Age range 2-9</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:39:16 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: (n = 20) midazolam 9.5 mg/kg</P>
<P>Group 2: (n = 20) ketamine 5 mg/kg</P>
<P>Group 3: (n = 20) zolpidem 0.4 mg/kg</P>
<P>Group 4: (n = 20) midazolam 0.4 mg/kg + ketamine 3 mg/kg</P>
<P>Group 5: (n = 20) midazolam 0.5 mg/kg + tramadol 2 mg/kg</P>
<P>Group 6: (n = 20) zolpidem 0.4 mg/kg + tramadol 2 mg/kg</P>
<P>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:39:29 +0000" MODIFIED_BY="[Empty name]">
<P>Onset of action, level of sedation, ease of treatment completion, recovery time, anterograde amnesia</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:40:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lahoud-2002">
<CHAR_METHODS MODIFIED="2012-02-10 11:39:52 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: UK</P>
<P>Funding: Abbot Laboratories provided the sevoflurane<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-09 11:55:51 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: anxious children 3-10 years able to sit in chair, tolerate dental exam, accept nasal hood, with unobstructed nasal airway<BR/>n = 411<BR/>Mean age (SD) in years<BR/>Group 1 (n = 170), 6.2 (1.9) years<BR/>Group 2 (n = 241), 6 (1.7) years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:40:22 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: 40:60 nitrous oxide/oxygen<BR/>Group 2: 40:60 nitrous oxide/oxygen + 0.1-0.3% sevoflurane<BR/>All inhalation, administered by anaesthetist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:40:30 +0000" MODIFIED_BY="[Empty name]">
<P>Venham scale, level of sedation, treatment completion</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:42:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lam-2005">
<CHAR_METHODS MODIFIED="2012-02-10 11:41:52 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:42:09 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy ASA I children with severe caries involving 2 or more quadrants, very anxious, unlikely to tolerate treatment with or without N2O, requiring IV sedation. Unco-operative (no index used)</P>
<P>n = 23, 15 males, 7 females</P>
<P>Mean age (range) in years, 5.13 (2-9)</P>
<P>Mean weight (range) in kg, 21.74 (12-30)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:42:45 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 12), midazolam 0.2 mg/kg, intramuscular</P>
<P>Group 2 (n = 11), midazolam 0.2 mg/kg, intranasal</P>
<P>All used as premed for unspecified IV sedation drug. Drug administered by anaesthetist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-06 14:03:37 +0100" MODIFIED_BY="[Empty name]">
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:42:50 +0000" MODIFIED_BY="[Empty name]">
<P>50% nitrous oxide all patients plus papoose board</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:44:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lee_x002d_Kim-2004">
<CHAR_METHODS MODIFIED="2012-02-10 11:43:19 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:43:42 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children ASA I requiring &gt; 1 visits for comprehensive dental care, who demonstrated definitely or slightly negative behaviour on Frankl scale</P>
<P>n = 40</P>
<P>Mean age (unclear, possibly SD) in months, mean weight (unclear, possibly SD) in kg</P>
<P>Group 1 (n = 20), 11 males, 9 females, 40.8 (11) months, 17 (3.6) kg</P>
<P>Group 2 (n = 20), 10 males, 10 females, 38.5 (9.8) months, 16.2 (4) kg</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:43:58 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam 0.7 mg/kg, oral</P>
<P>Group 2: midazolam 0.3 mg/kg, nasal</P>
<P>Administered by dental provider</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-08-09 11:59:28 +0100" MODIFIED_BY="[Empty name]">
<P>Modified Houpt, time of onset, duration of sedation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:44:12 +0000" MODIFIED_BY="[Empty name]">
<P>45% nitrous oxide all patients and papoose board</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:48:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McKee-1990">
<CHAR_METHODS MODIFIED="2012-02-10 11:44:45 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:44:54 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children 2-5 years, Frankl scale behaviour negative or definitely negative, failed non-pharma management, requiring restorative treatment with LA and rotary instrument<BR/>n = 60, mean age (SE) in months<BR/>Group 1 (n = 15), 36.5 (2.7)<BR/>Group 2 (n = 15), 41.7 (3)<BR/>Group 3 (n = 15), 35.9 (2.7)<BR/>Group 4 (n = 15), 43 ( 2.7)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:45:12 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: placebo<BR/>Group 2: meperidine 0.25 mg/lb (approximately 0.11 mg/kg)<BR/>Group 3: meperidine 0.50 mg/lb (approximately 0.22 mg/kg)<BR/>Group 4: meperidine 1 mg/lb (approximately 0.45 mg/kg)<BR/>All intramuscular, administered by "third party"</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:48:23 +0000" MODIFIED_BY="[Empty name]">
<P>Modified Houpt, dichotomous behavior scale, 10 point behaviour scale, global rating scale, adverse effects</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:49:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Meyer-1990">
<CHAR_METHODS MODIFIED="2012-02-10 11:49:19 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-08 15:03:22 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children who were unco-operative at screening visit, ASA I needing dental treatment<BR/>n = 40<BR/>Mean age (age range) in months<BR/>Group 1 (n = 20), 44 (21 to 74) months<BR/>Group 2 (n = 20), 42 (23 to 64) months<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:49:31 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: triazolam 0.02 mg/kg<BR/>Group 2: chloral hydrate 40 mg/kg + hydroxyzine 25 mg<BR/>All oral, administered by operating dentist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:49:41 +0000" MODIFIED_BY="[Empty name]">
<P>Papoose board<BR/>50:50 nitrous oxide/oxygen given to all</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:50:55 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moody-1986">
<CHAR_METHODS MODIFIED="2012-02-10 11:50:14 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:50:18 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children aged 27-74 months who were unco-operative at previous appointments and required dental restorations <BR/>n = 30<BR/>Mean age in months<BR/>Group 1 (n = 10), 39.6 months<BR/>Group 2 (n = 10), 42 months<BR/>Group 3 (n = 10), 38.4 months<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:50:39 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: chloral hydrate 50 mg/kg, oral<BR/>Group 2: chloral hydrate 50 mg/kg, rectal<BR/>Group 3: chloral hydrate 30 mg/kg + 25 mg hydroxyzine, oral</P>
<P>All administered by operating dentist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:50:49 +0000" MODIFIED_BY="[Empty name]">
<P>Modified Barker, overall quality sedation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:50:55 +0000" MODIFIED_BY="[Empty name]">
<P>50:50 nitrous oxide/oxygen given to all, reduced to 30-40% after LA administered</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:55:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Moore-1984">
<CHAR_METHODS MODIFIED="2012-02-10 11:55:05 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA/Canada</P>
<P>Funding: PHS grant<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:52:01 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children aged 2-5 who were considered unco-operative &amp; required treatment under local anaesthesia<BR/>n = 60<BR/>Gender, mean age in years<BR/>Group 1 (n = 15), 11 male, 4 female, mean 3.6 years<BR/>Group 2 (n = 15), 7 male, 8 female, mean 3.3 years<BR/>Group 3 (n = 15), 9 male, 6 female, mean 3.8 years<BR/>Group 4 (n = 15), 7 male, 8 female, mean 3.9 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:52:09 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: placebo<BR/>Group 2: chloral hydrate 20 mg/kg<BR/>Group 3: chloral hydrate 40 mg/kg<BR/>Group 4: chloral hydrate 60 mg/kg<BR/>All oral, administered by research assistant</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:52:17 +0000" MODIFIED_BY="[Empty name]">
<P>Behaviour evaluations, completion of treatment</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:52:22 +0000" MODIFIED_BY="[Empty name]">
<P>40:60 nitrous oxide/oxygen given to all</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:55:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mortazavi-2009">
<CHAR_METHODS MODIFIED="2011-07-19 15:11:17 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Iran</P>
<P>Funding: University Grant</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:55:27 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children rate 1 or 2 on Frankl scale requiring dental treatment</P>
<P>n = 40</P>
<P>Mean age (SD), 3.99 (0.38) years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:55:37 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: placebo</P>
<P>Group 2: midazolam 0.25 mg/kg</P>
<P>All oral, administered by dental nurse</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-09-06 14:03:37 +0100" MODIFIED_BY="[Empty name]">
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-09-06 14:03:37 +0100" MODIFIED_BY="[Empty name]">
<P>Lack of demographic data</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:56:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nathan-1988">
<CHAR_METHODS MODIFIED="2011-07-19 15:11:40 +0100" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: University grant<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-19 14:21:51 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children without previous dental experience requiring 4 restorative treatment visits, rated as anxious at screening visit<BR/>n = 35<BR/>Age range = 48 to 72 months</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:56:15 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: no intervention<BR/>Group 2: placebo inhalation (oxygen)<BR/>Group 3: 20-50:50 nitrous oxide/oxygen<BR/>Inhalation, all administered by anaesthetist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:56:24 +0000" MODIFIED_BY="[Empty name]">
<P>Venham scale, parental questionnaire, behavioral screening instrument</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 11:56:29 +0000" MODIFIED_BY="[Empty name]">
<P>Dr Nathan was contacted to clarify the blinding in this trial and to enquire about any unpublished trials</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:57:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rai-2007">
<CHAR_METHODS MODIFIED="2012-02-10 11:56:58 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: India</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:57:05 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy, unco-operative, anxious &amp; apprehensive children requiring oral prophylaxis/fluoride gel/restorations/extractions/composite fillings/pulp therapies</P>
<P>n = 30 (10 per group)</P>
<P>Age range 3-6 years</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:57:39 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam 0.1 mg/kg bolus + 0.004 mg/kg/min infusion</P>
<P>Group 2: propofol 1 mg/kg bolus + 0.06 mg/kg/min infusion</P>
<P>Group 3: ketamine 0.5 mg/kg bolus + 0.01 mg/kg/min infusion</P>
<P>All intravenous</P>
<P>All children had premedication 1 hr before, comprising 0.5 mg/kg midazolam and atropine (0.6 mg), all drugs administered by anaesthetist</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2010-02-05 12:58:25 +0000" MODIFIED_BY="[Empty name]">
<P>Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-05-23 18:04:45 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:58:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reeves-1996">
<CHAR_METHODS MODIFIED="2012-02-10 11:58:04 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: USA</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:58:19 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children aged 27-73 months, definitely negative behaviour on Frankl scale<BR/>n = 40<BR/>Mean age (age range) in months<BR/>Group 1 (n = 20), 11 male, 9 female, 48 (32 to 73) months<BR/>Group 2 (n = 20), 10 male, 10 female, 42 (27 to 70) months<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:58:31 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: chloral hydrate 50 mg/kg + hydroxyzine 25 mg<BR/>Group 2: midazolam 0.5 mg/kg + acetaminophen 10 mg/kg<BR/>All oral, administered by paediatric dentist not involved in study</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Modified Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Papoose-board<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 11:59:26 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roelofse-1996a">
<CHAR_METHODS MODIFIED="2012-02-10 11:58:53 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: South Africa</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:58:59 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: unco-operative<BR/>n = 100<BR/>Mean age (SD) in years<BR/>Group 1 (n = 50), 24 male 26 female, 4.3 (1) years<BR/>Group 2 (n = 50), 22 male 28 female, 4.3 (1.1) years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 11:59:14 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: ketamine 5 mg/kg + midazolam 0.35 mg/kg<BR/>Group 2: midazolam 1 mg/kg<BR/>All rectal, administered by member of research team</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 11:59:26 +0000" MODIFIED_BY="[Empty name]">
<P>Ramsay sedation score, movement, crying, overall sedation and behaviour</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:00:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roelofse-1996b">
<CHAR_METHODS MODIFIED="2012-02-10 11:59:47 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: South Africa</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 11:59:58 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children ASA I aged 2-7, requiring dental extraction under sedation</P>
<P>n = 60<BR/>Mean age (SD) in years<BR/>Group 1 (n = 30), 14 male, 16 female, 4.8 (1.3) years<BR/>Group 2 (n = 30), 16 male, 14 female, 4.9 (1.3) years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:00:12 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: 0.5 ml/kg of trimeprazine 6 mg/ml + physeptone 0.4 mg/ml (SOP)<BR/>Group 2: ketamine 12.5 mg/kg<BR/>All oral, administered by a member of the research team not the operator</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 12:00:24 +0000" MODIFIED_BY="[Empty name]">
<P>Anxiety, level of sedation, movement, crying, overall behaviour</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:10:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roelofse-1998">
<CHAR_METHODS MODIFIED="2012-02-10 12:00:36 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: South Africa</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 12:09:46 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children ASA I aged 2-7, randomly selected from dental clinic</P>
<P>n = 100<BR/>Mean age (SD) in years<BR/>Group 1 (n = 50), 27 male, 23 female, 4.1 (1.3) years<BR/>Group 2 (n = 50), 29 male, 21 female, 4 (1.2) years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:09:57 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: ketamine 5 mg/kg + midazolam 0.35 mg/kg<BR/>Group 2: trimeprazine 3 mg/kg + methadone 0.2 mg/kg<BR/>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 12:10:07 +0000" MODIFIED_BY="[Empty name]">
<P>Modified Houpt, Ramsay sedation score</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:12:24 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sams-1993a">
<CHAR_METHODS MODIFIED="2012-02-10 12:11:47 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location:USA</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 12:11:59 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: children ASA I with no prior sedation experience, needing &gt; 2 restorations, with Frankl score 1 (definitely negative behaviour)<BR/>n = 24<BR/>Mean age (SD) in months<BR/>Group 1 (n = 13), 31.0 (8.6)<BR/>Group 2 (n = 11), 35.8 (10.6)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:12:16 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: chloral hydrate 50 mg/kg + promethazine 1 mg/kg<BR/>Group 2: meperidine 1 mg/kg + promethazine 1 mg/kg<BR/>All oral, sedation administered by Principal Investigator or attending faculty member<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Modified Houpt</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 12:12:24 +0000" MODIFIED_BY="[Empty name]">
<P>Papoose-board<BR/>Nitrous oxide/oxygen where indicated</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:13:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shashikiran-2006">
<CHAR_METHODS MODIFIED="2012-02-10 12:12:43 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: India</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 12:13:08 +0000" MODIFIED_BY="[Empty name]">
<P>n = 40</P>
<P>Group 1 (11 males, 9 females), mean age 3.4 years (SD = 0.6), mean weight 12.2 kgs (SD = 1.2)</P>
<P>Group 2 (8 males, 12 females), mean age 3.5 years (SD = 0.7), mean weight 12.6 kgs (SD = 1.4)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:13:30 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 20): 0.2 mg/kg midazolam intramuscular</P>
<P>Group 2 (n = 20): 0.2 mg/kg midazolam intranasal</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-19 14:44:24 +0100" MODIFIED_BY="[Empty name]">
<P>Houpt, Fukuta</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:14:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Singh-2002">
<CHAR_METHODS MODIFIED="2012-02-10 12:13:46 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: India</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-19 14:44:46 +0100" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy children ASA I referred for short dental procedures </P>
<P>n = 90 (30 per group)<BR/>Age range 3 to 9 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:13:59 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: midazolam 0.5 mg/kg<BR/>Group 2: triclofos 70 mg/kg<BR/>Group 3: promethazine 1.2 mg/kg<BR/>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 12:14:03 +0000" MODIFIED_BY="[Empty name]">
<P>Sedation score, treatment completion</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:17:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Torres_x002d_Perez-2007">
<CHAR_METHODS MODIFIED="2012-02-10 12:14:17 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Mexico</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 12:14:19 +0000" MODIFIED_BY="[Empty name]">
<P>n = 54</P>
<P>Mean age (age range) in years</P>
<P>Mean weight (range)</P>
<P>Group 1, 3.9 (4-6) years, 11 males, 7 females, 18.1 kg (0.9-22)</P>
<P>Group 2, 2.83 (1-8) years, 11 males, 7 females, 15 kg (10.4-22.5)</P>
<P>Group 3, 2.94 (1-10) years, 10 males, 8 females, 16.33 kg (10.4-20)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:15:07 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 18): hydroxyzine 2 mg/kg 2 hours before, 1 mg/kg 20 minutes before</P>
<P>Group 2 (n = 18): midazolam 0.5 mg/kg + hydroxyzine 1.5 mg/kg</P>
<P>Group 3 (n = 18): chloral hydrate 50 mg/kg + hydroxyzine 1.5 mg/kg</P>
<P>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 12:17:31 +0000" MODIFIED_BY="[Empty name]">
<P>Ohio State behavioural rating scale, cardiac rate, O2 saturation</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:19:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Veerkamp-1993">
<CHAR_METHODS MODIFIED="2012-02-10 12:18:02 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: Netherlands</P>
<P>Funding: not stated<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 12:19:23 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy Dutch speaking children aged 6-11, requiring 2 dental treatment sessions. All children had previous treatment session aborted at separate location Scored high on Likert anxiety scale (n = 56)<BR/>Age range all subjects = 6 to 11 years<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:19:43 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 27): behaviour management<BR/>Group 2 (n = 29): up to 40:60 nitrous oxide/oxygen<BR/>Inhalation, interventions administered by dentist<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-10 12:19:52 +0000" MODIFIED_BY="[Empty name]">
<P>Venham scale</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 12:19:57 +0000" MODIFIED_BY="[Empty name]">
<P>Dr Veerkamp was contacted to clarify the blinding in this trial and to enquire about any unpublished trials</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-10 12:21:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wan-2006">
<CHAR_METHODS MODIFIED="2012-02-10 12:20:12 +0000" MODIFIED_BY="[Empty name]">
<P>Parallel group RCT</P>
<P>Location: China</P>
<P>Funding: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-10 12:21:14 +0000" MODIFIED_BY="[Empty name]">
<P>Inclusion criteria: healthy unco-operative children</P>
<P>n = 40</P>
<P>Mean age (range) in years all subjects 7.3 (5-10)</P>
<P>Mean weight (range) in kg all subjects 22.9 (16-32)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-10 12:21:00 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1 (n = 19): placebo</P>
<P>Group 2 (n = 21): 0.5 mg/kg midazolam</P>
<P>All oral</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-19 14:49:00 +0100" MODIFIED_BY="[Empty name]">
<P>Ramsay, Brietkopf and Buttner, Frankl, Houpt scales</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-10 12:21:25 +0000" MODIFIED_BY="[Empty name]">
<P>Papoose board</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>* calculated from data presented in the paper<BR/>** translated<BR/>*** data from third arm where no placebo or drug given was not reported</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-02-10 14:27:48 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2011-05-18 11:42:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Al_x002d_Zahrani-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-05-18 11:42:36 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Arya-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Patients not randomly assigned<BR/>INDIA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:11:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Badalaty-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:11:50 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Baldinelli-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>ITALY<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Berge-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>Ages ranging from 3 to 46 years<BR/>NORWAY<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Blake-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Age unclear, authors did not respond<BR/>Authors assumed the subjects were adults<BR/>United Kingdom (UK)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Campbell-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Patients not randomly assigned (explicitly stated)<BR/>United States of America (USA)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:16:03 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cathers-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:16:03 +0000" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chaushu-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>ISRAEL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-15 16:48:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coldwell-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-15 16:48:43 +0100" MODIFIED_BY="[Empty name]">
<P>Evaluates adverse effects only<BR/>ISRAEL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:12:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Da-Costa-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:12:03 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>BRAZIL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:12:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dallman--2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:12:11 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Davila-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Review<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Doring-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not comparative<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:12:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Downs-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:12:25 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Duncan-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Survey<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Duncan-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dunn_x002d_Russell-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:12:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-el-Magboul-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:12:37 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Erlandsson-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>SWEDEN</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-10-21 13:58:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Evans-1966">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-10-21 13:58:42 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:12:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Flaitz-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:12:46 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:12:53 +0100" MODIFIED_BY="Paul Francis Ashley" STUDY_ID="STD-Fuks-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:12:53 +0100" MODIFIED_BY="Paul Francis Ashley">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fukuta-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>Ages 4 to 21 years<BR/>JAPAN/USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fukuta-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Ages from 5 to 20 years<BR/>JAPAN/USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gallardo-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:02 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>CHILE</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gamonal-Aravena-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:08 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Garton-1970">
<CHAR_REASON_FOR_EXCLUSION>
<P>Review<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Haas-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:15 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>CANADA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-05 12:58:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hall-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-05 12:58:30 +0000" MODIFIED_BY="[Empty name]">
<P>Adults</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:17:55 +0000" MODIFIED_BY="Paul Francis Ashley" STUDY_ID="STD-Hartgraves-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:17:55 +0000" MODIFIED_BY="Paul Francis Ashley">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hasty-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:27 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-10-12 13:06:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heard-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-10-12 13:06:14 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:18:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Henry-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:18:16 +0000" MODIFIED_BY="[Empty name]">
<P>Compares scavenged/non-scavenged groups with regard to levels of ambient nitrous oxide<BR/>USA<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Houpt-1985a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:36 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Houpt-1985b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:43 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Houpt-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:50 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:13:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Houpt-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:13:55 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hulland-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective<BR/>CANADA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:14:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Isik-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:14:12 +0100" MODIFIED_BY="[Empty name]">
<P>Looked at the effect of flavouring on acceptability of oral sedatives</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-15 16:57:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jensen-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-15 16:57:00 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective study<BR/>SWEDEN</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:14:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kantovitz-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:14:19 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>Brazil</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kayalibay-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Review<BR/>TURKEY</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:19:51 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kerins-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:19:51 +0000" MODIFIED_BY="[Empty name]">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-05 12:58:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kopel-1971">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-05 12:58:30 +0000" MODIFIED_BY="[Empty name]">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Koroluk-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kramer-1991a">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>GERMANY</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kramer-1991b">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>GERMANY</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kupietzky-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>No relevant outcomes<BR/>ISRAEL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:20:08 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lahoud-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:20:08 +0000" MODIFIED_BY="[Empty name]">
<P>Pilot study - no comparative group </P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Leelataweedwud-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:14:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leelataweewud-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:14:48 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:14:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lima-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:14:55 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>BRAZIL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lindh_x002d_Stromberg-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>SWEDEN</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:15:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindsay-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:15:01 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:15:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindsay-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:15:23 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Litman-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Premedication before GA<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Litman-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised (author contacted)<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:15:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-L_x00f6_kken-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:15:33 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>NORWAY</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Machen-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>No relevant outcomes<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Malamed-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:20:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marshall-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:20:39 +0000" MODIFIED_BY="[Empty name]">
<P>The study was based on 56 different treatment attempts on 34 patients. Therefore it was a partial crossover design as some of the patients would have had more than one type of treatment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:20:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Martinez-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:20:53 +0000" MODIFIED_BY="[Empty name]">
<P>Not randomised</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:15:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McCann-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:15:52 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Milnes-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>CANADA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Moore-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:16:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Musial-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:16:01 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Myers-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:16:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Myers-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:16:09 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nathan-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised<BR/>USA<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Oei_x002d_Lim-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>Ages ranging from 23 to 37 mental and physical handicapped<BR/>NETHERLANDS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:21:12 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pandey-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:21:12 +0000" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:16:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pisalchaiyong-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:16:35 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>Thailand</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:16:41 +0100" MODIFIED_BY="Paul Francis Ashley" STUDY_ID="STD-Poorman-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:16:41 +0100" MODIFIED_BY="Paul Francis Ashley">
<P>Not Randomised</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:21:25 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Primosch-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:21:25 +0000" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Primosch-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study<BR/>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-16 11:03:30 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Quarnstrom-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-16 11:03:30 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:16:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ram-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:16:59 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>Israel</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:25:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Reinemer-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:25:57 +0000" MODIFIED_BY="[Empty name]">
<P>Inappropriate design, partial crossover with some subjects having both and others only one regimen<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:26:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robbins-1967">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:26:05 +0000" MODIFIED_BY="[Empty name]">
<P>Inappropriate design, partial crossover with some subjects having both and others only one regimen<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roberts-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Age range 4 to 17 years<BR/>No comparison of groups<BR/>UK<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-16 11:06:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roberts-1982">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-16 11:06:06 +0100" MODIFIED_BY="[Empty name]">
<P>No comparison of groups<BR/>UK<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:26:19 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roberts-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:26:19 +0000" MODIFIED_BY="[Empty name]">
<P>Inappropriate design, partial crossover with some subjects having both and others only one regimen<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:26:28 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Robertson-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:26:28 +0000" MODIFIED_BY="[Empty name]">
<P>Not randomised (quasi-randomisation). First patient randomised by toss of a coin, remaining patients alternated<BR/>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roelofse-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Premedication before GA<BR/>SOUTH AFRICA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Roelofse-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Premedication before GA<BR/>SOUTH AFRICA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rohlfing-1998">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sams-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>No relevant outcome<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sams-1993b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Review<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sanders-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>No comparison of groups<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:17:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shapira-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:17:33 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>ISRAEL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:17:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shapira-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:17:39 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>ISRAEL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:17:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shapira-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:17:50 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>ISRAEL</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:26:53 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sharma-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:26:53 +0000" MODIFIED_BY="[Empty name]">
<P>Inappropriate design (partial crossover)<BR/>INDIA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:17:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sheroan-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:17:58 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Silver-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Ages from 3 to 18 years<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:18:07 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Songvasin-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:18:07 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>Thailand</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:18:17 +0100" MODIFIED_BY="Paul Francis Ashley" STUDY_ID="STD-Sullivan-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:18:17 +0100" MODIFIED_BY="Paul Francis Ashley">
<P>Crossover</P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tanaka-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>General anaesthesia<BR/>JAPAN</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Tobias-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:18:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsinidou-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:18:29 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-van-der-Bijl-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Adults<BR/>SOUTH AFRICA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-08-16 09:21:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Varpio-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-08-16 09:21:33 +0100" MODIFIED_BY="[Empty name]">
<P>Not randomised<BR/>SWEDEN</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Veerkamp-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Deep sedation<BR/>NETHERLANDS</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Whitehead-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised (author contacted to confirm)<BR/>Dr David Durr contacted<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wilson-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Retrospective study<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:19:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:19:39 +0100" MODIFIED_BY="[Empty name]">
<P>Dose response study measuring physiological outcomes<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:18:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:18:54 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover </P>
<P>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:20:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:20:17 +0100" MODIFIED_BY="[Empty name]">
<P>Retrospective study<BR/>USA</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:20:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:20:22 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover </P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:20:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:20:27 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover </P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:20:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:20:31 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover </P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-09-22 14:20:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilson-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-09-22 14:20:35 +0100" MODIFIED_BY="[Empty name]">
<P>Crossover </P>
<P>UK</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-10 14:27:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yanase-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-10 14:27:48 +0000" MODIFIED_BY="[Empty name]">
<P>Crossover</P>
<P>JAPAN</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-02-10 12:21:35 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-02-10 12:21:35 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:23:20 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>"Selected at random" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:32:58 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:35:37 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>"Patients were randomised" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:36:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-18 14:30:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Computerised random number generation "used Newcastle Centre for Health Services Research web-based randomisation service"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:21:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>Computerised random number generation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:22:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>"Randomly chosen" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:25:14 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:25:53 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>"Randomly selected" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:28:14 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>"Subjects were assigned randomly" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:29:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:31:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:36:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>"Randomized" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:37:08 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>"Randomly allocated" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:37:58 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>"Randomly divided" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:39:41 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:41:41 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>"randomly allocated" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:43:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:48:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>"subjects randomly received&#8230;" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:49:08 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:50:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>"Random administration" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:51:05 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>"Randomly placed" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:55:11 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:55:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>"Randomly given" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:56:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:57:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>"Randomly divided" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:58:44 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>"Patients were assigned randomly" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:59:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:00:30 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>"Assigned randomly" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:11:40 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>"Randomly selected" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:12:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>"Assigned randomly" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:13:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>"Randomly allocated" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:14:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>"Patients were randomised" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:17:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>"Randomly assigned" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:20:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>"Divided randomly into two matching (age, sex) groups" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 12:21:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>"Randomly divided" - method of sequence generation not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-02-10 11:41:44 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 17:58:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 17:58:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 17:59:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 17:59:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:42:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Envelope which had been placed in patient's record card opened by anaesthetist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-08-25 13:13:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>Allocated by independent third person</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 17:59:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 17:59:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>Study drugs given by a trained nurse</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:00:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>Independent person randomly selected, allocated and administered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:09 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:56:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>Coded bottles</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:41:44 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>"allocated by means of sealed envelopes" - not stated whether these were numbered</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:58:19 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>"The principal investigator conducted subject selection and random assignment of PO or IN midazolam administration"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:00:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 13:04:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:01:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:02:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:02:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:02:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-08 18:02:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2010-11-09 11:07:28 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-14" LEVEL="GROUP" NO="14">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-15" LEVEL="GROUP" NO="15">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2010-11-09 11:07:28 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2010-11-09 11:07:28 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2010-11-09 11:08:17 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2012-02-10 11:56:45 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding - Patient</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>Double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 09:26:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>Both drugs masked using flavoured soft drink</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:27:15 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:27:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>Blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:32:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:55:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>Study described as being double blind, but no placebo used for group 4 who did not receive an oral medication</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:25:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>Study described as double blind - operator, dentist/anaesthetist and patient did not know which regimen was selected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:28:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>Drugs given at home by parents or administered at clinic by the assistant</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>Study reported as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:51:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>Subject blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>"delivered by the pharmacy in coded bottles and neither the dentist nor the parents knew which agent was being used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:50:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>Study reported as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>Study reported as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:54:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:43:05 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:44:34 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:02:32 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>"Dentist, patient and research observer were unaware of treatment allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:09:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>Not clear if the patient was blinded or not</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:51:08 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:34:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>"double blind conditions"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:03:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:56:45 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>Study described as double blind. This only applies to Group 2 and Group 3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:09:01 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>Not reported as being blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:11:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:13:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>No blinding reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:17:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2012-02-10 11:56:46 +0000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding - Operator/sedationist</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 09:17:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>Seems likely that operating dentist was blinded </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>Double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>"operating dentist was not aware of which drug the child received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 09:30:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>"dental procedures were completed by one dentist who was ignorant of the patient location group"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:03:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Dentist blinded to sedation type. Anaesthetist not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:34:55 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>Sedation administered by anaesthetist. Dentist unaware of allocated treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:32:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:51:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>Study drugs administered by nurse and described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:25:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>Study described as double blind - operator, dentist/anaesthetist and patient did not know which regimen was selected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:28:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>"Blinded to subject group assignment"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:29:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>Study described as double blind but likely that sedative effects of active intervention were obvious to dentist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:32:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>"neither the researcher nor the parents were informed which drug was administered"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:51:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>Dentist blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>"delivered by the pharmacy in coded bottles and neither the dentist nor the parents knew which agent was being used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:38:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>"chief investigator blind to treatment allocation" - performed the restorative procedures</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:39:45 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>No separate outcome assessor described. Assumed dentist was blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:54:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:30:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:44:38 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>Not possible</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:02:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>"Dentist, patient and research observer were unaware of treatment allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:09:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>Operating dentist not blind to drug given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:51:12 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>Operator administered sedation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:20:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>"double blind conditions"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 13:06:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>"operator blind to drug used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:56:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>Study described as double blind. This only applies to Group 2 and Group 3</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>"both operator and assessor blind to treatment received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:08:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>Operator blind to the treatment regimen</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:40:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>Operator blinded to route of administration</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 17:03:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:13:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>No blinding reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:17:53 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>Not blinded</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2010-11-09 11:08:40 +0000" MODIFIED_BY="[Empty name]" NO="9">
<NAME>New Item</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2012-02-10 11:51:14 +0000" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Blinding - Outcome assessor</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-12 15:49:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>Study described as double blind, but "significant desaturations observed early in the study resulted in breaking the code"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:33:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>"Behaviour of the child during treatment was evaluated by a trained observer who was also blind to the drug regimen used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 09:28:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>"The quality of the sedation was assessed by the operating dentist who was blinded to the study drug"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>Study described as double blind, independent rater unaware of patient treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:07:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Outcomes assessed by dentist</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:21:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>Dentist blinded to allocated treatment undertook outcome assessments</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:32:18 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>No blinding</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:53:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>One of the researchers who was blinded to the premedication drug evaluated every patient</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:25:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>Study described as double blind - operator, dentist/anaesthetist and patient did not know which regimen was selected</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:15:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>Outcomes assessed by the "monitoring dentist". Unclear whether this person was blinded to treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:22:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:25:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>Study reported as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:30:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>Separate outcome assessor, blinding unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:37:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>Dentist assessed outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:38:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>"chief investigator blind to treatment allocation" - recorded the various parameters</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:36:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>Study reported as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:54:40 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>"evaluators had no prior knowledge of which pre medication route had been used"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:32:16 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>Independent assessor using videotapes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:02:42 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>"Dentist, patient and research observer were unaware of treatment allocation"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:08:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>"Sedations were videotaped and evaluated by two paediatric dentists not involved in the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:51:14 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>Operator administered sedation and assessed outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:23:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>Each child was monitored by a single research assistant, assumed to be blinded to allocated treatment </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 13:07:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>Study described as double blind - outcomes assessed by "senior investigator"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-08 15:04:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>Ratings of unco-operative behaviour and anxiety were made by trained judges naive to experimental hypotheses and inhalant conditions</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:29:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>Outcomes were evaluated by primary operator and one observer</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:30:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>"Anxiety was scored by an independent observer"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>"both operator and assessor blind to treatment received"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:33:47 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>Operator evaluated the sedation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:35:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>Operators, who were blinded to allocated treatment, assessed outcomes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:42:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>Outcomes assessed by operator</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 17:03:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>Study described as double blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:13:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>Observer "was not informed of the objective of the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:18:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>Viewed by dentist and psychologist who "were not aware of the objective of the study"</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 11:55:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>Outcomes assessed from videotapes by dentist and anaesthetist unaware of allocated treatment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="STUDY" MODIFIED="2012-02-10 11:21:59 +0000" MODIFIED_BY="[Empty name]" NO="11">
<NAME>Incomplete Outcome Assessment</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>All patients included in outcome evaluation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:23:37 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>Number of participants included in outcome evaluation unclear as only % given</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:25:50 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>All patients included in outcome evaluation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:26:11 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:21:44 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Intention-to-treat (ITT) analysis done initially. However secondary outcomes only reported on 'successful sedations' (69% of those randomised)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:21:59 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>848 children randomised and 697 received intervention and were analysed. 22%, 16% &amp; 17% of children randomised to groups 1, 2 &amp; 3 did not receive allocated treatment. Paper states ITT performed but this appears to be only on those who received treatment (82% of those randomised)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:32:23 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:03:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>All randomised participants evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:33:49 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:34:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:42:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:42:48 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:43:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>Numbers evaluated not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>All randomised participants included in outcome evaluation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:57:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>Numbers evaluated unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:57:31 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>Dropouts/aborted patients reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:01:55 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>Numbers evaluated unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:02:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>Numbers evaluated unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:02:13 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>Numbers evaluated unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 13:08:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>All randomised participants included in outcome assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 15:16:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>Numbers included/dropouts unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:05:45 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:05:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:06:17 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:06:35 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:22:29 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:14:09 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P> All randomised participants included in outcome evaluation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:12:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:12:24 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>Numbers evaluated not stated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 18:14:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>All randomised participants included in outcome evaluation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 11:58:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>All randomised participants included in outcome assessment</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="STUDY" MODIFIED="2011-09-21 15:26:57 +0100" MODIFIED_BY="[Empty name]" NO="12">
<NAME>Free of selective reporting</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>Depth of sedation, time to onset of sedation and Houpt scores reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-21 15:26:57 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>All planned outcomes reported, but not for all participants</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:32:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>All planned outcomes reported, but secondary outcomes only reported for 'successful' sedations (65% of those initially randomised)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:08 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bui-2002">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:17:08 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION>
<P>All planned outcomes reported </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION>
<P>All planned outcomes reported on</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:09 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>Planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:10 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:11 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 13:09:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>Planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:13 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>All selected variables reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:16 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-08 20:25:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>All planned outcomes reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-13" LEVEL="STUDY" MODIFIED="2012-02-10 11:38:06 +0000" MODIFIED_BY="[Empty name]" NO="13">
<NAME>Free of other bias</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:23:24 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Abrams-1993">
<DESCRIPTION>
<P>Following significant desaturations and prolonged recovery time the dose of sufentanil was reduced to 1.0 µg/kg during the trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-05-23 17:23:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Al_x002d_Rakaf-2001">
<DESCRIPTION>
<P>No characteristics of the groups at baseline are reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 10:35:37 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993">
<DESCRIPTION>
<P>Nitrous oxide/oxygen titrated to desired effect - this is a co-intervention. Levels of nitrous oxide not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-09 13:22:15 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Avalos_x002d_Arenas-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:06:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Averley-2004a">
<DESCRIPTION>
<P>Some imbalance in the groups - gender and invasiveness of treatment </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:22:10 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Averley-2004b">
<DESCRIPTION>
<P>Baseline data only reported for those who received treatment. Unbalanced for gender and anxiety. Interim analysis led to discontinuation of group 1 after 222 children randomised</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 13:15:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aydintug-2004">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 10:56:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Baygin-2010">
<DESCRIPTION>
<P>No other risks identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-10 21:14:03 +0000" MODIFIED_BY="Paul Francis Ashley" RESULT="YES" STUDY_ID="STD-Bui-2002">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-09 13:29:38 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Faytrouny-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 17:21:40 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gallardo-1994">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 16:37:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Isik-2008a">
<DESCRIPTION>
<P>No apparent differences between the groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2010-11-10 21:56:34 +0000" MODIFIED_BY="Paul Francis Ashley" RESULT="YES" STUDY_ID="STD-Isik-2008b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:37:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Jensen-1999">
<DESCRIPTION>
<P>No differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-10 11:38:06 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kapur-2004">
<DESCRIPTION>
<P>No differences at baseline with regards to age, sex and body weight</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 15:16:02 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Koirala-2006">
<DESCRIPTION>
<P>No characteristics of the groups at baseline are reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 11:56:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lahoud-2002">
<DESCRIPTION>
<P>No reported differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 15:16:16 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lam-2005">
<DESCRIPTION>
<P>No characteristics of the groups at baseline are reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:00:22 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lee_x002d_Kim-2004">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:06:43 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McKee-1990">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:12:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Meyer-1990">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:16:57 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moody-1986">
<DESCRIPTION>
<P>No significant differences between groups reported at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-09 12:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Moore-1984">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:24:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mortazavi-2009">
<DESCRIPTION>
<P>Very little information on participant demographics at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 15:18:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nathan-1988">
<DESCRIPTION>
<P>No information on demographic characteristics at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 15:19:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rai-2007">
<DESCRIPTION>
<P>Very little information on participant demographics at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:28:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Reeves-1996">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:31:25 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996a">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:32:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1996b">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:34:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Roelofse-1998">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:35:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sams-1993a">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 16:42:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shashikiran-2006">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-10 17:01:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Singh-2002">
<DESCRIPTION>
<P>Little information on participants in each group at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 11:49:48 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Torres_x002d_Perez-2007">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 11:52:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Veerkamp-1993">
<DESCRIPTION>
<P>Little information on participants in each group at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-08-11 11:53:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wan-2006">
<DESCRIPTION>
<P>No apparent differences between groups at baseline</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2011-05-18 10:39:02 +0100" MODIFIED_BY="[Empty name]"/>
<ADDITIONAL_TABLES MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-02-10 14:28:45 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-02-08 16:00:49 +0000" MODIFIED_BY="[Empty name]">Comparison of behaviour/sedation rating scales</TITLE>
<TABLE COLS="5" ROWS="7">
<TR>
<TD VALIGN="TOP">
<P>
<B>Score</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Ramsay sedation scale</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Briekopf &amp; Buttner emotional status scale</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Frankl behaviour rating scale</B>
</P>
</TD>
<TD VALIGN="TOP">
<P>
<B>Houpt behaviour Rating Scale</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>1</P>
</TD>
<TD VALIGN="TOP">
<P>Awake, anxious &amp; agitated, restless or both</P>
</TD>
<TD VALIGN="TOP">
<P>Irritated: awake, restless, crying</P>
</TD>
<TD VALIGN="TOP">
<P>Refusal/distress</P>
</TD>
<TD VALIGN="TOP">
<P>Aborted: no treatment rendered</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2</P>
</TD>
<TD VALIGN="TOP">
<P>Awake, co-operative, orientated, tranquil</P>
</TD>
<TD VALIGN="TOP">
<P>Normal: awake, calm</P>
</TD>
<TD VALIGN="TOP">
<P>Unco-operative/reluctant</P>
</TD>
<TD VALIGN="TOP">
<P>Poor: treatment interrupted, only partial treatment was completed</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3</P>
</TD>
<TD VALIGN="TOP">
<P>Awake responds to commands only</P>
</TD>
<TD VALIGN="TOP">
<P>Inactive: tired, hardly moving</P>
</TD>
<TD VALIGN="TOP">
<P>Co-operative/reserved</P>
</TD>
<TD VALIGN="TOP">
<P>Fair: treatment interrupted but eventually completed</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4</P>
</TD>
<TD VALIGN="TOP">
<P>Asleep, brisk response</P>
</TD>
<TD VALIGN="TOP">
<P>Sleepy: drowsy, with reaction but rousable</P>
</TD>
<TD VALIGN="TOP">
<P>Interested/enjoyed</P>
</TD>
<TD VALIGN="TOP">
<P>Good: difficult but all treatment was performed</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5</P>
</TD>
<TD VALIGN="TOP">
<P>Asleep, sluggish response</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>Very good: some limited crying &amp; movement</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6</P>
</TD>
<TD VALIGN="TOP">
<P>Asleep, no response</P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P> </P>
</TD>
<TD VALIGN="TOP">
<P>Excellent: no crying or movement</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>(from <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>)</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2012-02-10 14:29:56 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2010-10-05 15:23:24 +0100" MODIFIED_BY="[Empty name]">Frequency of studies in which drug regimens were tested</TITLE>
<TABLE COLS="2" ROWS="29">
<TR>
<TH>
<P>Drug regimen tested</P>
</TH>
<TH>
<P>Study frequency</P>
</TH>
</TR>
<TR>
<TD>
<P>Chloral hydrate</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Chloral hydrate + hydroxyzine</P>
</TD>
<TD>
<P>5</P>
</TD>
</TR>
<TR>
<TD>
<P>Chloral hydrate + promethazine</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Diazepam</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Hydroxyzine</P>
</TD>
<TD>
<P>3</P>
</TD>
</TR>
<TR>
<TD>
<P>Ketamine</P>
</TD>
<TD>
<P>6</P>
</TD>
</TR>
<TR>
<TD>
<P>Ketamine + promethazine</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Ketamine + midazolam</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Melatonin</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Meperidine</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Meperidine + promethazine</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Midazolam</P>
</TD>
<TD>
<P>20</P>
</TD>
</TR>
<TR>
<TD>
<P>Midazolam + acetaminophen</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Midazolam + hydroxyzine</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Midazolam + ketamine</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Midazolam + sevoflurane + nitrous oxide/oxygen</P>
</TD>
<TD>
<P>2</P>
</TD>
</TR>
<TR>
<TD>
<P>Midazolam and tramadol</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Nitrous oxide/oxygen</P>
</TD>
<TD>
<P>4</P>
</TD>
</TR>
<TR>
<TD>
<P>Promethazine</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Propofol</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Sevoflurane + nitrous oxide/oxygen</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Sufentanil</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Triazolam</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Triclofos</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Trimeprazine + methadone</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Trimeprazine + physeptone</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Zolpidem</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
<TR>
<TD>
<P>Zolpidem + tramadol</P>
</TD>
<TD>
<P>1</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2010-10-05 15:22:29 +0100" MODIFIED_BY="[Empty name]">Outcome measures used (excluding physiological parameters)</TITLE>
<TABLE COLS="3" ROWS="20">
<TR>
<TH>
<P>Name</P>
</TH>
<TH>
<P>Studies used</P>
</TH>
<TH>
<P>Characteristics</P>
</TH>
</TR>
<TR>
<TD>
<P>Houpt<BR/>
</P>
</TD>
<TD>
<P>
<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>; <LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>; <LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>; <LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>; <LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>; <LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>; <LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>; <LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK>; <LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>; <LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>; <LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>
</P>
</TD>
<TD>
<P>3 point scale for sleep (awake to asleep); 4 point scale for movement (1 = violent movement to 4 = no movement); 4 point scale for crying (1 = hysterical crying to 4 = no crying); 6 point scale for overall behaviour (1 = no treatment rendered to 4 = difficult but all treatment completed to 6 = excellent/no crying or movement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Modified from Houpt</P>
</TD>
<TD>
<P>
<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>; <LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>
</P>
</TD>
<TD>
<P>4 point scale ranging from 1 = treatment aborted, 2 = poor (treatment frequently interrupted), 3 = fair (planned treatment completed), 4 = good (all treatment completed without crying or movement)</P>
</TD>
</TR>
<TR>
<TD>
<P>Modified from Houpt</P>
</TD>
<TD>
<P>
<LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>
</P>
</TD>
<TD>
<P>Modification not specified</P>
</TD>
</TR>
<TR>
<TD>
<P>Dichotomous behaviour scale</P>
</TD>
<TD>
<P>
<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>; <LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>
</P>
</TD>
<TD>
<P>Dichotomous behavioural scale rates specific events of treatment as satisfactory or unsatisfactory</P>
</TD>
</TR>
<TR>
<TD>
<P>Ohio State University behaviour rating scale</P>
</TD>
<TD>
<P>
<LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>
</P>
</TD>
<TD>
<P>4 point scale ranging from quiet to crying and struggling</P>
</TD>
</TR>
<TR>
<TD>
<P>Venham scale</P>
</TD>
<TD>
<P>
<LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>; <LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>
</P>
</TD>
<TD>
<P>6 point scale ranging from relaxed (0) to out of control (5)</P>
</TD>
</TR>
<TR>
<TD>
<P>Mental attitude, hypnotic effect, motor activity and overall sedation</P>
</TD>
<TD>
<P>
<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>
</P>
</TD>
<TD>
<P>2 point scale for mental attitude (relaxed or agitated); 3 point scale for hypnotic effect (asleep to or awake); 3 point scale for motor activity (absent to remarkable); 3 point scale for sedation (excellent to unsatisfactory)</P>
</TD>
</TR>
<TR>
<TD>
<P>Ramsay sedation score, movement, crying, overall sedation and behaviour</P>
</TD>
<TD>
<P>
<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK>; <LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>; <LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>; <LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>; <LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>; <LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>; <LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>
</P>
</TD>
<TD>
<P>6 point scale for Ramsay (patient anxious and agitated to no response); 3 point scale for movement (continuous movement to no movement); 4 point scale for crying (hysterical crying to no weeping); 4 point scale for overall sedation (impossible to very good)</P>
</TD>
</TR>
<TR>
<TD>
<P>Sedation scoring system</P>
</TD>
<TD>
<P>
<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>
</P>
</TD>
<TD>
<P>10 point scale: ranging from 1 = unmanageable, unable to examine/treat, to 10 = obtunded: apneic where 5 is ideal (well sedated, co-operative with normal oximetry)</P>
</TD>
</TR>
<TR>
<TD>
<P>Sedation scoring system</P>
</TD>
<TD>
<P>
<LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>; <LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK>
</P>
</TD>
<TD>
<P>5 point scale ranging from asleep to awake</P>
</TD>
</TR>
<TR>
<TD>
<P>Sedation scoring system</P>
</TD>
<TD>
<P>
<LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>
</P>
</TD>
<TD>
<P>4 point scale for level of sedation</P>
</TD>
</TR>
<TR>
<TD>
<P>Wiltons sedation scale</P>
</TD>
<TD>
<P>
<LINK REF="STD-Jensen-1999" TYPE="STUDY">Jensen 1999</LINK>
</P>
</TD>
<TD>
<P>4 point scale for Wilton (drowsy to agitated)</P>
</TD>
</TR>
<TR>
<TD>
<P>Acceptance of treatment (Holst, 1987)</P>
</TD>
<TD>
<P>
<LINK REF="STD-Jensen-1999" TYPE="STUDY">Jensen 1999</LINK>; <LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>
</P>
</TD>
<TD>
<P>4 point scale for Holst (positive to no)</P>
</TD>
</TR>
<TR>
<TD>
<P>Frankl</P>
</TD>
<TD>
<P>
<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>
</P>
</TD>
<TD>
<P>4 point scale for Frankl (definitely negative to definitely positive)</P>
</TD>
</TR>
<TR>
<TD>
<P>Modification Barker sedation scoring system, overall quality sedation</P>
</TD>
<TD>
<P>
<LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>
</P>
</TD>
<TD>
<P>Barker sedation score calculated by summing scores given at intervals throughout the treatment; 4 point rating scale for sedation quality (poor to excellent)</P>
</TD>
</TR>
<TR>
<TD>
<P>Global rating scale of overall behaviour</P>
</TD>
<TD>
<P>
<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>
</P>
</TD>
<TD>
<P>5 ratings from excellent to poor-aborted</P>
</TD>
</TR>
<TR>
<TD>
<P>Sedation rating scale</P>
</TD>
<TD>
<P>
<LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>
</P>
</TD>
<TD>
<P>7 point scale ranging from sleep to excited</P>
</TD>
</TR>
<TR>
<TD>
<P>Brietkopf and Buttner</P>
</TD>
<TD>
<P>
<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>
</P>
</TD>
<TD>
<P>4 point scale ranging from irritated to sleepy</P>
</TD>
</TR>
<TR>
<TD>
<P>Fukuta</P>
</TD>
<TD>
<P>
<LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>
</P>
</TD>
<TD>
<P>7 point scale ranging from asleep to violent rejection</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2012-02-10 15:59:01 +0000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2011-05-18 10:38:55 +0100" MODIFIED_BY="[Empty name]">Placebo study outcomes</TITLE>
<TABLE COLS="6" ROWS="14">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Sample</P>
</TH>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Outcomes</P>
</TH>
<TH>
<P>Results</P>
</TH>
<TH>
<P>Treatment completed</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Chloral hydrate</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Moore-1984" TYPE="STUDY">Moore 1984</LINK>
</P>
</TD>
<TD>
<P>n = 60<BR/>Mean age in years<BR/>Group 1 (n = 15), 3.6 years<BR/>11 male 4 female<BR/>Group 2 (n = 15), 3.3 years<BR/>7 male 8 female<BR/>Group 3 (n = 15), 3.8 years<BR/>9 male 6 female<BR/>Group 4 (n = 15), 3.9 years<BR/>7 male 8 female</P>
</TD>
<TD>
<P>Group 1<BR/>Placebo<BR/>Group 2<BR/>Chloral hydrate 20 mg/kg<BR/>Group 3<BR/>Chloral hydrate 40 mg/kg<BR/>Group 4<BR/>Chloral hydrate 60 mg/kg<BR/>All oral</P>
</TD>
<TD>
<P>Behaviour evaluations Completion of treatment. Analysed using Chi² and Fishers exact test</P>
</TD>
<TD>
<P>No statistically significant difference (P &lt; 0.05) seen between placebo and 60 mg/kg chloral hydrate group for outcome of positive behaviour in operatory. No statistically significant differences between placebo and other groups.</P>
<P>Data reported as numbers and % per group, at different stages of the treatment and displayed in graphical form.</P>
<P>Adverse effects: not clear, 4 children failed to respond to obstruction (group 4) after N2O/O2 started.</P>
<P>Monitoring: cardiovascular and respiratory monitoring mentioned</P>
</TD>
<TD>
<P>All participants completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Meperidine</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-McKee-1990" TYPE="STUDY">McKee 1990</LINK>
</P>
</TD>
<TD>
<P>n = 60<BR/>Mean age (SE) in months<BR/>Group 1 (n = 15)<BR/>36.5 (2.7)<BR/>Group 2 (n = 15)<BR/>41.7 (3)<BR/>Group 3 (n = 15)<BR/>35.9 (2.7)<BR/>Group 4 (n = 15)<BR/>43 ( 2.7)</P>
</TD>
<TD>
<P>Group 1<BR/>Placebo<BR/>Group 2<BR/>Meperidine 0.25 mg/lb<BR/>Group 3<BR/>Meperidine 0.50 mg/lb<BR/>Group 4<BR/>Meperidine 1 mg/lb<BR/>All intramuscular</P>
</TD>
<TD>
<P>Modified Houpt<BR/>Dichotomous Behavior Scale<BR/>10 point behaviour scale.<BR/>Global Rating Scale. Analysed using Kruskal-Wallis, multivariant analysis of covariance (MANCOVA) and Mann-Whitney U</P>
</TD>
<TD>
<P>Global rating scale (good to excellent) significantly favoured meperidine compared to placebo, (All doses of meperidine were significantly better than placebo (P &lt; 0.05) for values of Global sedation scale. All 3 scales significantly contributed to overall MANCOVA. Global rating reported as individual frequencies. Sleep mentioned. Adverse effects: sleep/drowsiness (groups1 and 3), nausea/vomiting (groups 3 and 4), hyperexcited (group 3). Monitoring: Precordial stethoscope, automatic sphygmomanometer, pulse oximeter</P>
</TD>
<TD>
<P>One participant from 0.25 mg/lb group and one from 0.5 mg/lb group became unmanageable and treatment was not completed</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Midazolam (oral)</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Gallardo-1994" TYPE="STUDY">Gallardo 1994</LINK>
</P>
</TD>
<TD>
<P>n = 32<BR/>Age range = 4 to 10 years<BR/>17 male 15 female</P>
</TD>
<TD>
<P>Group 1<BR/>Midazolam 7.5 mg (regardless of weight)<BR/>Group 2<BR/>Placebo<BR/>All oral<BR/>
</P>
</TD>
<TD>
<P>Overall sedation mental attitude<BR/>Hypnotic effects<BR/>Motor activity Ease of treatment<BR/>Analysed using Wilcoxon rank</P>
</TD>
<TD>
<P>Midazolam significantly better than placebo (P &lt; 0.001) in all categories.</P>
<P>Data presented graphically.</P>
<P>Sleeping mentioned.</P>
<P>Adverse effects and monitoring: not mentioned</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Isik-2008a" TYPE="STUDY">Isik 2008a</LINK>
</P>
</TD>
<TD>
<P>Mean age (SD) in years, gender, mean weight (SD) in kg</P>
<P>Group 1</P>
<P>n = 15</P>
<P>4.87 (0.99), 7 males 8 females</P>
<P>18.87 (2.5)</P>
<P>Group 2</P>
<P>n = 15</P>
<P>4.93 (1.11), 7 males 8 females</P>
<P>17.87 (3.88)</P>
<P>Group 3</P>
<P>n = 15</P>
<P>4.93 (1.10), 8 males, 7 females</P>
<P>18.6 (3.31)</P>
<P>Group 4</P>
<P>n = 15</P>
<P>5.01 (1.03), 9 males 6 females</P>
<P>19.73 (4.77)</P>
</TD>
<TD>
<P>Group 1</P>
<P>3 mg melatonin</P>
<P>Group 2</P>
<P>0.5 mg/kg melatonin</P>
<P>Group 3</P>
<P>0.75 mg/kg midazolam</P>
<P>Group 4</P>
<P>Placebo</P>
<P>All oral</P>
</TD>
<TD>
<P>Ramsay sedation score</P>
<P>Analysed with Kruskal-wallis</P>
</TD>
<TD>
<P>Ramsay sedation score significantly higher (i.e. more sedated) for group 3 versus all other groups (P &lt; 0.05).</P>
<P>Sedation significantly likely to be scored as satisfactory in group 3 versus other groups (P &lt; 0.05).</P>
<P>Data presented graphically. No sedations scored as unsatisfactory in Group 3.</P>
<P>Adverse effects: vomiting, hiccuping and coughing seen in all groups, amnesia reported in group 3.</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Kapur-2004" TYPE="STUDY">Kapur 2004</LINK>
</P>
</TD>
<TD>
<P>n = 40<BR/>Age: younger than 4 years old - no differences at baseline with regards to age, sex and body weight</P>
</TD>
<TD>
<P>Group 1<BR/>Midazolam 0.5 mg/kg oral/transmucosal<BR/>Group 2<BR/>Placebo (same volume)</P>
</TD>
<TD>
<P>Sedation score, treatment completion, time. No statistical tests described</P>
</TD>
<TD>
<P>Significantly better sedation in group 1 (mean 3.75, SD 0.85) compared to group 2 (mean 4.6, SD 0.5) (P &lt; 0.01). 18 completed group 1 versus 7 group 2 (P &lt; 0.01). Monitored with pulse oximeter</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Mortazavi-2009" TYPE="STUDY">Mortazavi 2009</LINK>
</P>
</TD>
<TD>
<P>n = 40</P>
<P>Mean age (SD)</P>
<P>3.99 (0.38)</P>
<P>Iran</P>
</TD>
<TD>
<P>Group 1</P>
<P>Placebo</P>
<P>Group 2</P>
<P>Midazolam 0.25 mg/kg</P>
<P>All oral</P>
</TD>
<TD>
<P>Houpt. Analysed using Mann-Whitney U</P>
</TD>
<TD>
<P>Significant improvement in overall behaviour in midazolam group compared to placebo group (5.1 versus 1.6, P &lt; 0.05).</P>
<P>Adverse effects: none</P>
<P>Monitoring: pulse oximeter, precordial stethoscope</P>
</TD>
<TD>
<P>11 out of 20 patients aborted treatment in placebo group</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Wan-2006" TYPE="STUDY">Wan 2006</LINK>
</P>
</TD>
<TD>
<P>n = 40</P>
<P>Group 1 n = 19</P>
<P>Group 2 n = 21</P>
<P>Mean age (range) in years all subjects 7.3 (5-10)</P>
<P>Mean weight (range) in kg all subjects</P>
<P>22.9 (16-32)</P>
</TD>
<TD>
<P>Group 1</P>
<P>Placebo</P>
<P>Group 2 0.5 mg/kg</P>
<P>Midazolam</P>
<P>All oral</P>
</TD>
<TD>
<P>Ramsey</P>
<P>Brietkopf and Buttner</P>
<P>Frankl</P>
<P>Houpt</P>
<P>Analysed using one way Anova</P>
</TD>
<TD>
<P>Scores significantly lower in placebo group for all outcomes (P &lt; 0.001). 15 subjects reported amnesia - all in the midazolam group. Monitoring: blood pressure, pulse oximeter</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Nitrous oxide</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Nathan-1988" TYPE="STUDY">Nathan 1988</LINK>
</P>
</TD>
<TD>
<P>n = 35<BR/>Age range = 48 to 72 months</P>
</TD>
<TD>
<P>Group 1</P>
<P>No intervention</P>
<P>Group 2</P>
<P>Placebo</P>
<P>inhalation</P>
<P>Group 3</P>
<P>20-50:50 nitrous oxide/oxygen</P>
<P>inhalation</P>
</TD>
<TD>
<P>Venham<BR/>Parental questionnaire<BR/>Behavioral screening instrument. Ratings of anxiety and behaviour analysed using two-way ANOVA.</P>
</TD>
<TD>
<P>Significantly lower anxiety and behaviour ratings in nitrous oxide group (P &lt; 0.05). Data presented graphically.</P>
<P>Adverse effects: not mentioned Monitoring: precordial electrodes: heart rate using Epstein's measure of mean heart rate</P>
</TD>
<TD>
<P>All participants completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Veerkamp-1993" TYPE="STUDY">Veerkamp 1993</LINK>
</P>
</TD>
<TD>
<P>n = 56<BR/>Group 1 (n = 27)<BR/>Group 2 (n = 29)<BR/>Age range all subjects = 6 to 11 years</P>
</TD>
<TD>
<P>Group 1 Behaviour management</P>
<P>Group 2 Up to 40:60 nitrous oxide/oxygen</P>
<P>All inhalation</P>
</TD>
<TD>
<P>Venham Scale. Analysed using t-test</P>
</TD>
<TD>
<P>Mean Venham scores from T1 p177 transformed for forest plots. Significantly better outcome (P &lt; 0.05) in nitrous oxide group (mean overall score Group 1 = 2.84, SD 0.80, Group 2 = 3.45, SD 0.92).</P>
<P/>
<P>Adverse effects and monitoring not mentioned</P>
</TD>
<TD>
<P>All participants completed treatment</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2012-02-10 16:00:15 +0000" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2011-05-18 10:38:58 +0100" MODIFIED_BY="[Empty name]">Dosage study outcomes</TITLE>
<TABLE COLS="6" ROWS="11">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Sample</P>
</TH>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Outcomes</P>
</TH>
<TH>
<P>Outcome results</P>
</TH>
<TH>
<P>Treatment completed</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Hydroxyzine</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Faytrouny-2007" TYPE="STUDY">Faytrouny 2007</LINK>
</P>
</TD>
<TD>
<P>n = 30</P>
<P>14 females 16 males</P>
<P>Mean age (SD) months</P>
<P>Group 1</P>
<P>61.9 (11.9)</P>
<P>Group 2</P>
<P>53.7 (12.8)</P>
</TD>
<TD>
<P>Group 1</P>
<P>Hydroxyzine 20 mg 24 hours before + hydroxyzine 3.7 mg/kg at the appointment</P>
<P>Group 2</P>
<P>Hydroxyzine 3.7 mg/kg at the appointment</P>
<P>All oral</P>
</TD>
<TD>
<P>Houpt. Analysed using ANOVA and Mann-Whitney</P>
</TD>
<TD>
<P>No significant differences at any time point. At 20 min Houpt Gp1, 5.2, (SD 1.5) &amp; Gp2, 4.6 (SD 1.6)</P>
<P>No adverse effects reported in either group.</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Midazolam (intranasal)</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Al_x002d_Rakaf-2001" TYPE="STUDY">Al-Rakaf 2001</LINK>
</P>
</TD>
<TD>
<P>n = 38 children<BR/>Mean age (SD) in years and gender<BR/>Group 1 (n = 12)<BR/>3.75 (0.75)<BR/>6 male, 6 female<BR/>Group 2 (n = 13)<BR/>4.3 (0.65)<BR/>6 male, 7 female<BR/>Group 3 (n = 13)<BR/>4 (0.71)<BR/>6 male, 7 female</P>
</TD>
<TD>
<P>Group 1<BR/>Midazolam 0.3 mg/kg<BR/>Group 2<BR/>Midazolam 0.4 mg/kg<BR/>Group 3<BR/>Midazolam 0.5 mg/kg<BR/>All intranasal</P>
</TD>
<TD>
<P>Houpt. Analysed using Tukey's range test and non parametric two factor ANOVA.</P>
<P>Duration of sedation</P>
</TD>
<TD>
<P>Significant difference in Houpt behavioural scores between group 3 and group 1 (P &lt; 0.0001) &amp; between group 3 and group 2 (P &lt; 0.01).</P>
<P>No difference in outcomes between fasting &amp; no-fasting in each group (P = 0.8286)</P>
<P>None of the children were asleep.</P>
<P>Adverse effects: sneezing and coughing during administration and drowsiness (groups 1 and 2), diplopia (only in group 3).</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P>79% 0.3 mg/kg, 96% 0.4 mg/kg and 100% 0.5 mg/kg completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Lam-2005" TYPE="STUDY">Lam 2005</LINK>
</P>
</TD>
<TD>
<P>n = 23 (12 group 1, 11 group 2)</P>
<P>Mean age (range) in years</P>
<P>5.13 (2-9)</P>
<P>Mean weight (range) in kg</P>
<P>21.74 (12-30)</P>
<P>15 males, 7 females</P>
</TD>
<TD>
<P>Group 1</P>
<P>Midazolam 0.2 mg/kg</P>
<P>intramuscular</P>
<P>Group 2</P>
<P>Midazolam 0.2 mg/kg</P>
<P>intranasal</P>
<P>All used as premed for unspecified IV sedation drug</P>
<P/>
<P/>
</TD>
<TD>
<P>Houpt. Analysed using Mann-Whitney. Inter-examiner variability assessed using Spearmans rank correlation.</P>
<P>Good/excellent sedation levels in each group</P>
</TD>
<TD>
<P>Patients more deeply sedated in Group 1 at time of LA admin and venepuncture (P &lt; 0.048, P &lt; 0.015 respectively). One observer found Group 1 (IM) significantly more effective than Group 2 (P &lt; 0.04). Not significant for the second observer (P = 0.056). Individual outcomes for each observer not reported.</P>
<P>Good/excellent sedation 12/12 (100%) in IM group and 6/11 (54%) in the IN group.</P>
<P>Children more likely to be drowsy in group 1.</P>
<P>Adverse effects: none reported</P>
<P>Monitoring: heart rate, respiratory rate, blood pressure, oxygen saturation</P>
<P/>
</TD>
<TD>
<P>Treatment completed by all participants</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Lee_x002d_Kim-2004" TYPE="STUDY">Lee-Kim 2004</LINK>
</P>
</TD>
<TD>
<P>n = 40</P>
<P>Mean age (unclear, possibly SD) in months</P>
<P>Mean weight (unclear, possibly SD) in kg</P>
<P>Group 1 (n = 20)</P>
<P>40.8 (11)</P>
<P>17 (3.6)</P>
<P>11 males, 9 females</P>
<P>Group 2 (n = 20)</P>
<P>38.5 (9.8)</P>
<P>16.2 (4)</P>
<P>10 males, 10 females</P>
</TD>
<TD>
<P>Group 1</P>
<P>Midazolam 0.7 mg/kg</P>
<P>oral</P>
<P>Group 2</P>
<P>Midazolam 0.3 mg/kg</P>
<P>nasal</P>
</TD>
<TD>
<P>Modified Houpt - domains of sleep movement &amp; crying but no overall measure. Analysed with ANOVA, Chi² and t-test</P>
<P>Mean time of onset and mean working time in each group</P>
</TD>
<TD>
<P>Data presented on graphs only and text states no significant differences in Houpt using multivariate ANOVA (P = 0.749).</P>
<P>Onset of sedation Mean 5.55 min (SD 2.2) for IN &amp; mean 15.5 min (SD 5) for PO (P &lt; 0.001)</P>
<P>Mean working time was 29.3 min (SD 11.6) for IN &amp; 38.1 min (SD 7.58) for PO (P = 0.007)</P>
<P>Adverse effects: none reported, no differences between groups.</P>
<P>Monitoring: oxygen saturation, heart rate, respiratory rate</P>
</TD>
<TD>
<P>All participants completed</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Shashikiran-2006" TYPE="STUDY">Shashikiran 2006</LINK>
</P>
</TD>
<TD>
<P>n = 40</P>
<P>Group 1</P>
<P>11 males, 9 females</P>
<P>Mean age (SD) in years 3.4 (0.6)</P>
<P>Mean weight (SD) in kgs 12.2 (1.2)</P>
<P>Group 2</P>
<P>8 males, 12 females</P>
<P>Mean age (SD) in years 3.5 (0.7)</P>
<P>Mean weight (SD) in kgs 12.6 (1.4)</P>
</TD>
<TD>
<P>Group 1</P>
<P>0.2 mg/kg midazolam intramuscular</P>
<P>Group 2</P>
<P>0.2 mg/kg midazolam intranasal</P>
</TD>
<TD>
<P>Houpt and Fukuta. Analysed using Chi² and Mann-Whitney U test</P>
<P/>
</TD>
<TD>
<P>No difference in behaviour between groups (Chi² = 0.37, P = 0.83), but both groups showed improvement from baseline. Intranasal midazolam was significantly faster acting at all time points and allowed a shorter treatment time overall (P &lt; 0.001).</P>
<P>Mean onset times 15.7 ± 2.0 minutes IM vs 10.8 ± 2.0 minutes IN.</P>
<P>Adverse effects: 2 patients in the intramuscular group and 6 patients in the intranasal group showed instances of sneezing / coughing / hiccoughs after the administration of the sedative (difference not statistically significant).</P>
<P>No fasting pre treatment and no vomiting in either group.</P>
<P>Monitoring: heart rate, respiratory rate</P>
</TD>
<TD>
<P>Score 3 given to excellent, 2 to satisfactory, 1 to unsatisfactory</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Midazolam (oral)</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Aydintug-2004" TYPE="STUDY">Aydintug 2004</LINK>
</P>
</TD>
<TD>
<P>n = 50</P>
<P>Mean age (unclear, possibly SD) in years</P>
<P>Mean weight (unclear, possibly SD) in kg</P>
<P>Group 1 (n = 25)</P>
<P>5.36 (1.7)</P>
<P>19.068 (3.43)</P>
<P>18 males 7 females</P>
<P>Group 2 (n = 25)</P>
<P>4.96 (1.513)</P>
<P>17.804 (3.08)</P>
<P>12 males 13 females</P>
</TD>
<TD>
<P>Group 1</P>
<P>Midazolam 0.5 mg/kg oral</P>
<P>Group 2</P>
<P>Midazolam 0.35 mg/kg rectal</P>
</TD>
<TD>
<P>Ramsay sedation score, acceptance of application, acceptance of LA, operating conditions, state of amnesia.</P>
<P>Analysed using Chi² test</P>
</TD>
<TD>
<P>Acceptance of application significantly better in oral group (72% excellent in oral group compared to 20% excellent in rectal group, P &lt; 0.05).</P>
<P>No significant difference seen (P &gt; 0.05) between acceptance of LA, state of amnesia or operating conditions. Ramsay sedation scores not reported.</P>
<P>Adverse effects:No significant difference (P &gt; 0.05) in adverse effects between groups (56% oral, 44% rectal, included hypoxaemia, vomiting and nausea, disinhibition).</P>
<P>Monitoring: oxygen saturation, heart rate, blood pressure</P>
</TD>
<TD>
<P>Treatment completed by all participants</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Isik-2008b" TYPE="STUDY">Isik 2008b</LINK>
</P>
</TD>
<TD>
<P>Mean age (SD) in years, gender, mean weight (SD) in kg</P>
<P>Group 1</P>
<P>n = 14</P>
<P>4.6 (1.2), 7 males 7 females</P>
<P>15.6 (2.8)</P>
<P>Group 2</P>
<P>n = 13</P>
<P>4.4 (1.0), 8 males 5 females</P>
<P>16.2 (2.4)</P>
<P>Group 3</P>
<P>n = 13</P>
<P>4.4 (0.9), 6 males 7 females</P>
<P>16.1 (2.4)</P>
<P>Group 4</P>
<P>n = 13</P>
<P>4.3 (0.9), 5 males 8 females</P>
<P>15.8 (2.6)</P>
</TD>
<TD>
<P>Group 1</P>
<P>0.2 mg/kg midazolam</P>
<P>Group 2</P>
<P>0.5 mg/kg midazolam</P>
<P>Group 3</P>
<P>0.75 mg/kg midazolam</P>
<P>Group 4</P>
<P>1 mg/kg midazolam</P>
<P>All oral</P>
</TD>
<TD>
<P>Ramsay sedation scale.</P>
<P>Analysed using Kruskal-Wallis, Mann-Whitney U</P>
</TD>
<TD>
<P>At the 20 minute time point, mean Ramsay sedation score was 1.2 (0.4), 1.6 (0.5), 2.2 (0.6), 2.7 (1.0) in groups 1-4 respectively. Children in Groups 3 and 4 were more sedated than children in Groups 1 and 2 (P &lt; 0.05).</P>
<P>Sedation considered inadequate in 12/14, 5/13, 3/13 and 5/13 in groups 1-4 respectively.</P>
<P>Mean recovery time was 45 (0), 45 (0), 47.3 (8.3), and 57.7 (42.8) minutes in groups 1-4 respectively.</P>
<P/>
<P>Adverse effects: most of the adverse effects were seen in Group 4 with 1 patient desaturating and 3 presenting with delayed recovery, no adverse effects in Group 1 and 'very few' in groups 2 &amp; 3.</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-06" MODIFIED="2012-02-10 16:59:32 +0000" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2011-05-18 10:39:02 +0100" MODIFIED_BY="[Empty name]">Drug comparison study outcomes</TITLE>
<TABLE COLS="6" ROWS="27">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Sample</P>
</TH>
<TH>
<P>Intervention</P>
</TH>
<TH>
<P>Outcomes</P>
</TH>
<TH>
<P>Outcome results</P>
</TH>
<TH>
<P>Treatment completed</P>
</TH>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Chloral Hydrate/Hydroxyzine versus</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Avalos_x002d_Arenas-1998" TYPE="STUDY">Avalos-Arenas 1998</LINK>
</P>
</TD>
<TD>
<P>n = 40<BR/>Mean age (SD) in months and gender<BR/>Group 1 (n = 20)<BR/>27.7 (2.9)<BR/>13 male 7 female<BR/>Group 2 (n = 20)<BR/>29.2 (3.6)<BR/>14 male 6 female</P>
</TD>
<TD>
<P>Group 1<BR/>Chloral hydrate 70 mg/kg<BR/>Group 2<BR/>Chloral hydrate 70 mg/kg + hydroxyzine 2 mg/kg<BR/>All oral</P>
</TD>
<TD>
<P>Houpt. Analysed using Kruskal-Wallis and Mann-Whitney U tests</P>
</TD>
<TD>
<P>No significant difference (P &gt; 0.05) for overall behaviour evaluation (mean values reported at seven different time intervals e.g. at injection mean behaviour group 1 = 4.9 (SD 1.1), group 2 = 5.0 (SD 0.68).</P>
<P>Crying and movement evaluations significantly better (P &lt; 0.05) at 45-60 minutes after application of rubber dam. for group 1.</P>
<P>Sleep mentioned</P>
<P>Adverse effects: Gp1 15-30% children has O2 saturation &lt;90% but in Gp2 range was 10-45%.</P>
<P>Monitoring: precordial stethoscope, pulse oximeter and sphygmomanometer</P>
</TD>
<TD>
<P>All participants completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Meyer-1990" TYPE="STUDY">Meyer 1990</LINK>
</P>
</TD>
<TD>
<P>n = 40<BR/>Mean age (age range) in months<BR/>Group 1 (n = 20)<BR/>44 (21 to 74)<BR/>Group 2 (n = 20)<BR/>42 (23 to 64)</P>
</TD>
<TD>
<P>
<BR/>Group 1<BR/>Chloral hydrate<BR/>40 mg/kg + hydroxyzine 25 mg<BR/>Group 2<BR/>Triazolam 0.02 mg/kg</P>
<P>All oral</P>
</TD>
<TD>
<P>Houpt. Analysed using ANOVA and Chi² test</P>
</TD>
<TD>
<P>No significant differences between groups (mean overall behaviour group 1 and group 2 the same with a value of 4.3 (SE 0.4354).</P>
<P>Sleeping mentioned</P>
<P>Adverse effects: vomiting (1 child in group 1)</P>
<P>Monitoring: pulse oximeter and precordial stethoscope</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Moody-1986" TYPE="STUDY">Moody 1986</LINK>
</P>
</TD>
<TD>
<P>n = 30<BR/>Mean age in months<BR/>Group 1 (n = 10)<BR/>39.6<BR/>Group 2 (n = 10)<BR/>42<BR/>Group 3 (n = 10)<BR/>38.4</P>
</TD>
<TD>
<P>Group 1<BR/>Chloral hydrate 50 mg/kg<BR/>Oral<BR/>Group 2<BR/>Chloral hydrate 50 mg/kg<BR/>Rectal<BR/>Group 3<BR/>Chloral hydrate 30 mg/kg + 25 mg hydroxyzine<BR/>Oral</P>
<P>All received nitrous oxide inhalation 30-50%</P>
</TD>
<TD>
<P>Modified Barker<BR/>Overall quality sedation. Behavioural data not statistically analysed</P>
</TD>
<TD>
<P>Good or excellent sedation achieved in 4/10, 7/10 and 7/10 of children in oral CH, rectal CH and oral CH/H groups respectively</P>
<P/>
<P>Adverse effects: not mentioned </P>
<P>Monitoring: precordial stethoscope and pulse oximeter</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Reeves-1996" TYPE="STUDY">Reeves 1996</LINK>
</P>
</TD>
<TD>
<P>n = 40<BR/>Mean age (age range) in months<BR/>Group 1 (n = 20)<BR/>48 (32 to 73)<BR/>11 male 9 female<BR/>Group 2 (n = 20)<BR/>42 (27 to 70)<BR/>10 male 10 female</P>
</TD>
<TD>
<P>Group 1<BR/>Chloral hydrate 50 mg/kg +<BR/>Hydroxyzine 25 mg<BR/>Group 2<BR/>Midazolam 0.5 mg/kg + Acetaminophen 10 mg/kg<BR/>All oral</P>
</TD>
<TD>
<P>Modified Houpt. Analysed using Wilcoxon matched pairs test and Chi² test</P>
</TD>
<TD>
<P>Subjects in chloral hydrate/hydroxyzine group were in a significantly deeper sleep (P &lt; 0.05). Data presented graphically. Sleeping mentioned </P>
<P>Adverse effects: not reported </P>
<P>Monitoring: pulse oximeter, precordial stethoscope and capnograph</P>
</TD>
<TD>
<P>Dental treatment aborted in one participant from chloral hydrate/hydroxyzine group</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Torres_x002d_Perez-2007" TYPE="STUDY">Torres-Perez 2007</LINK>
</P>
</TD>
<TD>
<P>n = 54</P>
<P>Mean age (age range) in years</P>
<P>Mean weight (range)</P>
<P>Group 1</P>
<P>3.9 (4-6)</P>
<P>11 males, 7 females</P>
<P>18.1 kg (0.9-22)</P>
<P>Group 2</P>
<P>2.83 (1-8)</P>
<P>11 males, 7 females</P>
<P>15 kg (10.4-22.5)</P>
<P>Group 3</P>
<P>2.94 (1-10)</P>
<P>10 males, 8 females</P>
<P>16.33 kg (10.4-20)</P>
</TD>
<TD>
<P>Group 1</P>
<P>Hydroxyzine 2 mg/kg 2 hours before, 1 mg/kg 20 minutes before</P>
<P>Group 2</P>
<P>Midazolam 0.5 mg/kg + hydroxyzine 1.5 mg/kg</P>
<P>Group 3</P>
<P>Chloral hydrate 50 mg/kg + hydroxyzine 1.5 mg/kg</P>
<P>All oral</P>
</TD>
<TD>
<P>Ohio State behavioural rating Scale. Analysed using Wilcoxon matched pairs test and Kruskal Wallis</P>
<P/>
<P/>
<P/>
</TD>
<TD>
<P>'Significantly quieter' (mean Cardiac rate 152, 146 &amp; 137 in H, M/H &amp; CH/H groups respectively (no P value given). Data presented graphically suggesting less movement in CH/H group.</P>
<P>Adverse Effect: in CH/H group 1/18 experienced O2 saturation &lt;90%.</P>
<P>Monitoring: oxygen saturation and cardiac rate</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Chloral hydrate/promethazine versus</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Sams-1993a" TYPE="STUDY">Sams 1993a</LINK>
</P>
</TD>
<TD>
<P>n = 24<BR/>Mean age (SD) in months<BR/>Group 1 (n = 13)<BR/>31.0 (8.6)<BR/>Group 2 (n = 11)<BR/>35.8 (10.6)</P>
</TD>
<TD>
<P>Group 1<BR/>Chloral hydrate 50 mg/kg + promethazine 1 mg/kg<BR/>Group 2<BR/>Meperidine 1 mg/kg + promethazine 1 mg/kg<BR/>All oral<BR/>
</P>
</TD>
<TD>
<P>Modified Houpt. Analysed using Hotelings T test and two sample t-test</P>
</TD>
<TD>
<P>Chloral hydrate/promethazine group significantly 'better' (P &lt; 0.05) for overall evaluation at 4 of the 10 measured time intervals (e.g. mean overall behaviour 15 minutes post injection group 1 = 5.2, SD 1.1, group 2 = 4.4, SD 1.3, P &lt; 0.05).</P>
<P>Adverse effects: not reported: Significantly more sleep in group 1 than group 2</P>
</TD>
<TD>
<P>All participants completed treatment &amp; mean treatment duration was 50.8 (SD 13.3) &amp; 50.9 (SD 17.6) in groups 1 &amp; 2 respectively</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Ketamine versus</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Abrams-1993" TYPE="STUDY">Abrams 1993</LINK>
</P>
</TD>
<TD>
<P>n = 30 (10 per group with Sufentanil divided into two subgroups of 5 each)<BR/>Age range = 17 to 62 months</P>
</TD>
<TD>
<P>Group 1<BR/>Ketamine 3 mg/kg<BR/>Group 2<BR/>Midazolam 0.4 mg/kg<BR/>Group 3<BR/>Sufentanil 1 µg</P>
<P>Group 4</P>
<P>Sufentanil 1.5 µg<BR/>All intranasal</P>
</TD>
<TD>
<P>Sedation scoring criteria. No statistical tests used</P>
</TD>
<TD>
<P>Group 1 to 3 had mean sedation score of 4 (acceptable sedation), group 4 had mean sedation score of 7 (heavy sedation).</P>
<P>Mean recovery times (±SD) were 7 (±7), 3 (± 2), 7 (±13), &amp; 58 (±40) minutes for groups 1-4 respectively.</P>
<P>Sleeping mentioned</P>
<P>Adverse effects: drowsiness (group 1), mild obtundation and deep sedation (group 3), desaturations in 4/5 children on high dose sufentanil.</P>
<P>Monitoring: pulse oximeter, automatic blood pressure and if necessary capnograph</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Rai-2007" TYPE="STUDY">Rai 2007</LINK>
</P>
</TD>
<TD>
<P>n = 30 (10 per group)</P>
<P>Age range 3-6 years</P>
</TD>
<TD>
<P>Group 1</P>
<P>Midazolam 0.1 mg/kg bolus + 0.004 mg/kg/min infusion</P>
<P>Group 2</P>
<P>Propofol 1 mg/kg bolus + 0.06 mg/kg/min infusion</P>
<P>Group 3</P>
<P>Ketamine 0.5 mg/kg bolus + 0.01 mg/kg/min infusion</P>
<P>All intravenous</P>
<P>All children had premed 1 hr before of 0.5 mg/kg midazolam and atropine (0.6 mg)</P>
</TD>
<TD>
<P>Houpt. Analysed Kruskal Wallis</P>
</TD>
<TD>
<P>The maximum level of cooperation was seen with ketamine then propofol and then midazolam (P &lt; 0.001).</P>
<P>At treatment end mean scores were 5.8 ±0.42, 3.5 ±1.08 &amp; 3.2 ±0.42 in ketamine, propofol &amp; midazolam groups respectively.</P>
<P>Propofol showed the fastest postoperative recovery score followed by ketamine and the midazolam. Sleeping was reported.</P>
<P>Adverse effects: pain on injection with propofol and intermittent cough. </P>
<P>Monitoring: vital signs</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Roelofse-1996a" TYPE="STUDY">Roelofse 1996a</LINK>
</P>
</TD>
<TD>
<P>n = 100<BR/>Mean age (SD) in years<BR/>Group 1 (n = 50)<BR/>4.3 (1)<BR/>24 male 26 female<BR/>Group 2 (n = 50)<BR/>4.3 (1.1)<BR/>22 male 28 female</P>
</TD>
<TD>
<P>Group 1<BR/>Ketamine 5 mg/kg + midazolam 0.35 mg/kg<BR/>Group 2<BR/>Midazolam 1 mg/kg<BR/>All rectal</P>
</TD>
<TD>
<P>Ramsay Sedation Score<BR/>Movement<BR/>Crying. Overall sedation and behaviour. Analysed using McNewman's test (sic), Chi² and Fisher's Exact test</P>
</TD>
<TD>
<P>Significant differences in level of sedation with 71% subjects in group 2 'orientated and calm' compared to 14% group 1 30 minutes after administration.</P>
<P>Significantly less movement and crying (P &lt; 0.05) in group 1 (58% no movement at all compared to 14% group 2).</P>
<P>Sleep mentioned</P>
<P>Adverse effects: hallucination (group 1(14%) and 2 (42%)), nausea (group 1)</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P>Dental treatment aborted in 1 participant (ketamine/midazolam group)</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Roelofse-1996b" TYPE="STUDY">Roelofse 1996b</LINK>
</P>
</TD>
<TD>
<P>n = 60<BR/>Mean age (SD) in years<BR/>Group 1 (n = 30)<BR/>4.8 (1.3)<BR/>14 male 16 female<BR/>Group 2 (n = 30)<BR/>4.9 (1.3)<BR/>16 male 14 female</P>
</TD>
<TD>
<P>Group 1<BR/>0.5 ml/kg of trimeprazine 6 mg/ml + physeptone (methadone) 0.4 mg/ml + droperidol (0.1 mg/kg)<BR/>Group 2<BR/>Ketamine 12.5 mg/kg<BR/>All oral</P>
</TD>
<TD>
<P>Anxiety<BR/>Level of sedation<BR/>Movement<BR/>Crying<BR/>Overall behaviour. Analysed using McNemar test, Chi² and Fisher's Exact test</P>
</TD>
<TD>
<P>Sedation was significantly 'better' (very good/excellent 80% &amp; 93% of SOP &amp; ketamine groups respectively).</P>
<P>Overall evaluation good/very good in 67% &amp; 90% of SOP &amp; ketamine groups respectively.</P>
<P>Sleeping mentioned</P>
<P>Adverse effects: hallucination (9 &amp; 5), restless/irritation 4 &amp; 1, in SOP &amp; ketamine groups.</P>
<P>Ketamine also 2 vomiting/nausea, 4 visual disturbances and 4 excess salivation</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P>All participants completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Roelofse-1998" TYPE="STUDY">Roelofse 1998</LINK>
</P>
</TD>
<TD>
<P>n = 100<BR/>Mean age (SD) in years<BR/>Group 1 (n = 50)<BR/>4.1 (1.3)<BR/>27 male 23 female<BR/>Group 2 (n = 50)<BR/>4 (1.2)<BR/>29 male 21 female</P>
</TD>
<TD>
<P>Group 1<BR/>Ketamine 5 mg/kg + midazolam 0.35 mg/kg<BR/>Group 2<BR/>Trimeprazine 3 mg/kg + methadone 0.2 mg/kg<BR/>All oral</P>
</TD>
<TD>
<P>Modified Houpt, Ramsay sedation score. Analysed using McNemar's test, Chi² and Fisher's Exact test</P>
</TD>
<TD>
<P>Significant differences (P &lt; 0.05) in level of sedation immediately before treatment with 46% participants in group 1 "oriented and calm" compared to 84% in group 2.</P>
<P>Overall surgeons rated 94% vs 78% of sedations as good/very good in Gp 1 vs Gp 2</P>
<P>Sedation rated as poor in significantly more children in group 2 (24%) than group 1 (6%).</P>
<P>Sleeping mentioned</P>
<P>Adverse effects: vomiting (n = 2) &amp; hallucination (n = 10) in group 1</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P>All participants completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Alfonzo_x002d_Echeverri-1993" TYPE="STUDY">Alfonzo-Echeverri 1993</LINK>
</P>
</TD>
<TD>
<P>n = 40<BR/>Mean age (SD) in months<BR/>Group 1 (n = 20)<BR/>40.4 (10.2)<BR/>Group 2 (n = 20)<BR/>37.5 (10.6)</P>
</TD>
<TD>
<P>Group 1<BR/>Ketamine 6 mg/kg<BR/>Group 2<BR/>Meperidine 2.0 mg/kg + promethazine 0.5 mg/kg<BR/>All oral</P>
<P/>
<P>All received nitrous oxide 30-50%</P>
</TD>
<TD>
<P>Modified Houpt. Analysed using Chi² test</P>
</TD>
<TD>
<P>"Good sedation" in 65% of ketamine group and 45% of meperidine/promethazine.</P>
<P>Overall no statistically significant difference in distribution of sedation outcomes between groups (P = 0.07) .</P>
<P>Sedation onset time and recovery time both shorter for ketamine (P &lt; 0.001 &amp; P = 0.08 respectively)</P>
<P>Adverse effects: vomiting (groups 1 (n = 8) and 2 (n = 1))</P>
<P>Monitoring: precordial stethoscope and pulse oximeter</P>
</TD>
<TD>
<P>Dental treatment aborted in 4 children receiving meperidine &amp; none in ketamine group</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Bui-2002" TYPE="STUDY">Bui 2002</LINK>
</P>
</TD>
<TD>
<P>n = 22<BR/>Mean age (SD) in months<BR/>Group 1 (n = 11)<BR/>34 (6.28)<BR/>Group 2 (n = 11)<BR/>33 (6.65)<BR/>USA</P>
</TD>
<TD>
<P>Group 1<BR/>Ketamine (10 mg/kg) + promethazine (1.1 mg/kg)<BR/>Group 2<BR/>Ketamine (10 mg/kg)<BR/>All oral</P>
<P/>
<P>All received nitrous oxide 50%</P>
</TD>
<TD>
<P>Houpt. Analysed using Mann-Whitney U test</P>
</TD>
<TD>
<P>Statistically significant difference in mean Houpt score favouring ketamine/promethazine group (mean score 4.27, SD 0.5) than in group 1 (mean score 3.12, SD 0.29) (P &lt; 0.05). Adverse effects: 3 patients from group 2 vomited. Most of the patients reported as being drowsy or asleep after 25 minutes</P>
</TD>
<TD>
<P>Dental treatment aborted in one participant from Group 1 due to violent physical movement and crying</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Midazolam (oral) versus</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Baygin-2010" TYPE="STUDY">Baygin 2010</LINK>
</P>
</TD>
<TD>
<P>n = 60 (n = 15 per group)</P>
<P>Mean age (unclear, possibly SD) in years</P>
<P>Mean weight (unclear, possibly SD) in kg</P>
<P>Group 1</P>
<P>5.33 (0.62)</P>
<P>18.93 (2.31)</P>
<P>10 males 5 females</P>
<P>Group 2</P>
<P>5.27 (0.80)</P>
<P>19.07 (3.62)</P>
<P>11 males 4 females</P>
<P>Group 3</P>
<P>5.20 (0.41)</P>
<P>18.20 (2.34)</P>
<P>9 males 6 females</P>
<P>Group 4</P>
<P>5.53 (0.99)</P>
<P>20.01 (3.99)</P>
<P>6 males 9 females</P>
</TD>
<TD>
<P>Group 1</P>
<P>1 mg/kg hydroxyzine oral</P>
<P>Group 2</P>
<P>0.7 mg/kg midazolam</P>
<P>Group 3</P>
<P>3 mg/kg ketamine + 0.25 mg/kg midazolam</P>
<P>Group 4</P>
<P>No oral premedication</P>
<P/>
<P>40% nitrous oxide oxygen was administered to all participants</P>
</TD>
<TD>
<P>Ramsay sedation score, Bispectral index</P>
</TD>
<TD>
<P>Ramsay sedation scores (RSS) were significantly greater in Gp 2 compared to groups 1, 3 &amp; 4 (P &lt; 0.05)</P>
<P/>
<P>RSS satisfactory/mid-level satisfactory/unsatisfactory<BR/>was as follows:</P>
<P>Gp 1: 13.3/53.3/33.3%</P>
<P>Gp 2: 54/20/26%<BR/>Gp 3: 33.3/33.3/33.3%</P>
<P>Gp 4: 6.7/60/33.3%</P>
<P>P value or significance not reported</P>
<P>Adverse effects:<BR/>nausea/vomiting (n = 1/2/3/4), cough (4/4//), hiccough (/1//5),</P>
<P>enuresis (/2//), bronchospasm (/1//), hypersalivation (//8/),</P>
<P>otalgia (///2), hallucination (//2/), and epistaxis (///1) in patients in<BR/>groups I, II, III, and IV, respectively.</P>
<P>Monitoring: pulse oximeter</P>
</TD>
<TD>
<P>Figure 5 used to extrapolate data with score 3 given to satisfactory, 2 middle level, 1 unsatisfactory</P>
<P/>
<P>All participants completed treatment</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Koirala-2006" TYPE="STUDY">Koirala 2006</LINK>
</P>
</TD>
<TD>
<P>n = 20 per group</P>
<P>Age range 2-9</P>
</TD>
<TD>
<P>Group 1</P>
<P>Midazolam 9.5 mg/kg</P>
<P>Group 2</P>
<P>Ketamine 5 mg/kg</P>
<P>Group 3</P>
<P>Zolpidem 0.4 mg/kg</P>
<P>Group 4</P>
<P>Midazolam 0.4 mg/kg + ketamine 3 mg/kg</P>
<P>Group 5</P>
<P>Midazolam 0.5 mg/kg + tramadol 2 mg/kg</P>
<P>Group 6</P>
<P>Zolpidem 0.4 mg/kg + tramadol 2 mg/kg</P>
<P>All oral</P>
</TD>
<TD>
<P>Onset of action</P>
<P>Level of sedation</P>
<P>Ease of treatment completion</P>
</TD>
<TD>
<P>Group 4 and 5 the "best" and groups 3 and 6 the "worst" when compared on level of sedation (P &lt; 0.001).</P>
<P>Group 4 had the shortest time of onset of sedation</P>
<P>(Data presented graphically)</P>
<P/>
<P>No adverse effects were reported.</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Singh-2002" TYPE="STUDY">Singh 2002</LINK>
</P>
</TD>
<TD>
<P>n = 90 (30 per group)<BR/>Age range 3 to 9 years</P>
</TD>
<TD>
<P>Group 1<BR/>Midazolam 0.5 mg/kg<BR/>Group 2<BR/>Triclofos 70 mg/kg<BR/>Group 3<BR/>Promethazine 1.2 mg/kg<BR/>All oral</P>
</TD>
<TD>
<P>Degree of sedation. Time of onset, time of recovery. Statistical techniques not described</P>
</TD>
<TD>
<P>Transofrmed sedative scores</P>
<P>Gp 1 3.3 ±0.7 (best)</P>
<P>Gp 2 3.07 ±0.6</P>
<P>Gp 3 2.73 ±0.5</P>
<P>Both groups 1 &amp; 2 were statistically significantly better than group 3 (P &lt; 0.05)</P>
<P>Time of onset and time of recovery were both shortest in group 1.</P>
<P>Adverse effects: not mentioned. </P>
<P>Monitoring: blood pressure, heart and respiratory rate</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Midazolam (rectal) versus</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Jensen-1999" TYPE="STUDY">Jensen 1999</LINK>
</P>
</TD>
<TD>
<P>n = 90<BR/>Median age (age range) in months and gender<BR/>Group 1 (n = 45)<BR/>32 (18 to 44)<BR/>23 male 22 female<BR/>Group 2 (n = 45)<BR/>29 (15 to 44)<BR/>23 male 22 female</P>
</TD>
<TD>
<P>Group 1<BR/>Diazepam 0.7 mg/kg<BR/>Group 2<BR/>Midazolam 0.3 mg/kg<BR/>All rectal</P>
</TD>
<TD>
<P>Wilton's sedation scale<BR/>Acceptance of treatment (Holst). Analysed using Wilcoxon matched pair test and Fisher's exact test</P>
</TD>
<TD>
<P>No difference in acceptance of dental procedures (P = 0.07).</P>
<P>At 1 hour significantly more children agitated in the diazepam group 13/45 (29%) vs 1/45 (2%) (P = 0.006).</P>
<P>Data presented graphically. </P>
<P>Adverse effects: lasting effect: aggressiveness, tiredness and unco-ordinated movements in diazepam group, children unusually quiet or lively on next day in group 2</P>
</TD>
<TD>
<P>Some children did not complete treatment however it is not possible to extract exact numbers as this data was only presented as bar chart</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P/>
</TD>
<TD COLSPAN="5">
<P>
<B>Sevoflurane versus</B>
</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Lahoud-2002" TYPE="STUDY">Lahoud 2002</LINK>
</P>
</TD>
<TD>
<P>n = 411<BR/>Mean age (SD) in years<BR/>Group 1 (n = 170)<BR/>6.2 (1.9)<BR/>Group 2<BR/>6 (1.7) (n = 241)</P>
</TD>
<TD>
<P>Group 1 </P>
<P>40:60 nitrous oxide/oxygen</P>
<P>Group 2 </P>
<P>40:60 nitrous oxide/oxygen + 0.1-0.3% sevoflurane</P>
<P>All inhalation</P>
</TD>
<TD>
<P>Venham scale level of sedation and failure rate. Analysed using Mann-Whitney U and Chi² test</P>
</TD>
<TD>
<P>Effective Sedation</P>
<P>Gp 1 215/241 (89%)</P>
<P>Gp 2 89/170 (52%)</P>
<P>(P &lt; 0.0001)</P>
<P>Venham scale - relaxed</P>
<P>group 1 = 32% </P>
<P>group 2 = 67%</P>
<P/>
<P>Significantly less failure in sevoflurane/N2O</P>
<P>Gp 1 48% failed (P &lt; 0.0001)</P>
<P>Gp 2 11% failed</P>
<P>Adverse effects: none mentioned</P>
<P>Monitoring: pulse oximeter, capnograph, pretracheal stethoscope, visual assessment, auscultation and visualization of chest movements</P>
</TD>
<TD>
<P>89% sevoflurane group completed treatment compared to 52% of nitrous oxide group</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Averley-2004a" TYPE="STUDY">Averley 2004a</LINK>
</P>
</TD>
<TD>
<P>n = 65<BR/>Mean age (SD) in months, weight and gender<BR/>Group 1 ( 13 males and 7 females)<BR/>33.6 (11.2) kg<BR/>9.3 (2.2) years<BR/>Group 2 (15 males and 5 females)<BR/>37.6 (14.6) kg<BR/>9.6 (2.3) years<BR/>Group 3 (4 males and 16 females)<BR/>36.1 (11.8) kg<BR/>9.9 (2.2) years</P>
</TD>
<TD>
<P>Group 1<BR/>Midazolam (IV) 0.5 mg/min + air (nasal inhalation)<BR/>Group 2<BR/>Midazolam (IV) 0.5 mg/min + nitrous oxide 40% (nasal inhalation)<BR/>Group 3<BR/>Midazolam (IV) 0.5 mg/min + nitrous oxide 40% (nasal inhalation) + sevoflurane 0.3% (nasal inhalation)</P>
</TD>
<TD>
<P>Primary: completion of treatment<BR/>Secondary: level of co-operation during treatment, recovery time, perception of anxiety and pain and parent's satisfaction. Analysed using Chi² test</P>
</TD>
<TD>
<P>Treatment completion</P>
<P>Group 1 10/20 (50%)</P>
<P>Group 2 16/22 (73%)</P>
<P>Group 3 19/23 (83%)</P>
<P>(Chi² = 5.53, df = 2, P = 0.07)</P>
<P>Of the 16 treatment failures in groups 1 &amp; 2, 9 were subsequently successfully treated with the addition of sevoflurane plus nitrous oxide.</P>
<P/>
<P>No adverse effects reported. </P>
<P>Monitoring: pulse oximeter, blood pressure, ECG</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>
<LINK REF="STD-Averley-2004b" TYPE="STUDY">Averley 2004b</LINK>
</P>
</TD>
<TD>
<P>n = 664<BR/>Mean age, weight and gender<BR/>Group 1 (n = 222, 81 males)<BR/>36.3 (13.4) kg<BR/>9.1 (2.7) years<BR/>Group 2 (n = 306, 127 males)<BR/>37.8 (14.1) Kg<BR/>9.5 (2.7) years<BR/>Group 3 (n = 320, 103 males)<BR/>37.7 (14) kg<BR/>9.6 (2.5) years</P>
</TD>
<TD>
<P>Group 1<BR/>Midazolam (IV) 0.5 mg/min + air (nasal inhalation)<BR/>Group 2<BR/>Midazolam (IV) 0.5 mg/min + nitrous oxide 40% (nasal inhalation)<BR/>Group 3<BR/>Midazolam (IV) 0.5 mg/min + nitrous oxide 40% (nasal inhalation) + sevoflurane 0.3% (nasal inhalation)</P>
</TD>
<TD>
<P>Primary: completion of treatment<BR/>Secondary: level of co-operation during treatment, recovery time, perception of anxiety and pain and parent's satisfaction. Analysed using Chi² test</P>
</TD>
<TD>
<P>Treatment Completion</P>
<P>Gp 1 94/174 (54%)</P>
<P>Gp 2 204/256 (80%)</P>
<P>Gp 3 249/267 (93%)</P>
<P>Chi² = 9.64, df = 2, P &lt; 0.001</P>
<P/>
<P>Adverse effects: 1 faint group 1, 6 vomited Group 3.</P>
<P>Monitoring: pulse oximeter, blood pressure, ECG</P>
</TD>
<TD>
<P/>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-02-10 17:25:15 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-01-23 10:21:18 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Sedatives versus placebo</NAME>
<CONT_OUTCOME CHI2="60.615815679953066" CI_END="1.5338397132894277" CI_START="0.49210939782858243" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="SMD" EFFECT_SIZE="1.012974555559005" ESTIMABLE="YES" I2="91.7513276957294" I2_Q="88.6884414526023" ID="CMP-001.01" MODIFIED="2012-01-23 10:21:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="9.067302464416116E-12" P_Q="0.002946183643172451" P_Z="1.380015355779073E-4" Q="8.840514733754857" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="2.01255422898115" TOTALS="SUB" TOTAL_1="119" TOTAL_2="115" UNITS="" WEIGHT="200.0" Z="3.811722893506869">
<NAME>Mean Houpt/other behavioural score</NAME>
<GROUP_LABEL_1>Sedative</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours placebo</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours sedative</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="42.96336025656837" CI_END="4.371606431095631" CI_START="1.5812712034013898" DF="4" EFFECT_SIZE="2.9764388172485106" ESTIMABLE="YES" I2="90.68974126764569" ID="CMP-001.01.01" MODIFIED="2012-01-23 10:21:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.053071063683575E-8" P_Z="2.8975709983540136E-5" STUDIES="5" TAU2="2.22874826321537" TOTAL_1="92" TOTAL_2="90" WEIGHT="100.0" Z="4.1813706296606465">
<NAME>Midazolam</NAME>
<CONT_DATA CI_END="7.488306749391615" CI_START="4.144186247807264" EFFECT_SIZE="5.8162464985994395" ESTIMABLE="YES" MEAN_1="2.89" MEAN_2="1.1" MODIFIED="2011-09-21 16:04:09 +0100" MODIFIED_BY="[Empty name]" ORDER="102" SD_1="0.3" SD_2="0.3" SE="0.8531076407429796" STUDY_ID="STD-Gallardo-1994" TOTAL_1="16" TOTAL_2="16" WEIGHT="17.13849562621818"/>
<CONT_DATA CI_END="3.1048753743436435" CI_START="1.2486194281778373" EFFECT_SIZE="2.1767474012607404" ESTIMABLE="YES" MEAN_1="2.6" MEAN_2="1.33" MODIFIED="2011-09-13 15:05:30 +0100" MODIFIED_BY="[Empty name]" ORDER="103" SD_1="0.51" SD_2="0.62" SE="0.47354338161510007" STUDY_ID="STD-Isik-2008a" TOTAL_1="15" TOTAL_2="15" WEIGHT="20.656680400019074"/>
<CONT_DATA CI_END="1.8731043941975098" CI_START="0.5163782604850066" EFFECT_SIZE="1.1947413273412582" ESTIMABLE="YES" MEAN_1="1.25" MEAN_2="0.4" MODIFIED="2011-09-21 15:49:33 +0100" MODIFIED_BY="[Empty name]" ORDER="100" SD_1="0.85" SD_2="0.5" SE="0.34610996539073824" STUDY_ID="STD-Kapur-2004" TOTAL_1="20" TOTAL_2="20" WEIGHT="21.575385320676943"/>
<CONT_DATA CI_END="5.908889946304075" CI_START="3.423761528472969" EFFECT_SIZE="4.666325737388522" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="1.6" MODIFIED="2011-09-13 15:05:30 +0100" MODIFIED_BY="[Empty name]" ORDER="104" SD_1="0.72" SD_2="0.75" SE="0.6339729804816523" STUDY_ID="STD-Mortazavi-2009" TOTAL_1="20" TOTAL_2="20" WEIGHT="19.261505012660244"/>
<CONT_DATA CI_END="2.487605387782221" CI_START="1.0073820751327633" EFFECT_SIZE="1.747493731457492" ESTIMABLE="YES" MEAN_1="4.71" MEAN_2="2.32" MODIFIED="2011-09-13 15:05:30 +0100" MODIFIED_BY="[Empty name]" ORDER="105" SD_1="1.19" SD_2="1.49" SE="0.37761492668367125" STUDY_ID="STD-Wan-2006" TOTAL_1="21" TOTAL_2="19" WEIGHT="21.367933640425562"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="1.2564485545307948" CI_START="0.13352711564065278" DF="0" EFFECT_SIZE="0.6949878350857238" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" MODIFIED="2011-09-22 15:18:43 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.015262717789126664" STUDIES="1" TAU2="0.0" TOTAL_1="27" TOTAL_2="25" WEIGHT="99.99999999999999" Z="2.42608446020549">
<NAME>N2O vs placebo</NAME>
<CONT_DATA CI_END="1.2564485545307948" CI_START="0.1335271156406529" EFFECT_SIZE="0.6949878350857239" ESTIMABLE="YES" MEAN_1="3.45" MEAN_2="2.84" MODIFIED="2011-09-22 15:18:43 +0100" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="0.92" SD_2="0.8" SE="0.28646481459547296" STUDY_ID="STD-Veerkamp-1993" TOTAL_1="27" TOTAL_2="25" WEIGHT="99.99999999999999">
<FOOTNOTE>reported mean scores subtracted from 5 to give comparable outcome data</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="64" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-09-22 13:57:37 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="90" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Good or better behaviour</NAME>
<GROUP_LABEL_1>Sedative</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="32" EVENTS_2="8" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2011-09-13 15:43:03 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Chloral hydrate</NAME>
<DICH_DATA CI_END="2.217480187914114" CI_START="0.8017107830172113" EFFECT_SIZE="1.3333333333333333" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="8" LOG_CI_END="0.3458597483152578" LOG_CI_START="-0.09598227509865796" LOG_EFFECT_SIZE="0.12493873660829992" MODIFIED="2011-09-13 15:43:03 +0100" MODIFIED_BY="[Empty name]" ORDER="106" O_E="0.0" SE="0.25954019170662396" STUDY_ID="STD-Moore-1984" TOTAL_1="45" TOTAL_2="15" VAR="0.06736111111111111" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="32" EVENTS_2="2" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2011-09-13 15:42:35 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Meperidine</NAME>
<DICH_DATA CI_END="19.63970041455623" CI_START="1.4483135610033266" EFFECT_SIZE="5.333333333333333" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="2" LOG_CI_END="1.293134858741286" LOG_CI_START="0.1608625971312386" LOG_EFFECT_SIZE="0.7269987279362623" MODIFIED="2011-09-13 15:42:35 +0100" MODIFIED_BY="[Empty name]" ORDER="107" O_E="0.0" SE="0.6651023313078305" STUDY_ID="STD-McKee-1990" TOTAL_1="45" TOTAL_2="15" VAR="0.4423611111111111" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-02-10 17:21:02 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Chloral hydrate (CH)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2012-02-10 17:20:42 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="73" TOTAL_2="71" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Overall behaviour (ordinal scale, Houpt or similar)</NAME>
<GROUP_LABEL_1>Group 1</GROUP_LABEL_1>
<GROUP_LABEL_2>Group 2</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group 2</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Group 1</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.01" MODIFIED="2012-02-10 17:19:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>CH vs CH/hydroxyzine</NAME>
<CONT_DATA CI_END="0.5131045564462184" CI_START="-0.7274724212231847" EFFECT_SIZE="-0.10718393238848306" ESTIMABLE="YES" MEAN_1="4.9" MEAN_2="5.0" MODIFIED="2010-11-09 15:05:47 +0000" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="1.1" SD_2="0.68" SE="0.31647953417892266" STUDY_ID="STD-Avalos_x002d_Arenas-1998" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.02" MODIFIED="2012-02-10 17:20:08 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>CH/hydroxyzine vs triazolam</NAME>
<CONT_DATA CI_END="0.6197950323045617" CI_START="-0.6197950323045617" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.3" MEAN_2="4.3" MODIFIED="2011-09-22 16:37:34 +0100" MODIFIED_BY="[Empty name]" ORDER="15" SD_1="1.9" SD_2="1.9" SE="0.31622776601683794" STUDY_ID="STD-Meyer-1990" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0">
<FOOTNOTE>All participants also received N2O</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.03" MODIFIED="2012-02-10 17:20:29 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>CH/hydroxyzine vs midazolam/acetaminophen</NAME>
<CONT_DATA CI_END="0.5370323118536929" CI_START="-0.7031504909102263" EFFECT_SIZE="-0.0830590895282667" ESTIMABLE="YES" MEAN_1="3.6" MEAN_2="3.7" MODIFIED="2011-01-06 12:24:50 +0000" MODIFIED_BY="[Empty name]" ORDER="16" SD_1="1.19" SD_2="1.17" SE="0.3163789775083427" STUDY_ID="STD-Reeves-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.01.04" MODIFIED="2012-02-10 17:20:42 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="13" TOTAL_2="11" WEIGHT="0.0" Z="0.0">
<NAME>CH/promethazine vs meperidine/promethazine</NAME>
<CONT_DATA CI_END="1.161358429380638" CI_START="-0.45916407201386644" EFFECT_SIZE="0.35109717868338586" ESTIMABLE="YES" MEAN_1="4.5" MEAN_2="4.1" MODIFIED="2011-09-26 11:15:53 +0100" MODIFIED_BY="[Empty name]" ORDER="19" SD_1="0.9" SD_2="1.3" SE="0.4134061937303387" STUDY_ID="STD-Sams-1993a" TOTAL_1="13" TOTAL_2="11" WEIGHT="0.0">
<FOOTNOTE>All participants also received N2O</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3513610368600701" CI_START="0.2416309212256127" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.13077139296648238" LOG_CI_START="-0.6168474903390714" LOG_EFFECT_SIZE="-0.24303804868629447" METHOD="MH" MODIFIED="2012-02-10 17:21:02 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.2025567148029801" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="1.27430120596177">
<NAME>Good or better behaviour</NAME>
<GROUP_LABEL_1>Chloral hydrate</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group 2</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Group 1</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.3513610368600701" CI_START="0.2416309212256127" DF="0" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.13077139296648238" LOG_CI_START="-0.6168474903390714" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2012-02-10 17:21:02 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2025567148029801" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="100.0" Z="1.27430120596177">
<NAME>Chloral hydrate vs chloral hydrate/hydroxyzine</NAME>
<DICH_DATA CI_END="1.35136103686007" CI_START="0.24163092122561275" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.1307713929664823" LOG_CI_START="-0.6168474903390713" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2011-09-22 11:25:59 +0100" MODIFIED_BY="[Empty name]" ORDER="78" O_E="0.0" SE="0.4391550328268399" STUDY_ID="STD-Moody-1986" TOTAL_1="10" TOTAL_2="10" VAR="0.1928571428571428" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-02-10 17:23:05 +0000" MODIFIED_BY="Paul Francis Ashley" NO="3">
<NAME>Ketamine</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2012-02-10 17:22:29 +0000" MODIFIED_BY="Paul Francis Ashley" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="12.762713697726328" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="111" TOTAL_2="111" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Overall behaviour (ordinal scale, Houpt or similar)</NAME>
<GROUP_LABEL_1>
Group 1
</GROUP_LABEL_1>
<GROUP_LABEL_2>
Group 2
</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group 
2
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Group 
1
</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.01" MODIFIED="2012-02-10 17:21:44 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine vs midazolam</NAME>
<CONT_DATA CI_END="0.8765225405765816" CI_START="-0.8765225405765816" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" MODIFIED="2011-01-19 12:12:39 +0000" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="1.0" SD_2="1.0" SE="0.4472135954999579" STUDY_ID="STD-Abrams-1993" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
<CONT_DATA CI_END="8.158785981286986" CI_START="3.6990275666674077" EFFECT_SIZE="5.928906773977197" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="3.2" MODIFIED="2011-01-19 12:14:40 +0000" MODIFIED_BY="[Empty name]" ORDER="43" SD_1="0.42" SD_2="0.42" SE="1.1377143788859343" STUDY_ID="STD-Rai-2007" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.02" MODIFIED="2012-02-10 17:21:49 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine vs propofol</NAME>
<CONT_DATA CI_END="3.966115647975453" CI_START="1.410608148115459" EFFECT_SIZE="2.688361898045456" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="3.5" MODIFIED="2011-01-19 12:59:32 +0000" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="0.42" SD_2="1.08" SE="0.6519271578502236" STUDY_ID="STD-Rai-2007" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.03" MODIFIED="2012-02-10 17:22:06 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine/midazolam vs trimeprazine/methadone</NAME>
<CONT_DATA CI_END="-0.9107839728326759" CI_START="-1.7823683141124669" EFFECT_SIZE="-1.3465761434725714" ESTIMABLE="YES" MEAN_1="2.37" MEAN_2="3.39" MODIFIED="2011-01-19 12:19:40 +0000" MODIFIED_BY="[Empty name]" ORDER="48" SD_1="0.8" SD_2="0.7" SE="0.22234702988287972" STUDY_ID="STD-Roelofse-1998" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.04" MODIFIED="2012-02-10 17:22:22 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine vs meperidine/promethazine</NAME>
<CONT_DATA CI_END="1.0356537192449808" CI_START="-0.2182106215339768" EFFECT_SIZE="0.408721548855502" ESTIMABLE="YES" MEAN_1="3.35" MEAN_2="2.9" MODIFIED="2011-01-19 12:26:54 +0000" MODIFIED_BY="[Empty name]" ORDER="49" SD_1="0.93" SD_2="1.21" SE="0.31986922991169214" STUDY_ID="STD-Alfonzo_x002d_Echeverri-1993" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-003.01.05" MODIFIED="2012-02-10 17:22:29 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine vs ketamine/promethazine</NAME>
<CONT_DATA CI_END="3.922431831562318" CI_START="1.49122966678613" EFFECT_SIZE="2.706830749174224" ESTIMABLE="YES" MEAN_1="4.27" MEAN_2="3.12" MODIFIED="2011-09-26 09:56:30 +0100" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="0.5" SD_2="0.29" SE="0.6202160304865805" STUDY_ID="STD-Bui-2002" TOTAL_1="11" TOTAL_2="11" WEIGHT="0.0">
<FOOTNOTE>All participants received 50% N2O</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="51" EVENTS_2="66" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-02-10 17:23:05 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="80" TOTAL_2="80" WEIGHT="0.0" Z="0.0">
<NAME>Good or better behaviour</NAME>
<GROUP_LABEL_1>Group 1</GROUP_LABEL_1>
<GROUP_LABEL_2>Group 2</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group2</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Group1</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="28" EVENTS_2="24" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-02-10 17:22:47 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine vs trimeprazine/methadone/droperidol</NAME>
<DICH_DATA CI_END="1.4290733486968317" CI_START="0.952443142510708" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="24" LOG_CI_END="0.15505451998535844" LOG_CI_START="-0.021160940724132007" LOG_EFFECT_SIZE="0.06694678963061322" MODIFIED="2011-09-22 17:14:02 +0100" MODIFIED_BY="[Empty name]" ORDER="62" O_E="0.0" SE="0.10350983390135315" STUDY_ID="STD-Roelofse-1996b" TOTAL_1="30" TOTAL_2="30" VAR="0.010714285714285718" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="23" EVENTS_2="42" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-02-10 17:23:05 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine/midazolam vs trimeprazine/methadone</NAME>
<DICH_DATA CI_END="0.7569874051309795" CI_START="0.39615800643777455" EFFECT_SIZE="0.5476190476190477" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="42" LOG_CI_END="-0.12091134629599065" LOG_CI_START="-0.4021315624646244" LOG_EFFECT_SIZE="-0.26152145438030755" MODIFIED="2011-09-22 17:22:48 +0100" MODIFIED_BY="[Empty name]" ORDER="63" O_E="0.0" SE="0.1651901470399764" STUDY_ID="STD-Roelofse-1998" TOTAL_1="50" TOTAL_2="50" VAR="0.02728778467908902" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2012-02-10 17:24:55 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Midazolam (versus other)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2012-02-10 17:24:42 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="8.0" SORT_BY="STUDY" STUDIES="11" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="313" TOTAL_2="312" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Overall behaviour (ordinal scale, Houpt or similar)</NAME>
<GROUP_LABEL_1>Group 1</GROUP_LABEL_1>
<GROUP_LABEL_2>Group 2</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group 2</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Group 1</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.01" MODIFIED="2011-09-21 16:23:47 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="26" TOTAL_2="26" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam (low dose) vs midazolam (high dose)</NAME>
<CONT_DATA CI_END="-0.5311357684744924" CI_START="-2.321249855359236" EFFECT_SIZE="-1.426192811916864" ESTIMABLE="YES" MEAN_1="3.4" MEAN_2="4.9" MODIFIED="2011-09-20 10:18:03 +0100" MODIFIED_BY="[Empty name]" ORDER="15" SD_1="1.31" SD_2="0.64" SE="0.4566701482794926" STUDY_ID="STD-Al_x002d_Rakaf-2001" TOTAL_1="12" TOTAL_2="13" WEIGHT="0.0">
<FOOTNOTE>IN 0.3mg/kg vs 0.5 mg/kg (fasting) Houpt</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-1.7530777297863671" CI_START="-3.9965180159743245" EFFECT_SIZE="-2.874797872880346" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="2.7" MODIFIED="2011-09-21 16:23:47 +0100" MODIFIED_BY="[Empty name]" ORDER="37" SD_1="0.4" SD_2="0.6" SE="0.5723167119099963" STUDY_ID="STD-Isik-2008b" TOTAL_1="14" TOTAL_2="13" WEIGHT="0.0">
<FOOTNOTE>0.2 mg/kg oral vs 1 mg/kg oral, plus N2O, Ramsay @ 20 minutes</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.02" MODIFIED="2012-02-10 17:23:37 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="32" TOTAL_2="31" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam (IM) vs midazolam (IN)</NAME>
<CONT_DATA CI_END="1.8720035480455774" CI_START="0.11801951893769758" EFFECT_SIZE="0.9950115334916375" ESTIMABLE="YES" MEAN_1="5.08" MEAN_2="3.9" MODIFIED="2011-09-20 10:28:21 +0100" MODIFIED_BY="[Empty name]" ORDER="16" SD_1="0.67" SD_2="1.5" SE="0.44745312744088206" STUDY_ID="STD-Lam-2005" TOTAL_1="12" TOTAL_2="11" WEIGHT="0.0">
<FOOTNOTE>All received N2O inhalation</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="0.7082538070893624" CI_START="-0.5320034871777536" EFFECT_SIZE="0.0881251599558044" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.15" MODIFIED="2011-09-20 11:14:52 +0100" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="0.52" SD_2="0.59" SE="0.31639798079202147" STUDY_ID="STD-Shashikiran-2006" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0">
<FOOTNOTE>N2O not given</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.03" MODIFIED="2012-02-10 17:23:46 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs ketamine</NAME>
<CONT_DATA CI_END="0.8765225405765816" CI_START="-0.8765225405765816" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.0" MODIFIED="2011-01-18 20:03:50 +0000" MODIFIED_BY="[Empty name]" ORDER="41" SD_1="1.0" SD_2="1.0" SE="0.4472135954999579" STUDY_ID="STD-Abrams-1993" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
<CONT_DATA CI_END="-3.6990275666674077" CI_START="-8.158785981286986" EFFECT_SIZE="-5.928906773977197" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="5.8" MODIFIED="2011-01-18 20:06:31 +0000" MODIFIED_BY="[Empty name]" ORDER="42" SD_1="0.42" SD_2="0.42" SE="1.1377143788859343" STUDY_ID="STD-Rai-2007" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.04" MODIFIED="2011-09-26 10:51:43 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs N2O</NAME>
<CONT_DATA CI_END="1.5224691026492523" CI_START="0.030325888013166602" EFFECT_SIZE="0.7763974953312095" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="1.73" MODIFIED="2011-09-21 12:00:28 +0100" MODIFIED_BY="[Empty name]" ORDER="71" SD_1="0.82" SD_2="0.59" SE="0.3806557738830716" STUDY_ID="STD-Baygin-2010" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0">
<FOOTNOTE>Participants also given 40% N2O</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.05" MODIFIED="2012-02-10 17:23:51 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs hydroxyzine</NAME>
<CONT_DATA CI_END="1.3826845750377805" CI_START="-0.09100107787272593" EFFECT_SIZE="0.6458417485825273" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="1.8" MODIFIED="2011-09-21 16:24:26 +0100" MODIFIED_BY="[Empty name]" ORDER="70" SD_1="0.82" SD_2="0.68" SE="0.3759471256958676" STUDY_ID="STD-Baygin-2010" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0">
<FOOTNOTE>Participants also given 40% N2O</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.06" MODIFIED="2012-02-10 17:24:00 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="65" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs midazolam/ketamine</NAME>
<CONT_DATA CI_END="1.0714553478137767" CI_START="-0.3724258738460948" EFFECT_SIZE="0.34951473698384095" ESTIMABLE="YES" MEAN_1="2.3" MEAN_2="2.0" MODIFIED="2011-09-21 12:00:35 +0100" MODIFIED_BY="[Empty name]" ORDER="69" SD_1="0.82" SD_2="0.85" SE="0.36834381474583777" STUDY_ID="STD-Baygin-2010" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0">
<FOOTNOTE>Participants also given 40% N2O</FOOTNOTE>
</CONT_DATA>
<CONT_DATA CI_END="-0.1644782037018987" CI_START="-0.9645541036117401" EFFECT_SIZE="-0.5645161536568194" ESTIMABLE="YES" MEAN_1="3.24" MEAN_2="3.57" MODIFIED="2011-10-12 16:29:23 +0100" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="0.59" SD_2="0.57" SE="0.2041047453475518" STUDY_ID="STD-Roelofse-1996a" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.07" MODIFIED="2012-02-10 17:24:06 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs promethazine</NAME>
<CONT_DATA CI_END="1.45913906917725" CI_START="0.3906697957754972" EFFECT_SIZE="0.9249044324763736" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="2.73" MODIFIED="2011-09-21 14:19:11 +0100" MODIFIED_BY="[Empty name]" ORDER="76" SD_1="0.7" SD_2="0.5" SE="0.2725737008000407" STUDY_ID="STD-Singh-2002" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.08" MODIFIED="2012-02-10 17:24:13 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs triclofos</NAME>
<CONT_DATA CI_END="0.8583708473513729" CI_START="-0.16192679514087766" EFFECT_SIZE="0.3482220261052476" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="3.07" MODIFIED="2011-09-21 14:18:50 +0100" MODIFIED_BY="[Empty name]" ORDER="75" SD_1="0.7" SD_2="0.6" SE="0.2602847936340229" STUDY_ID="STD-Singh-2002" TOTAL_1="30" TOTAL_2="30" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.09" MODIFIED="2012-02-10 17:24:19 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs propofol</NAME>
<CONT_DATA CI_END="0.5342154868503994" CI_START="-1.235527286340518" EFFECT_SIZE="-0.3506558997450593" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.5" MODIFIED="2011-01-19 12:50:28 +0000" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="0.42" SD_2="1.08" SE="0.45147328908858086" STUDY_ID="STD-Rai-2007" TOTAL_1="10" TOTAL_2="10" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.10" MODIFIED="2012-02-10 17:24:27 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam/acetaminophen vs CH/hydroxyzine</NAME>
<CONT_DATA CI_END="0.7031504909102263" CI_START="-0.5370323118536929" EFFECT_SIZE="0.0830590895282667" ESTIMABLE="YES" MEAN_1="3.7" MEAN_2="3.6" MODIFIED="2011-01-18 19:57:30 +0000" MODIFIED_BY="[Empty name]" ORDER="39" SD_1="1.17" SD_2="1.19" SE="0.3163789775083427" STUDY_ID="STD-Reeves-1996" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-004.01.11" MODIFIED="2012-02-10 17:24:42 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam/ketamine vs trimeprazine/methadone</NAME>
<CONT_DATA CI_END="1.7823683141124669" CI_START="0.9107839728326759" EFFECT_SIZE="1.3465761434725714" ESTIMABLE="YES" MEAN_1="3.39" MEAN_2="2.37" MODIFIED="2011-01-18 21:13:00 +0000" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="0.7" SD_2="0.8" SE="0.22234702988287972" STUDY_ID="STD-Roelofse-1998" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="43" EVENTS_2="28" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2012-02-10 17:24:55 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Good or better sedation</NAME>
<GROUP_LABEL_1>Group 1</GROUP_LABEL_1>
<GROUP_LABEL_2>Group 2</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="43" EVENTS_2="28" I2="0.0" ID="CMP-004.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2012-02-10 17:24:55 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="45" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Midazolam vs diazepam</NAME>
<DICH_DATA CI_END="60.92176529090118" CI_START="2.796959776644315" EFFECT_SIZE="13.053571428571429" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="28" LOG_CI_END="1.7847724791188602" LOG_CI_START="0.44668622078445996" LOG_EFFECT_SIZE="1.11572934995166" MODIFIED="2011-09-22 12:36:06 +0100" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.78599849177943" STUDY_ID="STD-Jensen-1999" TOTAL_1="45" TOTAL_2="45" VAR="0.6177936290795388" WEIGHT="0.0">
<FOOTNOTE>Data read from graph</FOOTNOTE>
</DICH_DATA>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2012-02-10 17:25:15 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Nitrous oxide (N2O)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="SMD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.01" MODIFIED="2012-02-10 17:25:15 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="2.07" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="43" TOTAL_2="43" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Overall behaviour (ordinal scale, Houpt or similar)</NAME>
<GROUP_LABEL_1>
Group 1
</GROUP_LABEL_1>
<GROUP_LABEL_2>
Group 2
</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Group 
2
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Group
 
1
</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.01" MODIFIED="2011-09-19 16:47:46 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="28" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>N2O vs placebo</NAME>
<CONT_DATA CI_END="-0.3049019359709516" CI_START="-1.4026903386354777" EFFECT_SIZE="-0.8537961373032147" ESTIMABLE="YES" MEAN_1="2.42" MEAN_2="3.47" MODIFIED="2011-09-19 10:14:20 +0100" MODIFIED_BY="[Empty name]" ORDER="40" SD_1="1.29" SD_2="1.13" SE="0.2800532079476309" STUDY_ID="STD-Veerkamp-1993" TOTAL_1="28" TOTAL_2="28" WEIGHT="0.0">
<FOOTNOTE>reported mean scores subtracted from 5 to give comparable outcome data</FOOTNOTE>
</CONT_DATA>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-005.01.02" MODIFIED="2012-02-10 17:25:15 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>N2O vs midazolam</NAME>
<CONT_DATA CI_END="-0.030325888013166602" CI_START="-1.5224691026492523" EFFECT_SIZE="-0.7763974953312095" ESTIMABLE="YES" MEAN_1="1.73" MEAN_2="2.3" MODIFIED="2011-01-19 12:11:51 +0000" MODIFIED_BY="[Empty name]" ORDER="41" SD_1="0.59" SD_2="0.82" SE="0.3806557738830716" STUDY_ID="STD-Baygin-2010" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-02-10 12:21:36 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-02-10 12:21:36 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAYYAAAVRCAIAAAALlrk2AABlxklEQVR42u29vW7jSPa4TcCJAwUO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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-01-20 10:23:14 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-02-15 14:32:10 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-28 11:29:29 +0100" MODIFIED_BY="[Empty name]">MEDLINE (OVID) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-02-15 14:32:10 +0000" MODIFIED_BY="[Empty name]">
<P>1. exp Oral Surgical Procedures/<BR/>2. exp tooth/<BR/>3. (((((dental$ or dentist$ or oral) adj4 surgery) or oral) adj4 surgical$) or orthodont$ or endodont$ or pulpot$ or carie$ or carious).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>4. ((dental or tooth or teeth) or (filling$ or restor$ or extract$ or treat$)).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>5. or/1-4<BR/>6. Conscious sedation/<BR/>7. Preanesthetic medication/<BR/>8. (preanesthetic medication or preanaesthetic medication).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>9. sedat$.mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>10. exp "Hypnotics and Sedatives"/<BR/>11. exp Anti-Anxiety Agents/<BR/>12. exp Barbiturates/<BR/>13. exp Benzodiazepines/<BR/>14. relative analgesia.mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>15. Anxiety/<BR/>16. Dental anxiety/<BR/>17. ((anxiety or anxious or fear$ or fright$ or stress$ or distress$ or phobi$ or uncooperative or un-cooperative or unco-operative) and (dental$ or dentist$)).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>18. (nitrous oxide or midazolam or diazepam or chloral hydrate or hydroxyzine or temazepam or ketamine or meperidine or promethazine or triazolam or trimeprazine or metaclopramide or flunitrazepam or sevoflurane).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>19. or/6-18<BR/>20. exp Child/<BR/>21. Infant/<BR/>22. Adolescent/<BR/>23. (pediatric or paediatric).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>24. (child$ or infant$ or adolescen$).mp. [mp=title, original title, abstract, name of substance word, subject heading word]<BR/>25. or/20-24<BR/>26. 5 and 19 and 25</P>
<P>
<I>Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomized trials in MEDLINE: sensitivity maximising version (2009 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of The Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009].</I>
</P>
<P> </P>
<P>1. randomized controlled trial.pt.</P>
<P>2. controlled clinical trial.pt.</P>
<P>3. randomized.ab.</P>
<P>4. placebo.ab.</P>
<P>5. drug therapy.fs.</P>
<P>6. randomly.ab.</P>
<P>7. trial.ab.</P>
<P>8. groups.ab.</P>
<P>9. or/1-8</P>
<P>10. exp animals/ not humans.sh.</P>
<P>11. 9 not 10</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2011-09-12 13:51:14 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2011-09-12 13:51:14 +0100" MODIFIED_BY="[Empty name]">EMBASE</TITLE>
<APPENDIX_BODY MODIFIED="2010-02-15 14:28:28 +0000" MODIFIED_BY="[Empty name]">
<P>1.     exp Oral Surgical Procedures/</P>
<P>2.     exp Tooth/</P>
<P>3.     (((((dental$ or dentist$ or oral) adj4 surgery) or oral) adj4 surgical$) or orthodont$ or endodont$ or pulpot$ or carie$ or carious).mp.</P>
<P>4.     ((dental or tooth or teeth) and (filling$ or restor$ or extract$ or treat$)).mp.</P>
<P>5.     or/1-4</P>
<P>6.     Conscious sedation/</P>
<P>7.     Preanesthetic medication/</P>
<P>8.     ("preanesthetic medication" or "preanaesthetic medication").mp.</P>
<P>9.     sedat$.mp.</P>
<P>10.  exp "Hypnotics and Sedatives"/</P>
<P>11.  exp Anti-Anxiety Agents/</P>
<P>12.  exp Barbiturates/</P>
<P>13.  exp Benzodiazepines/</P>
<P>14.  "relative analgesia".mp.</P>
<P>15.  Anxiety/</P>
<P>16.  Dental anxiety/</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2010-02-15 14:30:06 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2010-02-15 14:29:10 +0000" MODIFIED_BY="[Empty name]">OHG trials register search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-02-15 14:30:06 +0000" MODIFIED_BY="[Empty name]">
<P>((sedation or sedative* or "pre anesthetic medication" or "pre anaesthetic medication" or hypnotic* or "anti anxiety agent*" or barbiturate* or benzodiazepine* or "relative analgesia" or "nitrous oxide" or "nitrous-oxide" or midazolam or diazepam or "chloral hydrate" or hydroxyzine or temazepam or ketamine or meperidine or promethazine or triazolam or trimeprazine or metaclopramide or flunitrazepam or sevoflurane) OR (anxiety or anxious or fear* or fright* or distress* or phobi* or uncopoperative or un-cooperative or un-cooperative) AND (child* or infant* or adolescen* OR pediatric* or paediatric*))</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2010-02-15 14:30:18 +0000" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2010-02-15 14:29:32 +0000" MODIFIED_BY="[Empty name]">CENTRAL search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2010-02-15 14:30:18 +0000" MODIFIED_BY="[Empty name]">
<P>#1            MeSH descriptor Oral Surgical Procedures explode all trees</P>
<P>#2            MeSH descriptor Tooth explode all trees</P>
<P>#3            (dental* or dentist* or oral) and (surgery or surgical or orthodont* or</P>
<P>endodont* or pulpot* or carie* or carious)</P>
<P>#4            ((dental or tooth or teeth) and (filling* or restor* or extract* or treat*))</P>
<P>#5            (#1 OR #2 OR #3 OR #4)</P>
<P>#6            MeSH descriptor Conscious Sedation, this term only</P>
<P>#7            MeSH descriptor Preanesthetic Medication, this term only</P>
<P>#8            ("preanesthetic medication" or "preanaesthetic medication")</P>
<P>#9            sedat*</P>
<P>#10            MeSH descriptor Hypnotics and Sedatives explode all trees</P>
<P>#11            MeSH descriptor Anti-Anxiety Agents explode all trees</P>
<P>#12            MeSH descriptor Barbiturates explode all trees</P>
<P>#13            MeSH descriptor Benzodiazepines explode all trees</P>
<P>#14            "relative analgesia"</P>
<P>#15            MeSH descriptor Anxiety, this term only</P>
<P>#16            MeSH descriptor Dental Anxiety, this term only</P>
<P>#17            ((anxiety or anxious or fear* or fright* or stress* or distress* or phobi* or</P>
<P>uncooperative or un-cooperative or unco-operative) and (dental* or</P>
<P>dentist*))</P>
<P>#18            ("nitrous oxide" or midazolam or diazepam or "chloral hydrate" or</P>
<P>hydroxyzine or temazepam or ketamine or meperidine or promethazine</P>
<P>or triazolam or trimeprazine or metaclopramide or flunitrazepam or</P>
<P>sevoflurane)</P>
<P>#19            (#6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR</P>
<P>#15 OR #16 OR #17 OR #18)</P>
<P>#20            MeSH descriptor Child explode all trees</P>
<P>#21            MeSH descriptor Infant, this term only</P>
<P>#22            MeSH descriptor Adolescent, this term only</P>
<P>#23            pediatric* or paediatric*</P>
<P>#24            child* or infant* or adolescent*</P>
<P>#25            (#20 OR #21 OR #22 OR #23 OR #24)</P>
<P>#26            (#5 AND #19 AND #25)</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2011-09-12 13:51:32 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2011-09-12 13:51:32 +0100" MODIFIED_BY="[Empty name]">Other Databases</TITLE>
<APPENDIX_BODY MODIFIED="2008-11-19 17:43:54 +0000" MODIFIED_BY="[Empty name]">
<P>Free text search for dent* and sed*</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>